<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE patent-application-publication SYSTEM "pap-v16-2002-01-01.dtd" [
<!ENTITY US20030004235A1-20030102-C00001.CDX SYSTEM "US20030004235A1-20030102-C00001.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00001.MOL SYSTEM "US20030004235A1-20030102-C00001.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00001.TIF SYSTEM "US20030004235A1-20030102-C00001.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00002.CDX SYSTEM "US20030004235A1-20030102-C00002.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00002.MOL SYSTEM "US20030004235A1-20030102-C00002.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00002.TIF SYSTEM "US20030004235A1-20030102-C00002.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00003.CDX SYSTEM "US20030004235A1-20030102-C00003.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00003.MOL SYSTEM "US20030004235A1-20030102-C00003.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00003.TIF SYSTEM "US20030004235A1-20030102-C00003.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00004.CDX SYSTEM "US20030004235A1-20030102-C00004.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00004.MOL SYSTEM "US20030004235A1-20030102-C00004.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00004.TIF SYSTEM "US20030004235A1-20030102-C00004.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00005.CDX SYSTEM "US20030004235A1-20030102-C00005.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00005.MOL SYSTEM "US20030004235A1-20030102-C00005.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00005.TIF SYSTEM "US20030004235A1-20030102-C00005.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00006.CDX SYSTEM "US20030004235A1-20030102-C00006.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00006.MOL SYSTEM "US20030004235A1-20030102-C00006.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00006.TIF SYSTEM "US20030004235A1-20030102-C00006.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00007.CDX SYSTEM "US20030004235A1-20030102-C00007.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00007.MOL SYSTEM "US20030004235A1-20030102-C00007.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00007.TIF SYSTEM "US20030004235A1-20030102-C00007.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00008.CDX SYSTEM "US20030004235A1-20030102-C00008.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00008.MOL SYSTEM "US20030004235A1-20030102-C00008.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00008.TIF SYSTEM "US20030004235A1-20030102-C00008.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00009.CDX SYSTEM "US20030004235A1-20030102-C00009.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00009.MOL SYSTEM "US20030004235A1-20030102-C00009.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00009.TIF SYSTEM "US20030004235A1-20030102-C00009.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00010.CDX SYSTEM "US20030004235A1-20030102-C00010.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00010.MOL SYSTEM "US20030004235A1-20030102-C00010.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00010.TIF SYSTEM "US20030004235A1-20030102-C00010.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00011.CDX SYSTEM "US20030004235A1-20030102-C00011.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00011.MOL SYSTEM "US20030004235A1-20030102-C00011.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00011.TIF SYSTEM "US20030004235A1-20030102-C00011.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00012.CDX SYSTEM "US20030004235A1-20030102-C00012.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00012.MOL SYSTEM "US20030004235A1-20030102-C00012.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00012.TIF SYSTEM "US20030004235A1-20030102-C00012.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00013.CDX SYSTEM "US20030004235A1-20030102-C00013.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00013.MOL SYSTEM "US20030004235A1-20030102-C00013.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00013.TIF SYSTEM "US20030004235A1-20030102-C00013.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00014.CDX SYSTEM "US20030004235A1-20030102-C00014.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00014.MOL SYSTEM "US20030004235A1-20030102-C00014.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00014.TIF SYSTEM "US20030004235A1-20030102-C00014.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00015.CDX SYSTEM "US20030004235A1-20030102-C00015.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00015.MOL SYSTEM "US20030004235A1-20030102-C00015.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00015.TIF SYSTEM "US20030004235A1-20030102-C00015.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00016.CDX SYSTEM "US20030004235A1-20030102-C00016.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00016.MOL SYSTEM "US20030004235A1-20030102-C00016.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00016.TIF SYSTEM "US20030004235A1-20030102-C00016.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00017.CDX SYSTEM "US20030004235A1-20030102-C00017.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00017.MOL SYSTEM "US20030004235A1-20030102-C00017.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00017.TIF SYSTEM "US20030004235A1-20030102-C00017.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00018.CDX SYSTEM "US20030004235A1-20030102-C00018.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00018.MOL SYSTEM "US20030004235A1-20030102-C00018.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00018.TIF SYSTEM "US20030004235A1-20030102-C00018.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00019.CDX SYSTEM "US20030004235A1-20030102-C00019.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00019.MOL SYSTEM "US20030004235A1-20030102-C00019.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00019.TIF SYSTEM "US20030004235A1-20030102-C00019.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00020.CDX SYSTEM "US20030004235A1-20030102-C00020.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00020.MOL SYSTEM "US20030004235A1-20030102-C00020.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00020.TIF SYSTEM "US20030004235A1-20030102-C00020.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00021.CDX SYSTEM "US20030004235A1-20030102-C00021.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00021.MOL SYSTEM "US20030004235A1-20030102-C00021.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00021.TIF SYSTEM "US20030004235A1-20030102-C00021.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00022.CDX SYSTEM "US20030004235A1-20030102-C00022.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00022.MOL SYSTEM "US20030004235A1-20030102-C00022.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00022.TIF SYSTEM "US20030004235A1-20030102-C00022.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00023.CDX SYSTEM "US20030004235A1-20030102-C00023.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00023.MOL SYSTEM "US20030004235A1-20030102-C00023.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00023.TIF SYSTEM "US20030004235A1-20030102-C00023.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00024.CDX SYSTEM "US20030004235A1-20030102-C00024.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00024.MOL SYSTEM "US20030004235A1-20030102-C00024.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00024.TIF SYSTEM "US20030004235A1-20030102-C00024.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00025.CDX SYSTEM "US20030004235A1-20030102-C00025.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00025.MOL SYSTEM "US20030004235A1-20030102-C00025.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00025.TIF SYSTEM "US20030004235A1-20030102-C00025.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00026.CDX SYSTEM "US20030004235A1-20030102-C00026.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00026.MOL SYSTEM "US20030004235A1-20030102-C00026.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00026.TIF SYSTEM "US20030004235A1-20030102-C00026.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00027.CDX SYSTEM "US20030004235A1-20030102-C00027.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00027.MOL SYSTEM "US20030004235A1-20030102-C00027.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00027.TIF SYSTEM "US20030004235A1-20030102-C00027.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00028.CDX SYSTEM "US20030004235A1-20030102-C00028.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00028.MOL SYSTEM "US20030004235A1-20030102-C00028.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00028.TIF SYSTEM "US20030004235A1-20030102-C00028.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00029.CDX SYSTEM "US20030004235A1-20030102-C00029.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00029.MOL SYSTEM "US20030004235A1-20030102-C00029.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00029.TIF SYSTEM "US20030004235A1-20030102-C00029.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00030.CDX SYSTEM "US20030004235A1-20030102-C00030.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00030.MOL SYSTEM "US20030004235A1-20030102-C00030.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00030.TIF SYSTEM "US20030004235A1-20030102-C00030.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00031.CDX SYSTEM "US20030004235A1-20030102-C00031.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00031.MOL SYSTEM "US20030004235A1-20030102-C00031.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00031.TIF SYSTEM "US20030004235A1-20030102-C00031.TIF" NDATA TIF>
<!ENTITY US20030004235A1-20030102-C00032.CDX SYSTEM "US20030004235A1-20030102-C00032.CDX" NDATA CDX>
<!ENTITY US20030004235A1-20030102-C00032.MOL SYSTEM "US20030004235A1-20030102-C00032.MOL" NDATA MOL>
<!ENTITY US20030004235A1-20030102-C00032.TIF SYSTEM "US20030004235A1-20030102-C00032.TIF" NDATA TIF>
]>
<patent-application-publication>
<subdoc-bibliographic-information>
<document-id>
<doc-number>20030004235</doc-number>
<kind-code>A1</kind-code>
<document-date>20030102</document-date>
</document-id>
<publication-filing-type>new</publication-filing-type>
<domestic-filing-data>
<application-number>
<doc-number>10075837</doc-number>
</application-number>
<application-number-series-code>10</application-number-series-code>
<filing-date>20020213</filing-date>
</domestic-filing-data>
<technical-information>
<classification-ipc>
<classification-ipc-primary>
<ipc>C08K005/34</ipc>
</classification-ipc-primary>
<classification-ipc-secondary>
<ipc>C07D249/04</ipc>
</classification-ipc-secondary>
<classification-ipc-edition>07</classification-ipc-edition>
</classification-ipc>
<classification-us>
<classification-us-primary>
<uspc>
<class>524</class>
<subclass>089000</subclass>
</uspc>
</classification-us-primary>
<classification-us-secondary>
<uspc>
<class>548</class>
<subclass>255000</subclass>
</uspc>
</classification-us-secondary>
</classification-us>
<title-of-invention>Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith</title-of-invention>
</technical-information>
<continuity-data>
<continuations>
<continuation-in-part-of>
<parent-child>
<child>
<document-id>
<doc-number>10075837</doc-number>
<kind-code>A1</kind-code>
<document-date>20020213</document-date>
</document-id>
</child>
<parent>
<document-id>
<doc-number>09632216</doc-number>
<document-date>20000803</document-date>
<country-code>US</country-code>
</document-id>
</parent>
<parent-status>PENDING</parent-status>
</parent-child>
</continuation-in-part-of>
</continuations>
</continuity-data>
<inventors>
<first-named-inventor>
<name>
<given-name>Mervin</given-name>
<middle-name>G.</middle-name>
<family-name>Wood</family-name>
</name>
<residence>
<residence-us>
<city>Poughquag</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</first-named-inventor>
<inventor>
<name>
<given-name>Stephen</given-name>
<middle-name>D.</middle-name>
<family-name>Pastor</family-name>
</name>
<residence>
<residence-us>
<city>Danbury</city>
<state>CT</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Jacqueline</given-name>
<family-name>Lau</family-name>
</name>
<residence>
<residence-us>
<city>Jericho</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Michael</given-name>
<family-name>DiFazio</family-name>
</name>
<residence>
<residence-us>
<city>Mobile</city>
<state>AL</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
<inventor>
<name>
<given-name>Joseph</given-name>
<family-name>Suhadolnik</family-name>
</name>
<residence>
<residence-us>
<city>Yorktown Heights</city>
<state>NY</state>
<country-code>US</country-code>
</residence-us>
</residence>
<authority-applicant>INV</authority-applicant>
</inventor>
</inventors>
<correspondence-address>
<name-1>CIBA SPECIALTY CHEMICALS CORPORATION</name-1>
<name-2>PATENT DEPARTMENT</name-2>
<address>
<address-1>540 WHITE PLAINS RD</address-1>
<address-2>P O BOX 2005</address-2>
<city>TARRYTOWN</city>
<state>NY</state>
<postalcode>10591-9005</postalcode>
<country>
<country-code>US</country-code>
</country>
</address>
</correspondence-address>
</subdoc-bibliographic-information>
<subdoc-abstract>
<paragraph id="A-0001" lvl="0">2H-Benzotriazole UV absorbers substituted at the 3-position and/or the 5-position of the phenyl ring by a phenyl moiety which is substituted by a heteroatom are particularly photostable in automotive coatings, and are of low color and exhibit low volatility in thermoplastic compositions. </paragraph>
</subdoc-abstract>
<subdoc-description>
<cross-reference-to-related-applications>
<paragraph id="P-0001" lvl="0"><number>&lsqb;0001&rsqb;</number> This is a continuation-in-part of application Ser. No. 09/632,216, filed Aug. 03, 2000.</paragraph>
</cross-reference-to-related-applications>
<summary-of-invention>
<paragraph id="P-0002" lvl="0"><number>&lsqb;0002&rsqb;</number> The instant invention pertains to 2H-benzotriazole UV absorbers substituted at the 3-position and/or the 5-position of the phenyl ring by a phenyl moiety which is substituted by a group containing a heteroatom. </paragraph>
<section>
<heading lvl="1">BACKGROUND OF THE INVENTION </heading>
<paragraph id="P-0003" lvl="0"><number>&lsqb;0003&rsqb;</number> One of the most important classes of UV absorbers are the 2H-benzotriazoles. There are a myriad of patents and other references to these materials and their compositions. Indeed, several of the 2H-benzotriazole UV absorbers have achieved great commercial importance for a host of end-use applications. Several of these commerical compounds are substituted by one or more unsubstituted &agr;-cumyl moieties. </paragraph>
<paragraph id="P-0004" lvl="0"><number>&lsqb;0004&rsqb;</number> Benzotriazole UV absorbers which are substituted at the 5-position of the benzo ring by an electron withdrawing group exhibit enhanced durability and very low loss rates when incorporated into automotive coatings. This is particularly the case when the 3-position of the phenyl ring is also substituted by phenyl or phenylalkyl such as &agr;-cumyl. Compounds where the 5-position of the benzo ring are substituted by perfluoroalkyl such as trifluoromethyl are particularly of interest for both their enhanced durability and for their excellent solubility and excellent color properties in some thermoplastic compositions when the phenyl ring is substituted at the 3-position by hydrogen or tert-alkyl. </paragraph>
<paragraph id="P-0005" lvl="0"><number>&lsqb;0005&rsqb;</number> It is well known that the stabilization and other physical properties exhibited by the 2H-benzotriazole UV absorbers can be markedly altered depending on the nature and location of the various substituents used to modify the basic 2H-benzotriazole structure. </paragraph>
<paragraph id="P-0006" lvl="0"><number>&lsqb;0006&rsqb;</number> Although there has been some generic disclosure of substituted &agr;-cumyl groups on benzotriazoles, none of these compounds have ever been exemplified nor prepared and their properities evaluated. </paragraph>
<paragraph id="P-0007" lvl="0"><number>&lsqb;0007&rsqb;</number> U.S. Pat. Nos. 4,727,158 and 4,904,712 describe 2H-benzotriazole compounds which are substituted at the 5-position on the benzo ring by higher alkyl groups of 8 to 18 carbon atoms. While it is generically disclosed that these compounds could be substituted on the 3- and/or 5-positions of the phenyl ring by &agr;-cumyl or &agr;-cumyl substituted by alkyl of 1 to 4 carbon atoms or by halogen, none of such compounds were actually prepared nor tested. </paragraph>
<paragraph id="P-0008" lvl="0"><number>&lsqb;0008&rsqb;</number> U.S. Pat. No. 5,097,041 teaches that benzotriazole UV absorbers can be substituted on the phenyl ring by phenyl substituted by alkyl. </paragraph>
<paragraph id="P-0009" lvl="0"><number>&lsqb;0009&rsqb;</number> U.S. Pat. No. 5,977,219 discloses highly stable benzotriazole UV absorbers. </paragraph>
<paragraph id="P-0010" lvl="0"><number>&lsqb;0010&rsqb;</number> WO 98/41186 is directed to hair dye compositions and the various components which may be included therein. This reference contains a host of generic structures for such components including 2H-benzotriazoles. </paragraph>
</section>
<section>
<heading lvl="1">DETAILED DISCLOSURE </heading>
<paragraph id="P-0011" lvl="0"><number>&lsqb;0011&rsqb;</number> The instant invention pertains to novel benzotriazole UV absorbers having enhanced stability and durability and a low loss rate when incorporated into automotive coatings. These new benzotriazole UV absorbers are also soluble in a variety of substrates including thermoplastic polymers and often are essentially colorless even though absorbing in the 350-390 nm range. </paragraph>
<paragraph id="P-0012" lvl="0"><number>&lsqb;0012&rsqb;</number> More specifically, the instant invention pertains to new benzotriazole compounds of formula I, II or III  
<chemistry-cwu id="CHEM-US-00001">
<number>1</number>
<image id="EMI-C00001" he="301.2471" wi="198.02475" file="US20030004235A1-20030102-C00001.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00001" file="US20030004235A1-20030102-C00001.CDX"/>
<chemistry-mol-file id="CHEMMOL-00001" file="US20030004235A1-20030102-C00001.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0013" lvl="7"><number>&lsqb;0013&rsqb;</number> Wherein </paragraph>
<paragraph id="P-0014" lvl="2"><number>&lsqb;0014&rsqb;</number> G<highlight><subscript>1 </subscript></highlight>is hydrogen or halogen, </paragraph>
<paragraph id="P-0015" lvl="2"><number>&lsqb;0015&rsqb;</number> G<highlight><subscript>2 </subscript></highlight>is hydrogen, cyano, perfluoroalkyl of 1 to 12 carbon atoms, halogen, &mdash;CO&mdash;G<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, &mdash;CONHG<highlight><subscript>3</subscript></highlight>, &mdash;CON(G<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>SO&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash;, nitro, &mdash;P(O)(C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>5</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;P(O)(OG<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>,  
<chemistry-cwu id="CHEM-US-00002">
<number>2</number>
<image id="EMI-C00002" he="33.1128" wi="142.57215" file="US20030004235A1-20030102-C00002.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00002" file="US20030004235A1-20030102-C00002.CDX"/>
<chemistry-mol-file id="CHEMMOL-00002" file="US20030004235A1-20030102-C00002.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0016" lvl="2"><number>&lsqb;0016&rsqb;</number> G<highlight><subscript>3 </subscript></highlight>is hydrogen, straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 4 alkyl of 1 to 4 carbon atoms, </paragraph>
<paragraph id="P-0017" lvl="2"><number>&lsqb;0017&rsqb;</number> E<highlight><subscript>1 </subscript></highlight>is hydrogen, straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 24 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 4 alkyl of 1 to 4 carbon atoms; or E<highlight><subscript>1 </subscript></highlight>is alkyl of 1 to 24 carbon atoms substituted by one or two hydroxy groups; </paragraph>
<paragraph id="P-0018" lvl="2"><number>&lsqb;0018&rsqb;</number> or E<highlight><subscript>1 </subscript></highlight>is alkyl of 1 to 24 carbon atoms, alkenyl of 2 to 18 carbon atoms, said alkyl or said alkenyl substituted by one or more &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11</subscript></highlight>, or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or straight or branched chain alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2</subscript></highlight>, or mixtures thereof; </paragraph>
<paragraph id="P-0019" lvl="2"><number>&lsqb;0019&rsqb;</number> or E<highlight><subscript>1 </subscript></highlight>is a group of formula IV or V  
<chemistry-cwu id="CHEM-US-00003">
<number>3</number>
<image id="EMI-C00003" he="157.93785" wi="198.02475" file="US20030004235A1-20030102-C00003.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00003" file="US20030004235A1-20030102-C00003.CDX"/>
<chemistry-mol-file id="CHEMMOL-00003" file="US20030004235A1-20030102-C00003.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0020" lvl="2"><number>&lsqb;0020&rsqb;</number> &emsp;where </paragraph>
<paragraph id="P-0021" lvl="2"><number>&lsqb;0021&rsqb;</number> E<highlight><subscript>27 </subscript></highlight>and E<highlight><subscript>28 </subscript></highlight>are independently alkyl of 1 to 18 carbon atoms, or cycloalkyl of 5 to 12 carbon atoms; </paragraph>
<paragraph id="P-0022" lvl="2"><number>&lsqb;0022&rsqb;</number> E<highlight><subscript>22</subscript></highlight>, E<highlight><subscript>23</subscript></highlight>, E24, E<highlight><subscript>25 </subscript></highlight>and E<highlight><subscript>26 </subscript></highlight>are independently hydrogen, halogen, straight or branched alkyl of 1 to 18 carbon atoms, alkenyl of 2 to 18 carbon atoms, said alkyl or said alkenyl substituted by one or more halogen, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or straight or branched chain alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2</subscript></highlight>, or mixtures thereof; or </paragraph>
<paragraph id="P-0023" lvl="2"><number>&lsqb;0023&rsqb;</number> E<highlight><subscript>22, </subscript></highlight>E<highlight><subscript>23</subscript></highlight>, E<highlight><subscript>24</subscript></highlight>, E<highlight><subscript>25 </subscript></highlight>and E<highlight><subscript>26 </subscript></highlight>are independently phenyl, &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>29</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, cyano, nitro, perfluoroalkyl of 1 to 12 carbon atoms, &mdash;COG<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, &mdash;CON(G<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;CONHG<highlight><subscript>3</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>S&mdash;, E<highlight><subscript>3</subscript></highlight>SO&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;P(O)(C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>5</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;P(O))OG<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;X<highlight><subscript>1</subscript></highlight>&mdash;E<highlight><subscript>29</subscript></highlight>; </paragraph>
<paragraph id="P-0024" lvl="2"><number>&lsqb;0024&rsqb;</number> X<highlight><subscript>1 </subscript></highlight>is &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash;; </paragraph>
<paragraph id="P-0025" lvl="2"><number>&lsqb;0025&rsqb;</number> E<highlight><subscript>29 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, said alkyl or said alkenyl substituted by one or more &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11</subscript></highlight>, &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, phthalimido,  
<chemistry-cwu id="CHEM-US-00004">
<number>4</number>
<image id="EMI-C00004" he="33.1128" wi="142.57215" file="US20030004235A1-20030102-C00004.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00004" file="US20030004235A1-20030102-C00004.CDX"/>
<chemistry-mol-file id="CHEMMOL-00004" file="US20030004235A1-20030102-C00004.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0026" lvl="2"><number>&lsqb;0026&rsqb;</number> &emsp;or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2</subscript></highlight>, or mixtures thereof; or E<highlight><subscript>29 </subscript></highlight>is phenyl or phenylalkyl of 7 to 15 carbon atoms, or said phenyl or said phenylalkyl substituted by one to three alkyl groups of 1 to 4 carbon atoms; </paragraph>
<paragraph id="P-0027" lvl="2"><number>&lsqb;0027&rsqb;</number> E<highlight><subscript>2 </subscript></highlight>is straight or branched alkyl chain of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by one to three alkyl of 1 to 4 carbon atoms; or E<highlight><subscript>2 </subscript></highlight>is alkyl of 1 to 24 carbon atoms or said alkenyl of 2 to 18 carbon atoms substituted by one or more &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11</subscript></highlight>, or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2 </subscript></highlight>groups or mixtures thereof, or E<highlight><subscript>2 </subscript></highlight>is a group of formula IV or formula V as described above; </paragraph>
<paragraph id="P-0028" lvl="2"><number>&lsqb;0028&rsqb;</number> n is 1 or 2, </paragraph>
<paragraph id="P-0029" lvl="2"><number>&lsqb;0029&rsqb;</number> when n is 1, E<highlight><subscript>5 </subscript></highlight>is OE<highlight><subscript>6 </subscript></highlight>or NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or </paragraph>
<paragraph id="P-0030" lvl="2"><number>&lsqb;0030&rsqb;</number> E<highlight><subscript>5 </subscript></highlight>is &mdash;PO(OE<highlight><subscript>12</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;OSi(E<highlight><subscript>11</subscript></highlight>)<highlight><subscript>3 </subscript></highlight>or &mdash;OCO&mdash;E<highlight><subscript>11</subscript></highlight>, </paragraph>
<paragraph id="P-0031" lvl="2"><number>&lsqb;0031&rsqb;</number> or straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl which is interrupted by &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NE<highlight><subscript>11</subscript></highlight>, and which can be unsubstituted or substituted by &mdash;OH or &mdash;OCO&mdash;E<highlight><subscript>11</subscript></highlight>, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>12 </subscript></highlight>cycloalkyl which is unsubstituted or substituted by &mdash;OH, straight chain or branched C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkenyl which is unsubstituted or substituted by &mdash;OH, C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CHOH-E<highlight><subscript>13 </subscript></highlight>or glycidyl, </paragraph>
<paragraph id="P-0032" lvl="2"><number>&lsqb;0032&rsqb;</number> E<highlight><subscript>6 </subscript></highlight>is hydrogen, straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl which is unsubstituted or substituted by one or more OH, OE<highlight><subscript>4 </subscript></highlight>or NH<highlight><subscript>2 </subscript></highlight>grlups, or &mdash;OE<highlight><subscript>6 </subscript></highlight>is &mdash;(OCH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>w</subscript></highlight>OH or &mdash;(OCH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>w</subscript></highlight>OE<highlight><subscript>21 </subscript></highlight>where w is 1 to 12 and E<highlight><subscript>21 </subscript></highlight>is alkyl of 1 to 12 carbon atoms, </paragraph>
<paragraph id="P-0033" lvl="2"><number>&lsqb;0033&rsqb;</number> E<highlight><subscript>7 </subscript></highlight>and E<highlight><subscript>8 </subscript></highlight>are independently hydrogen, alkyl of 1 to 18 carbon atoms, straight or branched chain C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl which is interrupted by &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NE<highlight><subscript>11</subscript></highlight>&mdash;, straight or branched chain alkenyl of 2 to 18 carbon atoms, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>cycloalkyl, C<highlight><subscript>6</subscript></highlight>-C<highlight><subscript>14</subscript></highlight>aryl or C<highlight><subscript>1-C</subscript></highlight><highlight><subscript>3</subscript></highlight>hydroxylalkyl, or E<highlight><subscript>7 </subscript></highlight>and E<highlight><subscript>8 </subscript></highlight>together with the N atom are a pyrrolidine, piperidine, piperazine or morpholine ring, or </paragraph>
<paragraph id="P-0034" lvl="2"><number>&lsqb;0034&rsqb;</number> E<highlight><subscript>5 </subscript></highlight>is &mdash;X&mdash;(Z)<highlight><subscript>p</subscript></highlight>&mdash;Y&mdash;E<highlight><subscript>15 </subscript></highlight></paragraph>
<paragraph id="P-0035" lvl="2"><number>&lsqb;0035&rsqb;</number> wherein </paragraph>
<paragraph id="P-0036" lvl="3"><number>&lsqb;0036&rsqb;</number> X is &mdash;O&mdash; or &mdash;N(E<highlight><subscript>16</subscript></highlight>)&mdash;, </paragraph>
<paragraph id="P-0037" lvl="3"><number>&lsqb;0037&rsqb;</number> Y is &mdash;O&mdash; or &mdash;N(E<highlight><subscript>17</subscript></highlight>)&mdash;, </paragraph>
<paragraph id="P-0038" lvl="3"><number>&lsqb;0038&rsqb;</number> Z is C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkylene, C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkylene interrupted by one to three nitrogen atoms, oxygen atoms or a mixture thereof, or is C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkylene, butenylene, butynylene, cyclohexylene or phenylene, each substituted by a hydroxyl group, </paragraph>
<paragraph id="P-0039" lvl="3"><number>&lsqb;0039&rsqb;</number> m is zero, 1 or 2, </paragraph>
<paragraph id="P-0040" lvl="3"><number>&lsqb;0040&rsqb;</number> p is 1, or p is also zero when X and Y are &mdash;N(E<highlight><subscript>16</subscript></highlight>)&mdash; and &mdash;N(E<highlight><subscript>17</subscript></highlight>)&mdash;, respectively, </paragraph>
<paragraph id="P-0041" lvl="3"><number>&lsqb;0041&rsqb;</number> E<highlight><subscript>15 </subscript></highlight>is a group &mdash;CO&mdash;C(E<highlight><subscript>18</subscript></highlight>)&boxH;C(H)E<highlight><subscript>19 </subscript></highlight>or, when Y is &mdash;N(E<highlight><subscript>17</subscript></highlight>)&mdash;, forms together with E<highlight><subscript>17 </subscript></highlight>a group &mdash;CO&mdash;CH&boxH;CH&mdash;CO&mdash;, wherein E<highlight><subscript>18 </subscript></highlight>is hydrogen or methyl, and E<highlight><subscript>19 </subscript></highlight>is hydrogen, methyl or CO&mdash;X&mdash;E<highlight><subscript>20</subscript></highlight>, wherein E<highlight><subscript>20 </subscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkyl or a group of the formula  
<chemistry-cwu id="CHEM-US-00005">
<number>5</number>
<image id="EMI-C00005" he="72.009" wi="182.65905" file="US20030004235A1-20030102-C00005.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00005" file="US20030004235A1-20030102-C00005.CDX"/>
<chemistry-mol-file id="CHEMMOL-00005" file="US20030004235A1-20030102-C00005.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0042" lvl="3"><number>&lsqb;0042&rsqb;</number> &emsp;wherein the symbols E<highlight><subscript>1</subscript></highlight>, G<highlight><subscript>2</subscript></highlight>, X, Z, m and p have the meanings defined above, and E<highlight><subscript>16 </subscript></highlight>and E<highlight><subscript>17 </subscript></highlight>independently of one another are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkyl interrupted by 1 to 3 oxygen atoms, or is cyclohexyl or C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, and E<highlight><subscript>16 </subscript></highlight>together with E<highlight><subscript>17 </subscript></highlight>in the case where Z is ethylene, also forms ethylene, </paragraph>
<paragraph id="P-0043" lvl="3"><number>&lsqb;0043&rsqb;</number> when n is 2, E<highlight><subscript>5 </subscript></highlight>is one of divalent radicals &mdash;O&mdash;E<highlight><subscript>9</subscript></highlight>&mdash;O&mdash; or &mdash;N(E<highlight><subscript>11</subscript></highlight>)&mdash;E<highlight><subscript>10</subscript></highlight>&mdash;N(E<highlight><subscript>11</subscript></highlight>)&mdash;, </paragraph>
<paragraph id="P-0044" lvl="3"><number>&lsqb;0044&rsqb;</number> E<highlight><subscript>9 </subscript></highlight>is C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>8</subscript></highlight>alkylene, C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>8</subscript></highlight>alkenylene, C<highlight><subscript>4</subscript></highlight>alkynylene, cyclohexylene, straight or branched chain C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>10</subscript></highlight>alkylene which is interrupted by &mdash;O&mdash; or by &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CHOH&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;O&mdash;E<highlight><subscript>14</subscript></highlight>&mdash;O&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CHOH&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;, </paragraph>
<paragraph id="P-0045" lvl="3"><number>&lsqb;0045&rsqb;</number> E<highlight><subscript>10 </subscript></highlight>being straight or branched chain C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>alkylene which may be interrupted by &mdash;O&mdash;, cyclohexylene, or  
<chemistry-cwu id="CHEM-US-00006">
<number>6</number>
<image id="EMI-C00006" he="79.69185" wi="148.3272" file="US20030004235A1-20030102-C00006.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00006" file="US20030004235A1-20030102-C00006.CDX"/>
<chemistry-mol-file id="CHEMMOL-00006" file="US20030004235A1-20030102-C00006.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0046" lvl="3"><number>&lsqb;0046&rsqb;</number> &emsp;or E<highlight><subscript>10 </subscript></highlight>and E<highlight><subscript>11 </subscript></highlight>with the two nitrogen atoms form a piperazine ring, </paragraph>
<paragraph id="P-0047" lvl="3"><number>&lsqb;0047&rsqb;</number> E<highlight><subscript>14 </subscript></highlight>is straight or branched chain C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>8</subscript></highlight>alkylene, straight or branched chain C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>10</subscript></highlight>alkylene which is interrupted by &mdash;O&mdash;, cycloalkylene, arylene or  
<chemistry-cwu id="CHEM-US-00007">
<number>7</number>
<image id="EMI-C00007" he="106.56765" wi="144.49995" file="US20030004235A1-20030102-C00007.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00007" file="US20030004235A1-20030102-C00007.CDX"/>
<chemistry-mol-file id="CHEMMOL-00007" file="US20030004235A1-20030102-C00007.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0048" lvl="3"><number>&lsqb;0048&rsqb;</number> E<highlight><subscript>11</subscript></highlight>, is hydrogen, straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>cycloalkyl, straight or branched chain C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkenyl, C<highlight><subscript>6</subscript></highlight>-C<highlight><subscript>14</subscript></highlight>aryl or C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, </paragraph>
<paragraph id="P-0049" lvl="3"><number>&lsqb;0049&rsqb;</number> E<highlight><subscript>12 </subscript></highlight>is straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl, straight or branched chain C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkenyl, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>10</subscript></highlight>cycloalkyl, C<highlight><subscript>6</subscript></highlight>-C<highlight><subscript>16</subscript></highlight>aryl or C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, </paragraph>
<paragraph id="P-0050" lvl="3"><number>&lsqb;0050&rsqb;</number> E<highlight><subscript>13 </subscript></highlight>is hydrogen, straight chain or branched C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl which is substituted by &mdash;PO(OE<highlight><subscript>12</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, phenyl which is unsubstituted or substituted by OH, C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl or &mdash;CH<highlight><subscript>2</subscript></highlight>OE<highlight><subscript>12</subscript></highlight>, </paragraph>
<paragraph id="P-0051" lvl="3"><number>&lsqb;0051&rsqb;</number> E<highlight><subscript>3 </subscript></highlight>is alkyl of 1 to 20 carbon atoms, hydroxyalkyl of 2 to 20 carbon atoms, alkenyl of 3 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms or said aryl substituted by one or two alkyl of 1 to 4 carbon atoms or 1,1,2,2-tetrahydroperfluoroalkyl where the perfluoroalkyl moiety is of 6 to 16 carbon atoms, </paragraph>
<paragraph id="P-0052" lvl="3"><number>&lsqb;0052&rsqb;</number> T is &mdash;SO&mdash;, &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;SO&mdash;E&mdash;SO&mdash;, &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;E&mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;CO&mdash;, &mdash;CO&mdash;CO&mdash;, &mdash;CO&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CO&mdash;, &mdash;CO&mdash;E&mdash;CO&mdash;, &mdash;COO&mdash;E&mdash;OCO&mdash; or &mdash;CO&mdash;NG<highlight><subscript>5</subscript></highlight>&mdash;E&mdash;NG<highlight><subscript>5</subscript></highlight>&mdash;CO&mdash;, </paragraph>
<paragraph id="P-0053" lvl="3"><number>&lsqb;0053&rsqb;</number> where E is alkylene of 2 to 12 carbon atoms, cycloalkylene of 5 to 12 carbon atoms, or alkylene interrupted or terminated by cyclohexylene of 8 to 12 carbon atoms; </paragraph>
<paragraph id="P-0054" lvl="3"><number>&lsqb;0054&rsqb;</number> G<highlight><subscript>5 </subscript></highlight>is G<highlight><subscript>3 </subscript></highlight>or hydrogen, and </paragraph>
<paragraph id="P-0055" lvl="3"><number>&lsqb;0055&rsqb;</number> with the proviso that at least one of E<highlight><subscript>1 </subscript></highlight>and E<highlight><subscript>2 </subscript></highlight>is a group of formula IV or formula V where E<highlight><subscript>22 </subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>are not each hydrogen; where if 1 to 4 of E<highlight><subscript>22 </subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>are each hydrogen, the remaining E<highlight><subscript>22 </subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>groups are not alkyl; and where if 4 of E22 to E<highlight><subscript>26 </subscript></highlight>are each hydrogen, the remaining E<highlight><subscript>22 </subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>group is not halogen. </paragraph>
<paragraph id="P-0056" lvl="0"><number>&lsqb;0056&rsqb;</number> Preferably, the new benzotriazole is a compound of formula I  
<chemistry-cwu id="CHEM-US-00008">
<number>8</number>
<image id="EMI-C00008" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00008.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00008" file="US20030004235A1-20030102-C00008.CDX"/>
<chemistry-mol-file id="CHEMMOL-00008" file="US20030004235A1-20030102-C00008.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0057" lvl="7"><number>&lsqb;0057&rsqb;</number> wherein </paragraph>
<paragraph id="P-0058" lvl="2"><number>&lsqb;0058&rsqb;</number> G<highlight><subscript>1 </subscript></highlight>is hydrogen, </paragraph>
<paragraph id="P-0059" lvl="2"><number>&lsqb;0059&rsqb;</number> G<highlight><subscript>2 </subscript></highlight>is hydrogen, cyano, &mdash;CF<highlight><subscript>3</subscript></highlight>, fluoro, chloro, &mdash;CO&mdash;G<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3 </subscript></highlight>or E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash;, </paragraph>
<paragraph id="P-0060" lvl="2"><number>&lsqb;0060&rsqb;</number> G<highlight><subscript>3 </subscript></highlight>is hydrogen, straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 4 alkyl of 1 to 4 carbon atoms, </paragraph>
<paragraph id="P-0061" lvl="2"><number>&lsqb;0061&rsqb;</number> E<highlight><subscript>1 </subscript></highlight>is a group of formula IV or formula V wherein E<highlight><subscript>22</subscript></highlight>-E<highlight><subscript>26 </subscript></highlight>are independently hydrogen, alkyl of 1 to 12 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, OH, cyano, &mdash;OE<highlight><subscript>29</subscript></highlight>, chloro, fluoro, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;CF<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>S&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash; or &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;NH&mdash;E<highlight><subscript>29</subscript></highlight>; </paragraph>
<paragraph id="P-0062" lvl="2"><number>&lsqb;0062&rsqb;</number> E<highlight><subscript>27 </subscript></highlight>and E<highlight><subscript>28 </subscript></highlight>are methyl; </paragraph>
<paragraph id="P-0063" lvl="2"><number>&lsqb;0063&rsqb;</number> E<highlight><subscript>2 </subscript></highlight>is straight or branched alkyl chain of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 3 alkyl of 1 to 4 carbon atoms; or E<highlight><subscript>2 </subscript></highlight>is said alkyl of 1 to 24 carbon atoms or straight or branched alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl substituted by one or more &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or straight or branched chain alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2 </subscript></highlight>groups or mixtures thereof; or E<highlight><subscript>2 </subscript></highlight>is a group of formula IV or formula V wherein E<highlight><subscript>22</subscript></highlight>-E<highlight><subscript>26 </subscript></highlight>are independently hydrogen, alkyl of 1 to 12 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, OH, cyano, &mdash;OE<highlight><subscript>29</subscript></highlight>, chloro, fluoro, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;CF<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>S&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash; or &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;NH&mdash;E<highlight><subscript>29</subscript></highlight>; </paragraph>
<paragraph id="P-0064" lvl="2"><number>&lsqb;0064&rsqb;</number> E<highlight><subscript>3 </subscript></highlight>is alkyl of 1 to 20 carbon atoms, hydroxyalkyl of 2 to 20 carbon atoms, alkenyl of 3 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms or said aryl substituted by one or two alkyl of 1 to 4 carbon atoms or 1,1,2,2-tetrahydroperfluoroalkyl where the perfluoroalkyl moiety is of 6 to 16 carbon atoms; and where E<highlight><subscript>11</subscript></highlight>, and E<highlight><subscript>29 </subscript></highlight>are as defined above. </paragraph>
<paragraph id="P-0065" lvl="0"><number>&lsqb;0065&rsqb;</number> For example, the instant compounds of formula I is </paragraph>
<paragraph id="P-0066" lvl="2"><number>&lsqb;0066&rsqb;</number> a. 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0067" lvl="2"><number>&lsqb;0067&rsqb;</number> b. 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-fluoro-&agr;-cumyl)-54tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0068" lvl="2"><number>&lsqb;0068&rsqb;</number> c. 2-&lsqb;2-hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0069" lvl="2"><number>&lsqb;0069&rsqb;</number> d. 2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0070" lvl="2"><number>&lsqb;0070&rsqb;</number> e. 5-chloro-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0071" lvl="2"><number>&lsqb;0071&rsqb;</number> f. 5-chloro-2-&lsqb;2-hydroxy-3,5-di-(4-chloro-&agr;-cumyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0072" lvl="2"><number>&lsqb;0072&rsqb;</number> g. 5-chloro-2-&lsqb;2-hydroxy-3,5-di-(4-methoxy-&agr;-cumyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0073" lvl="2"><number>&lsqb;0073&rsqb;</number> h. 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0074" lvl="2"><number>&lsqb;0074&rsqb;</number> i. 5-chloro-2-&lsqb;2-hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0075" lvl="2"><number>&lsqb;0075&rsqb;</number> j. 2-&lcub;2-hydroxy-3-&lsqb;4-(2-dimethylaminoethyl)aminosulfonyl-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0076" lvl="2"><number>&lsqb;0076&rsqb;</number> k. 2-&lcub;2-hydroxy-3-&lsqb;4-(3-dimethylaminopropyl)aminosulfonyl-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0077" lvl="2"><number>&lsqb;0077&rsqb;</number> l. 5-carboxy-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0078" lvl="2"><number>&lsqb;0078&rsqb;</number> m. 5-methoxycarbonyl-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzo-triazole; </paragraph>
<paragraph id="P-0079" lvl="2"><number>&lsqb;0079&rsqb;</number> n. 2-&lcub;2-hydroxy-3-&lsqb;4-(2-hydroxyethoxy)-&agr;-cumyl&rsqb;-5-tert-butylphenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0080" lvl="2"><number>&lsqb;0080&rsqb;</number> o. 2-&lcub;2-hydroxy-3-&lsqb;4-(2-phthalimidoethoxy)-&agr;-cumyl&rsqb;-5-tert-butylphenyl&rcub;2H-benzotriazole; </paragraph>
<paragraph id="P-0081" lvl="2"><number>&lsqb;0081&rsqb;</number> p. 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-(3-isopropenyl-&agr;-cumyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0082" lvl="2"><number>&lsqb;0082&rsqb;</number> q. 5-trifluoromethyl-2-&lcub;2-hydroxy-3-&lsqb;3-(2-hydroxy-1-methylethyl)-&agr;-cumyl&rsqb;-5-tert-octyl-phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0083" lvl="2"><number>&lsqb;0083&rsqb;</number> r. 5-trifluoromethyl-2-&lcub;2-hydroxy-3-&lsqb;3-(2-methacryloyloxy-1-methylethyl)-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0084" lvl="2"><number>&lsqb;0084&rsqb;</number> s. 5-chloro-2-&lsqb;2-hydroxy-3-(4-carboxy-&agr;-cumyl)-5-methylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0085" lvl="2"><number>&lsqb;0085&rsqb;</number> t. 5-chloro-2-&lsqb;2-hydroxy-3-(4-octadecyloxycarbonyl-&agr;-cumyl)-5-methylphenyl&rsqb;-2H-benzotriazole; or </paragraph>
<paragraph id="P-0086" lvl="2"><number>&lsqb;0086&rsqb;</number> u. 2-&lsqb;2-hydroxy-3-(4-octadecylaminosulfonyl-&agr;-cumyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; or is 4&prime;-methoxy-5-(1,1,3,3-tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, 3&prime;-methoxy-5-(1,1,3,3-tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, 2&prime;-methoxy-5-(1,1,3,3-tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, </paragraph>
<paragraph id="P-0087" lvl="2"><number>&lsqb;0087&rsqb;</number> 5-(1,1,3,3-tetramethyl-butyl)-3&prime;-trifluromethyl-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol,  
<chemistry-cwu id="CHEM-US-00009">
<number>9</number>
<image id="EMI-C00009" he="581.3451" wi="173.53035" file="US20030004235A1-20030102-C00009.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00009" file="US20030004235A1-20030102-C00009.CDX"/>
<chemistry-mol-file id="CHEMMOL-00009" file="US20030004235A1-20030102-C00009.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0088" lvl="0"><number>&lsqb;0088&rsqb;</number> The instant invention also pertains to a stabilized composition which comprises </paragraph>
<paragraph id="P-0089" lvl="2"><number>&lsqb;0089&rsqb;</number> (a) an organic material subject to degradation by heat, light or oxygen, and </paragraph>
<paragraph id="P-0090" lvl="2"><number>&lsqb;0090&rsqb;</number> (b) an effective stabilizing amount of a compound of formula I, II or III as described above. </paragraph>
<paragraph id="P-0091" lvl="0"><number>&lsqb;0091&rsqb;</number> Preferably, the organic material is a natural, semi-synthetic or synthetic polymer, especially a thermoplastic polymer. </paragraph>
<paragraph id="P-0092" lvl="0"><number>&lsqb;0092&rsqb;</number> Most preferably, the polymer is a polyolefin or polycarbonate, especially polyethylene or polypropylene; most especially polypropylene; or the polymer is a styrenic, ABS, a nylon, a polyester such as poly(ethylene terephthalate) or poly(butylene terephthalate), a polyurethane, an acrylate, a rubber modified styrenic, poly(vinyl chloride), poly(vinyl butyral), polyacetal (polyoxymethylene), poly(ethylene naphthalenedicarboxylate), or other blends or copolymers such as poly(ethylene/1,4-cyclohexylenedimethylene terephthalate) PETG or an ionomer as described on page 29. </paragraph>
<paragraph id="P-0093" lvl="0"><number>&lsqb;0093&rsqb;</number> In another preferred embodiment of the instant invention, the organic material is a resin selected from the group consisting of a thermoset acrylic melamine resin, an acrylic urethane resin, an epoxy carboxy resin, a silane modified acrylic melamine, an acrylic resin with carbamate pendant groups crosslinked with melamine or an acrylic polyol resin crosslinked with melamine containing carbamate groups. </paragraph>
<paragraph id="P-0094" lvl="0"><number>&lsqb;0094&rsqb;</number> Most preferably, the resin is a thermoset acrylic melamine resin or an acrylic urethane resin. </paragraph>
<paragraph id="P-0095" lvl="0"><number>&lsqb;0095&rsqb;</number> In yet another preferred embodiment of the instant invention, the organic material is a recording material. </paragraph>
<paragraph id="P-0096" lvl="0"><number>&lsqb;0096&rsqb;</number> The recording materials according to the invention are suitable for pressure-sensitive copying systems, photocopying systems using microcapsules, heat-sensitive copying systems, photographic materials and ink jet printing. </paragraph>
<paragraph id="P-0097" lvl="0"><number>&lsqb;0097&rsqb;</number> The recording materials according to the invention are distinguished by an unexpected improvement in quality, especially with regard to the fastness to light. </paragraph>
<paragraph id="P-0098" lvl="0"><number>&lsqb;0098&rsqb;</number> The recording materials according to the invention have the construction known for the particular use. They consist of a customary carrier, for example, paper or plastic film, which has been coated with one or more layers. Depending on the type of material, these layers contain the appropriate necessary components, in the case of photographic materials, for example, silver halide emulsions, dye couplers, dyes and the like. Material particularly suitable for ink jet printing has a layer particularly absorptive for ink on a customary carrier. Uncoated paper can also be employed for ink jet printing. In this case the paper acts at the same time as the carrier material and as the ink-absorbent layer. Suitable material for ink jet printing is, for example, described in U.S. Pat. No. 5,073,448 which is incorporated herein by reference. </paragraph>
<paragraph id="P-0099" lvl="0"><number>&lsqb;0099&rsqb;</number> The recording material can also be transparent as, for example, in the case of projection films. </paragraph>
<paragraph id="P-0100" lvl="0"><number>&lsqb;0100&rsqb;</number> The compounds of formula I, II or III can be incorporated into the carder material as early as the production of the latter, in the production of paper, for example, being added to the paper pulp. A second method of application is to spray the carder material with an aqueous solution of compounds of formula I, II or III or to add the compounds to the coating composition. </paragraph>
<paragraph id="P-0101" lvl="0"><number>&lsqb;0101&rsqb;</number> Coating compositions intended for transparent recording materials suitable for projection cannot contain any particles which scatter light, such as pigments and fillers. </paragraph>
<paragraph id="P-0102" lvl="0"><number>&lsqb;0102&rsqb;</number> The dye-binding coating composition can contain a number of other additives, for example, antioxidants, light stabilizers (including also UV absorbers which do not fall under the scope of the UV absorbers of this invention), viscosity improvers, fluorescent brighteners, biocides and/or antistatic agents. </paragraph>
<paragraph id="P-0103" lvl="0"><number>&lsqb;0103&rsqb;</number> The coating composition is usually prepared as follows: the water-soluble components, for example, the binder, are dissolved in water and stirred together; the solid components, for example, fillers and other additives already described, are dispersed in this aqueous medium; and disperison is advantageously carried out by means of devices, for example, ultrasonic systems, turbine stirrers, homogenizers, colloid mills, bead mills, sand mills, high-speed stirrers and the like. The compounds of formula I, II or III can be easily incorporated into the coating composition. </paragraph>
<paragraph id="P-0104" lvl="0"><number>&lsqb;0104&rsqb;</number> The recording material according to this invention preferably contains 1 to 5000 mg/M<highlight><superscript>2</superscript></highlight>, in particular 50-1200 mg/M<highlight><superscript>2</superscript></highlight>, of a compound of formula I, III or III. </paragraph>
<paragraph id="P-0105" lvl="0"><number>&lsqb;0105&rsqb;</number> As already mentioned, the recording materials according to the invention embrace a wide field. The compounds of formula I, II or III can, for example, be employed in pressure-sensitive copying systems. They can be introduced either into the paper in order to protect the microencapsulated dye precursors there from light, or into the binder of the developer layer in order to protect the dyes formed there. </paragraph>
<paragraph id="P-0106" lvl="0"><number>&lsqb;0106&rsqb;</number> Photocopying systems using light-sensitive microcapsules which are developed by means of pressure are described in U.S. Pat. Nos. 4,416,966; 4,483,912; 4,352,200; 4,535,050; 4,535,463; 4,551,407; 4,562,137 and 4,608,330; and also in EP-A 139,479; EP-A 162,664; EP-A 164,931; EP-A 237,024; EP-A 237,025 and EP-A 260,129. In all these systems, the compounds can be put into the dye-receiving layer. The compounds can, however, also be put into the donor layer in order to protect the color formers from light. </paragraph>
<paragraph id="P-0107" lvl="0"><number>&lsqb;0107&rsqb;</number> Photographic materials which can be stabilized are photographic dyes and layers containing such dyes or precursors thereof, for example, photographic paper and films. Suitable materials are, for example, described in U.S. Pat. No. 5,364,749 which is incorporated herein by reference. The compounds of formula I, II or III act here as a UV filter against electrostatic flashes. In color photographic materials, couplers and dyes are also protected against photochemical decomposition. </paragraph>
<paragraph id="P-0108" lvl="0"><number>&lsqb;0108&rsqb;</number> The instant compounds can be used for all types of color photographic materials. For example, they can be employed for color paper, color reversal paper, direct-positive color material, color negative film, color positive film, color reversal film and the like. They are preferably used inter alia for photographic color material which contains a reversal substrate or form positives. </paragraph>
<paragraph id="P-0109" lvl="0"><number>&lsqb;0109&rsqb;</number> Color-photographic recording materials usually contain, on a support, a blue-sensitive and/or a green-sensitive and/or a red-sensitive silver halide emulsion layer and, if desired, a protection layer, with the instant compounds being, preferably, either in the green-sensitive or the red-sensitive layer or in a layer between the green-sensitive and the red-sensitive layer or in a layer on top of the silver halide emulsion layers. </paragraph>
<paragraph id="P-0110" lvl="0"><number>&lsqb;0110&rsqb;</number> The compounds of formula I, II or III can also be employed in recording materials based on the principles of photopolymerization, photoplasticization or the rupture of microcapsules, or in cases where heat-sensitive and light-sensitive diazonium salts, leuko dyes having an oxidizing agent or dye lactones having Lewis acids are used. </paragraph>
<paragraph id="P-0111" lvl="0"><number>&lsqb;0111&rsqb;</number> Furthermore, the instant compounds can be employed in recording materials for dye diffusion transfer printing, thermal wax transfer printing and non-matrix printing and for use with electrostatic, electrographic, electrophoretic, magnetographic and laser-electrophotographic printers and pen-plotters. Of the above, recording materials for dye diffusion transfer printing are preferred, for example, as described in EP-A 507,734. </paragraph>
<paragraph id="P-0112" lvl="0"><number>&lsqb;0112&rsqb;</number> The instant compounds can also be employed in inks, preferably for ink jet printing, for example, as described in U.S. Pat. No. 5,098,477 which is incorporated herein by reference. </paragraph>
<paragraph id="P-0113" lvl="0"><number>&lsqb;0113&rsqb;</number> The instant compounds also are effective in the protection of dyes present in candle wax from premature degradation and fading. </paragraph>
<paragraph id="P-0114" lvl="0"><number>&lsqb;0114&rsqb;</number> The instant compounds of formula I, II or III are also useful in adhesives used in solar films, optical films and other laminated structures against the adverse effects of ultraviolet light and actinic radiation. </paragraph>
<paragraph id="P-0115" lvl="0"><number>&lsqb;0115&rsqb;</number> The compounds of this invention exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in a stabilized composition. </paragraph>
<paragraph id="P-0116" lvl="0"><number>&lsqb;0116&rsqb;</number> The methodology to make the instant compounds is described in the prior art. The intermediates needed to make the instant compounds are largely items of commerce. </paragraph>
<paragraph id="P-0117" lvl="0"><number>&lsqb;0117&rsqb;</number> Preferred compounds are those in which one of X and Y is &mdash;O&mdash;; and particularly those in which both X and Y are &mdash;O&mdash;. </paragraph>
<paragraph id="P-0118" lvl="0"><number>&lsqb;0118&rsqb;</number> In general polymers which can be stabilized include p<highlight><bold>1</bold></highlight> 1. Polymers of monoolefins and diolefins, for example polypropylene, polyisobutylene, polybut-1-ene, poly-4-methylpent-1-ene, polyisoprene or polybutadiene, as well as polymers of cycloolefins, for instance of cyclopentene or norbornene, polyethylene (which optionally can be crosslinked), for example high density polyethylene (HDPE), low density polyethylene (LDPE), linear low density polyethylene (LLDPE), branched low density polyethylene (BLDPE). </paragraph>
<paragraph id="P-0119" lvl="0"><number>&lsqb;0119&rsqb;</number> Polyolefins, i.e. the polymers of monoolefins exemplified in the preceding paragraph, preferably polyethylene and polypropylene, can be prepared by different, and especially by the following, methods: </paragraph>
<paragraph id="P-0120" lvl="2"><number>&lsqb;0120&rsqb;</number> a) radical polymerisation (normally under high pressure and at elevated temperature). </paragraph>
<paragraph id="P-0121" lvl="2"><number>&lsqb;0121&rsqb;</number> b) catalytic polymerisation using a catalyst that normally contains one or more than one metal of groups IVb, Vb, VIb or VII of the Periodic Table. These metals usually have one or more than one ligand, typically oxides, halides, alcoholates, esters, ethers, amines, alkyls, alkenyls and/or aryls that may be either &pgr;- or &sgr;-coordinated. These metal complexes may be in the free form or fixed on substrates, typically on activated magnesium chloride, titanium(III) chloride, alumina or silicon oxide. These catalysts may be soluble or insoluble in the polymerisation medium. The catalysts can be used by themselves in the polymerisation or further activators may be used, typically metal alkyls, metal hydrides, metal alkyl halides, metal alkyl oxides or metal alkyloxanes, said metals being elements of groups Ia, IIa and/or IIIa of the Periodic Table. The activators may be modified conveniently with further ester, ether, amine or silyl ether groups. These catalyst systems are usually termed Phillips, Standard Oil Indiana, Ziegler (-Natta), TNZ (DuPont), metallocene or single site catalysts (SSC). </paragraph>
<paragraph id="P-0122" lvl="2"><number>&lsqb;0122&rsqb;</number> 2. Mixtures of the polymers mentioned under 1), for example mixtures of polypropylene with polyisobutylene, polypropylene with polyethylene (for example PP/HDPE, PP/LDPE) and mixtures of different types of polyethylene (for example LDPE/HDPE). </paragraph>
<paragraph id="P-0123" lvl="2"><number>&lsqb;0123&rsqb;</number> 3. Copolymers of monoolefins and diolefins with each other or with other vinyl monomers, for example ethylene/propylene copolymers, linear low density polyethylene (LLDPE) and mixtures thereof with low density polyethylene (LDPE), propylene/but-1-ene copolymers, propylene/isobutylene copolymers, ethylene/but-1-ene copolymers, ethylene/hexene copolymers, ethylene/methylpentene copolymers, ethylene/heptene copolymers, ethylene/octene copolymers, propylene/butadiene copolymers, isobutylene/isoprene copolymers, ethylene/alkyl acrylate copolymers, ethylene/alkyl methacrylate copolymers, ethylene/vinyl acetate copolymers and their copolymers with carbon monoxide or ethylene/acrylic acid copolymers and their salts (ionomers) as well as terpolymers of ethylene with propylene and a diene such as hexadiene, dicyclopentadiene or ethylidene-norbornene; and mixtures of such copolymers with one another and with polymers mentioned in 1) above, for example polypropylene/ethylene-propylene copolymers, LDPE/ethylene-vinyl acetate copolymers (EVA), LDPE/ethylene-acrylic acid copolymers (EAA), LLDPE/EVA, LLDPE/EAA and alternating or random polyalkylene/carbon monoxide copolymers and mixtures thereof with other polymers, for example polyamides. </paragraph>
<paragraph id="P-0124" lvl="2"><number>&lsqb;0124&rsqb;</number> 4. Hydrocarbon resins (for example C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>9</subscript></highlight>) including hydrogenated modifications thereof (e.g. tackifiers) and mixtures of polyalkylenes and starch. </paragraph>
<paragraph id="P-0125" lvl="2"><number>&lsqb;0125&rsqb;</number> 5. Polystyrene, poly(p-methylstyrene), poly(&agr;-methylstyrene). </paragraph>
<paragraph id="P-0126" lvl="2"><number>&lsqb;0126&rsqb;</number> 6. Copolymers of styrene or &agr;-methylstyrene with dienes or acrylic derivatives, for example styrene/butadiene, styrene/acrylonitrile, styrene/alkyl methacrylate, styrene/butadiene/alkyl acrylate, styrene/butadiene/alkyl methacrylate, styrene/maleic anhydride, styrene/acrylonitrile/methyl acrylate; mixtures of high impact strength of styrene copolymers and another polymer, for example a polyacrylate, a diene polymer or an ethylene/propylene/diene terpolymer; and block copolymers of styrene such as styrene/butadiene/styrene, styrene/isoprene/styrene, styrene/ethylene/butylene/styrene or styrene/ethylene/propylene/styrene. </paragraph>
<paragraph id="P-0127" lvl="2"><number>&lsqb;0127&rsqb;</number> 7. Graft copolymers of styrene or o-methylstyrene, for example styrene on polybutadiene, styrene on polybutadiene-styrene or polybutadiene-acrylonitrile copolymers; styrene and acrylonitrile (or methacrylonitrile) on polybutadiene; styrene, acrylonitrile and methyl methacrylate on polybutadiene; styrene and maleic anhydride on polybutadiene; styrene, acrylonitrile and maleic anhydride or maleimide on polybutadiene; styrene and maleimide on polybutadiene; styrene and alkyl acrylates or methacrylates on polybutadiene; styrene and acrylonitrile on ethylene/propylene/diene terpolymers; styrene and acrylonitrile on polyalkyl acrylates or polyalkyl methacrylates, styrene and acrylonitrile on acrylate/butadiene copolymers, as well as mixtures thereof with the copolymers listed under 6), for example the copolymer mixtures known as ABS, MBS, ASA or AES polymers. </paragraph>
<paragraph id="P-0128" lvl="2"><number>&lsqb;0128&rsqb;</number> 8. Halogen-containing polymers such as polychloroprene, chlorinated rubbers, chlorinated or sulfochlorinated polyethylene, copolymers of ethylene and chlorinated ethylene, epichlorohydrin homo- and copolymers, especially polymers of halogen-containing vinyl compounds, for example polyvinyl chloride, polyvinylidene chloride, polyvinyl fluoride, polyvinylidene fluoride, as well as copolymers thereof such as vinyl chloride/vinylidene chloride, vinyl chloride/vinyl acetate or vinylidene chloride/vinyl acetate copolymers. </paragraph>
<paragraph id="P-0129" lvl="2"><number>&lsqb;0129&rsqb;</number> 9. Polymers derived from &agr;,&bgr;-unsaturated acids and derivatives thereof such as polyacrylates and polymethacrylates; polymethyl methacrylates, polyacrylamides and polyacrylonitriles, impact-modified with butyl acrylate. </paragraph>
<paragraph id="P-0130" lvl="2"><number>&lsqb;0130&rsqb;</number> 10. Copolymers of the monomers mentioned under 9) with each other or with other unsaturated monomers, for example acrylonitrile/butadiene copolymers, acrylonitrile/alkyl acrylate copolymers, acrylonitrile/alkoxyalkyl acrylate or acrylonitrile/vinyl halide copolymers or acrylonitrile/alkyl methacrylate/butadiene terpolymers. </paragraph>
<paragraph id="P-0131" lvl="2"><number>&lsqb;0131&rsqb;</number> 11. Polymers derived from unsaturated alcohols and amines or the acyl derivatives or acetals thereof, for example polyvinyl alcohol, polyvinyl acetate, polyvinyl stearate, polyvinyl benzoate, polyvinyl maleate, polyvinyl butyral, polyallyl phthalate or polyallyl melamine; as well as their copolymers with olefins mentioned in 1) above. </paragraph>
<paragraph id="P-0132" lvl="2"><number>&lsqb;0132&rsqb;</number> 12. Homopolymers and copolymers of cyclic ethers such as polyalkylene glycols, polyethylene oxide, polypropylene oxide or copolymers thereof with bisglycidyl ethers. </paragraph>
<paragraph id="P-0133" lvl="2"><number>&lsqb;0133&rsqb;</number> 13. Polyacetals such as polyoxymethylene and those polyoxymethylenes which contain ethylene oxide as a comonomer; polyacetals modified with thermoplastic polyurethanes, acrylates or MBS. </paragraph>
<paragraph id="P-0134" lvl="2"><number>&lsqb;0134&rsqb;</number> 14. Polyphenylene oxides and sulfides, and mixtures of polyphenylene oxides with styrene polymers or polyamides. </paragraph>
<paragraph id="P-0135" lvl="2"><number>&lsqb;0135&rsqb;</number> 15. Polyurethanes derived from hydroxyl-terminated polyethers, polyesters or polybutadienes on the one hand and aliphatic or aromatic polyisocyanates on the other, as well as precursors thereof. </paragraph>
<paragraph id="P-0136" lvl="2"><number>&lsqb;0136&rsqb;</number> 16. Polyamides and copolyamides derived from diamines and dicarboxylic acids and/or from aminocarboxylic acids or the corresponding lactams, for example polyamide 4, polyamide 6, polyamide 6/6, 6/10, 6/9, 6/12, 4/6, 12/12, polyamide 11, polyamide 12, aromatic polyamides starting from m-xylene diamine and adipic acid; polyamides prepared from hexamethylenediamine and isophthalic or/and terephthalic acid and with or without an elastomer as modifier, for example poly-2,4,4,-trimethylhexamethylene terephthalamide or poly-m-phenylene isophthalamide; and also block copolymers of the aforementioned polyamides with polyolefins, olefin copolymers, ionomers or chemically bonded or grafted elastomers; or with polyethers, e.g. with polyethylene glycol, polypropylene glycol or polytetramethylene glycol; as well as polyamides or copolyamides modified with EPDM or ABS; and polyamides condensed during processing (RIM polyamide systems). </paragraph>
<paragraph id="P-0137" lvl="2"><number>&lsqb;0137&rsqb;</number> 17. Polyureas, polyimides, polyamide-imides and polybenzimidazoles. </paragraph>
<paragraph id="P-0138" lvl="2"><number>&lsqb;0138&rsqb;</number> 18. Polyesters derived from dicarboxylic acids and diols and/or from hydroxycarboxylic acids or the corresponding lactones, for example polyethylene terephthalate, polybutylene terephthalate, poly-1,4-dimethylolcyclohexane terephthalate and polyhydroxybenzoates, as well as block copolyether esters derived from hydroxyl-terminated polyethers; and also polyesters modified with polycarbonates or MBS. </paragraph>
<paragraph id="P-0139" lvl="2"><number>&lsqb;0139&rsqb;</number> 19. Polycarbonates and polyester carbonates. </paragraph>
<paragraph id="P-0140" lvl="2"><number>&lsqb;0140&rsqb;</number> 20. Polysulfones, polyether sulfones and polyether ketones. </paragraph>
<paragraph id="P-0141" lvl="2"><number>&lsqb;0141&rsqb;</number> 21. Crosslinked polymers derived from aldehydes on the one hand and phenols, ureas and melamines on the other hand, such as phenol/formaldehyde resins, urea/formaldehyde resins and melamine/formaldehyde resins. </paragraph>
<paragraph id="P-0142" lvl="2"><number>&lsqb;0142&rsqb;</number> 22. Drying and non-drying alkyd resins. </paragraph>
<paragraph id="P-0143" lvl="2"><number>&lsqb;0143&rsqb;</number> 23. Unsaturated polyester resins derived from copolyesters of saturated and unsaturated dicarboxylic acids with polyhydric alcohols and vinyl compounds as crosslinking agents, and also halogen-containing modifications thereof of low flammability. </paragraph>
<paragraph id="P-0144" lvl="2"><number>&lsqb;0144&rsqb;</number> 24. Crosslinkable acrylic resins derived from substituted acrylates, for example epoxy acrylates, urethane acrylates or polyester acrylates. </paragraph>
<paragraph id="P-0145" lvl="2"><number>&lsqb;0145&rsqb;</number> 25. Alkyd resins, polyester resins and acrylate resins crosslinked with melamine resins, urea resins, polyisocyanates or epoxy resins. </paragraph>
<paragraph id="P-0146" lvl="2"><number>&lsqb;0146&rsqb;</number> 26. Crosslinked epoxy resins derived from polyepoxides, for example from bisglycidyl ethers or from cycloaliphatic diepoxides. </paragraph>
<paragraph id="P-0147" lvl="2"><number>&lsqb;0147&rsqb;</number> 27. Natural polymers such as cellulose, rubber, gelatin and chemically modified homologous derivatives thereof, for example cellulose acetates, cellulose propionates and cellulose butyrates, or the cellulose ethers such as methyl cellulose; as well as rosins and their derivatives. </paragraph>
<paragraph id="P-0148" lvl="2"><number>&lsqb;0148&rsqb;</number> 28. Blends of the aforementioned polymers (polyblends), for example PP/EPDM, Polyamide/EPDM or ABS, PVC/EVA, PVC/ABS, PVC/MBS, PC/ABS, PBTP/ABS, PC/ASA, PC/PBT, PVC/CPE, PVC/acrylates, POM/thermoplastic PUR, PC/thermoplastic PUR, POM/acrylate, POM/MBS, PPO/HIPS, PPO/PA 6.6 and copolymers, PA/HDPE, PA/PP, PA/PPO. </paragraph>
<paragraph id="P-0149" lvl="2"><number>&lsqb;0149&rsqb;</number> 29. Naturally occurring and synthetic organic materials which are pure monomeric compounds or mixtures of such compounds, for example mineral oils, animal and vegetable fats, oil and waxes, or oils, fats and waxes based on synthetic esters (e.g. phthalates, adipates, phosphates or trimellitates) and also mixtures of synthetic esters with mineral oils in any weight ratios, typically those used as spinning compositions, as well as aqueous emulsions of such materials. </paragraph>
<paragraph id="P-0150" lvl="2"><number>&lsqb;0150&rsqb;</number> 30. Aqueous emulsions of natural or synthetic rubber, e.g. natural latex or latices of carboxylated styrene/butadiene copolymers. </paragraph>
<paragraph id="P-0151" lvl="2"><number>&lsqb;0151&rsqb;</number> 31. Polysiloxanes such as the soft, hydrophilic polysiloxanes described, for example, in U.S. Pat. No. 4,259,467; and the hard polyorganosiloxanes described, for example, in U.S. Pat. No. 4,355,147. </paragraph>
<paragraph id="P-0152" lvl="2"><number>&lsqb;0152&rsqb;</number> 32. Polyketimines in combination with unsaturated acrylic polyacetoacetate resins or with unsaturated acrylic resins. The unsaturated acrylic resins include the urethane acrylates, polyether acrylates, vinyl or acryl copolymers with pendant unsaturated groups and the acrylated melamines. The polyketimines are prepared from polyamines and ketones in the presence of an acid catalyst. </paragraph>
<paragraph id="P-0153" lvl="2"><number>&lsqb;0153&rsqb;</number> 33. Radiation curable compositions containing ethylenically unsaturated monomers or oligomers and a polyunsaturated aliphatic oligomer. </paragraph>
<paragraph id="P-0154" lvl="2"><number>&lsqb;0154&rsqb;</number> 34. Epoxymelamine resins such as light-stable epoxy resins crosslinked by an epoxy functional coetherified high solids melamine resin such as LSE-4103 (Monsanto). </paragraph>
<paragraph id="P-0155" lvl="0"><number>&lsqb;0155&rsqb;</number> In general, the compounds of the present invention are employed in from about 0.01 to about 5% by weight of the stabilized composition, although this will vary with the particular substrate and application. An advantageous range is from about 0.05 to about 3%, and especially 0.05 to about 1%. However, some high performance films or in UV absorbing layers of laminates such as those produced by coextrusion may contain from 5-15% by weight of the instant compounds. Concentrations of 5-10% by weight are typical in certain coextrusion applications. </paragraph>
<paragraph id="P-0156" lvl="0"><number>&lsqb;0156&rsqb;</number> The stabilizers of the instant invention may readily be incorporated into the organic polymers by conventional techniques, at any convenient stage prior to the manufacture of shaped articles therefrom. For example, the stabilizer may be mixed with the polymer in dry powder form, or a suspension or emulsion of the stabilizer may be mixed with a solution, suspension, or emulsion of the polymer. The resulting stabilized polymer compositions of the invention may optionally also contain from about 0.01 to about 5%, preferably from about 0.025 to about 2%, and especially from about 0.1 to about 1% by weight of various conventional additives, such as the materials listed below, or mixtures thereof. </paragraph>
<paragraph id="P-0157" lvl="7"><number>&lsqb;0157&rsqb;</number> 1. Antioxidants </paragraph>
<paragraph id="P-0158" lvl="0"><number>&lsqb;0158&rsqb;</number> 1.1. Alkylated Monophenols, for Example. </paragraph>
<paragraph id="P-0159" lvl="2"><number>&lsqb;0159&rsqb;</number> 2,6-di-tert-butyl-4-methylphenol </paragraph>
<paragraph id="P-0160" lvl="2"><number>&lsqb;0160&rsqb;</number> 2-tert-butyl-4,6-dimethylphenol </paragraph>
<paragraph id="P-0161" lvl="2"><number>&lsqb;0161&rsqb;</number> 2,6-di-tert-butyl-4-ethylphenol </paragraph>
<paragraph id="P-0162" lvl="2"><number>&lsqb;0162&rsqb;</number> 2,6-di-tert-butyl-4-n-butylphenol </paragraph>
<paragraph id="P-0163" lvl="2"><number>&lsqb;0163&rsqb;</number> 2,6-di-tert-butyl-4-i-butylphenol </paragraph>
<paragraph id="P-0164" lvl="2"><number>&lsqb;0164&rsqb;</number> 2,6-di-cyclopentyl-4-methylphenol </paragraph>
<paragraph id="P-0165" lvl="2"><number>&lsqb;0165&rsqb;</number> 2-(&agr;-methylcyclohexyl)4,6-dimethylphenol </paragraph>
<paragraph id="P-0166" lvl="2"><number>&lsqb;0166&rsqb;</number> 2,6-di-octadecyl-4-methylphenol </paragraph>
<paragraph id="P-0167" lvl="2"><number>&lsqb;0167&rsqb;</number> 2,4,6-tri-cyclohexylphenol </paragraph>
<paragraph id="P-0168" lvl="2"><number>&lsqb;0168&rsqb;</number> 2,6-di-tert-butyl-4-methoxymethylphenol </paragraph>
<paragraph id="P-0169" lvl="0"><number>&lsqb;0169&rsqb;</number> 1.2. Alkylated Hydroquinones, for Example, </paragraph>
<paragraph id="P-0170" lvl="2"><number>&lsqb;0170&rsqb;</number> 2,6-di-tert-butyl-4-methoxyphenol </paragraph>
<paragraph id="P-0171" lvl="2"><number>&lsqb;0171&rsqb;</number> 2,5-di-tert-butyl-hydroquinone </paragraph>
<paragraph id="P-0172" lvl="2"><number>&lsqb;0172&rsqb;</number> 2,5-di-tert-amyl-hydroquinone </paragraph>
<paragraph id="P-0173" lvl="2"><number>&lsqb;0173&rsqb;</number> 2,6-diphenyl-4-octadecyloxyphenol </paragraph>
<paragraph id="P-0174" lvl="0"><number>&lsqb;0174&rsqb;</number> 1.3. Hydroxylated Thiodiphenyl Ethers, for Example, </paragraph>
<paragraph id="P-0175" lvl="2"><number>&lsqb;0175&rsqb;</number> 2,2&prime;-thio-bis-(6-tert-butyl-4-methylphenol) </paragraph>
<paragraph id="P-0176" lvl="2"><number>&lsqb;0176&rsqb;</number> 2,2&prime;-thio-bis-(4-octylphenol) </paragraph>
<paragraph id="P-0177" lvl="2"><number>&lsqb;0177&rsqb;</number> 4,4&prime;-thio-bis-(6-tert-butyl-3-methylphenol) </paragraph>
<paragraph id="P-0178" lvl="2"><number>&lsqb;0178&rsqb;</number> 4,4&prime;-thio-bis-(6-tert-butyl-2-methylphenol) </paragraph>
<paragraph id="P-0179" lvl="0"><number>&lsqb;0179&rsqb;</number> 1.4. Alkylidene-Bisphenols, for Example. </paragraph>
<paragraph id="P-0180" lvl="2"><number>&lsqb;0180&rsqb;</number> 2,2&prime;-methylene-bis-(6-tert-butyl-4-methylphenol) </paragraph>
<paragraph id="P-0181" lvl="2"><number>&lsqb;0181&rsqb;</number> 2,2&prime;-methylene-bis-(6-tert-butyl-4-ethylphenol) </paragraph>
<paragraph id="P-0182" lvl="2"><number>&lsqb;0182&rsqb;</number> 2,2&prime;-methylene-bis-&lsqb;4-methyl-6-(&agr;-methylcyclohexyl)-phenol&rsqb;</paragraph>
<paragraph id="P-0183" lvl="2"><number>&lsqb;0183&rsqb;</number> 2,2&prime;-methylene-bis-(4-methyl-6-cyclohexylphenol) </paragraph>
<paragraph id="P-0184" lvl="2"><number>&lsqb;0184&rsqb;</number> 2,2&prime;-methylene-bis-(6-nonyl-4-methylphenol) </paragraph>
<paragraph id="P-0185" lvl="2"><number>&lsqb;0185&rsqb;</number> 2,2&prime;-methylene-bis-&lsqb;6-(&agr;-methylbenzyl)4-nonylphenol&rsqb;</paragraph>
<paragraph id="P-0186" lvl="2"><number>&lsqb;0186&rsqb;</number> 2,2&prime;-methylene-bis-&lsqb;6-(&agr;,&agr;-dimethylbenzyl)4-nonylphenol&rsqb;</paragraph>
<paragraph id="P-0187" lvl="2"><number>&lsqb;0187&rsqb;</number> 2,2&prime;-methylene-bis-(4,6-di-tert-butylphenol) </paragraph>
<paragraph id="P-0188" lvl="2"><number>&lsqb;0188&rsqb;</number> 2,2&prime;-ethylidene-bis-(4,6-di-tert-butylphenol) </paragraph>
<paragraph id="P-0189" lvl="2"><number>&lsqb;0189&rsqb;</number> 2,2&prime;-ethylidene-bis-(6-tert-butyl-4-isobutylphenol) </paragraph>
<paragraph id="P-0190" lvl="2"><number>&lsqb;0190&rsqb;</number> 4,4&prime;-methylene-bis-(2,6-di-tert-butylphenol) </paragraph>
<paragraph id="P-0191" lvl="2"><number>&lsqb;0191&rsqb;</number> 4,4&prime;-methylene-bis-(6-tert-butyl-2-methylphenol) </paragraph>
<paragraph id="P-0192" lvl="2"><number>&lsqb;0192&rsqb;</number> 1,1-bis-(5-tert-butyl-4-hydroxy-2-methylphenyl)-butane </paragraph>
<paragraph id="P-0193" lvl="2"><number>&lsqb;0193&rsqb;</number> 2,6-di-(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol </paragraph>
<paragraph id="P-0194" lvl="2"><number>&lsqb;0194&rsqb;</number> 1,1,3-tris-(5-tert-butyl-4-hydroxy-2-methylphenyl)-butane </paragraph>
<paragraph id="P-0195" lvl="2"><number>&lsqb;0195&rsqb;</number> 1,1-bis-(5-tert-butyl-4-hydroxy-2-methylphenyl)-3-n-dodecylmercaptobutane </paragraph>
<paragraph id="P-0196" lvl="2"><number>&lsqb;0196&rsqb;</number> ethyleneglycol bis-&lsqb;3,3-bis-(3&prime;-tert-butyl-4&prime;-hydroxyphenyl)-butyrate&rsqb;</paragraph>
<paragraph id="P-0197" lvl="2"><number>&lsqb;0197&rsqb;</number> di-(3-tert-butyl-4-hydroxy-5-methylphenyl)-dicyclopentadiene </paragraph>
<paragraph id="P-0198" lvl="2"><number>&lsqb;0198&rsqb;</number> di-&lsqb;2-(3&prime;-tert-butyl-2&prime;-hydroxy-5&prime;-methyl-benzyl)-6-tert-butyl-4-methylphenyl&rsqb; terephthalate. </paragraph>
<paragraph id="P-0199" lvl="0"><number>&lsqb;0199&rsqb;</number> 1.5. Benzyl Compounds, for Example, </paragraph>
<paragraph id="P-0200" lvl="2"><number>&lsqb;0200&rsqb;</number> 1,3,5-tri-(3,5-di-tert-butyl-4-hydroxybenzyl)-2,4,6-trimethylbenzene </paragraph>
<paragraph id="P-0201" lvl="2"><number>&lsqb;0201&rsqb;</number> di-(3,5-di-tert-butyl-4-hydroxybenzyl) sulfide </paragraph>
<paragraph id="P-0202" lvl="2"><number>&lsqb;0202&rsqb;</number> 3,5-di-tert-butyl-4-hydroxybenzyl-mercapto-acetic acid isooctyl ester </paragraph>
<paragraph id="P-0203" lvl="2"><number>&lsqb;0203&rsqb;</number> bis-(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)dithiol terephthalate </paragraph>
<paragraph id="P-0204" lvl="2"><number>&lsqb;0204&rsqb;</number> 1,3,5-tris-(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate </paragraph>
<paragraph id="P-0205" lvl="2"><number>&lsqb;0205&rsqb;</number> 1,3,5-tris-(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate </paragraph>
<paragraph id="P-0206" lvl="2"><number>&lsqb;0206&rsqb;</number> 3,5-di-tert-butyl-4-hydroxybenzyl-phosphoric acid dioctadecyl ester </paragraph>
<paragraph id="P-0207" lvl="2"><number>&lsqb;0207&rsqb;</number> 3,5-di-tert-butyl-4-hydroxybenzyl-phosphoric acid monoethyl ester, calcium-salt </paragraph>
<paragraph id="P-0208" lvl="0"><number>&lsqb;0208&rsqb;</number> 1.6. Acylaminophenols, for Example, </paragraph>
<paragraph id="P-0209" lvl="2"><number>&lsqb;0209&rsqb;</number> 4-hydroxy-lauric acid anilide </paragraph>
<paragraph id="P-0210" lvl="2"><number>&lsqb;0210&rsqb;</number> 4-hydroxy-stearic acid anilide </paragraph>
<paragraph id="P-0211" lvl="2"><number>&lsqb;0211&rsqb;</number> 2,4-bis-octylmercapto-6-(3,5-tert-butyl-4-hydroxyanilino)-s-triazine </paragraph>
<paragraph id="P-0212" lvl="2"><number>&lsqb;0212&rsqb;</number> octyl-N-(3,5-di-tert-butyl-4-hydroxyphenyl)-carbamate </paragraph>
<paragraph id="P-0213" lvl="0"><number>&lsqb;0213&rsqb;</number> 1.7. Esters of &bgr;-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionic Acid with Monohydric or Polyhydric Alcohols, for Example,  
<table-cwu id="TABLE-US-00001">
<number>1</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="77PT" align="left"/>
<colspec colname="2" colwidth="126PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>methanol</entry>
<entry>diethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>octadecanol</entry>
<entry>triethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>1,6-hexanediol</entry>
<entry>pentaerythritol</entry>
</row>
<row>
<entry></entry>
<entry>neopentyl glycol</entry>
<entry>tris-hydroxyethyl isocyanurate</entry>
</row>
<row>
<entry></entry>
<entry>thiodiethylene glycol</entry>
<entry>di-hydroxyethyl oxalic acid diamide</entry>
</row>
<row>
<entry></entry>
<entry>triethanolamine</entry>
<entry>triisopropanolamine</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0214" lvl="0"><number>&lsqb;0214&rsqb;</number> 1.8. Esters of &bgr;-(5-tert-butyl-4-hydroxy-3-methylphenyl)-propionic Acid with Monohydric or Polyhydric Alcohols, for Example,  
<table-cwu id="TABLE-US-00002">
<number>2</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="77PT" align="left"/>
<colspec colname="2" colwidth="126PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>methanol</entry>
<entry>diethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>octadecanol</entry>
<entry>triethylene glycol</entry>
</row>
<row>
<entry></entry>
<entry>1,6-hexanediol</entry>
<entry>pentaerythritol</entry>
</row>
<row>
<entry></entry>
<entry>neopentyl glycol</entry>
<entry>tris-hydroxyethyl isocyanurate</entry>
</row>
<row>
<entry></entry>
<entry>thiodiethylene glycol</entry>
<entry>di-hydroxyethyl oxalic acid diamide</entry>
</row>
<row>
<entry></entry>
<entry>triethanolamine</entry>
<entry>triisopropanolamine</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0215" lvl="0"><number>&lsqb;0215&rsqb;</number> 1.9. Amides of &bgr;13-(3.5-di-tert-butyl-4-hydroxyphenyl)-propionic Acid for Example, </paragraph>
<paragraph id="P-0216" lvl="2"><number>&lsqb;0216&rsqb;</number> N,N&prime;-di-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-hexamethylenediamine </paragraph>
<paragraph id="P-0217" lvl="2"><number>&lsqb;0217&rsqb;</number> N,N&prime;-di-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-trimethylenediamine </paragraph>
<paragraph id="P-0218" lvl="2"><number>&lsqb;0218&rsqb;</number> N,N&prime;-di-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-hydrazine </paragraph>
<paragraph id="P-0219" lvl="0"><number>&lsqb;0219&rsqb;</number> 1.10 Diarylamines, for Example, diphenylamine, N-phenyl-1-naphthylamine, N-(4-tert-octylphenyl)-1-naphthylamine, 4,4&prime;-di-tert-octyl-diphenylamine, reaction product of N-phenylbenzylamine and 2,4,4-trimethylpentene, reaction product of diphenylamine and 2,4,4-trimethylpentene, reaction product of N-phenyl-1-naphthylamine and 2,4,4-trimethylpentene. </paragraph>
<paragraph id="P-0220" lvl="7"><number>&lsqb;0220&rsqb;</number> 2. UV Absorbers and Light Stabilizers </paragraph>
<paragraph id="P-0221" lvl="0"><number>&lsqb;0221&rsqb;</number> 2.1. 2-(2&prime;-Hydroxyphenyl)-benzotriazoles, for example, the 5&prime;-methyl-, 3&prime;,5&prime;-di-tert-butyl-, 5&prime;-tert-butyl-, 5&prime;-(1,1,3,3-tetramethylbutyl)-, 5-chloro-3&prime;,5&prime;-di-tert-butyl-, 5-chloro-3&prime;-tert-butyl-5&prime;-methyl-, 3&prime;-sec-butyl-5&prime;-tert-butyl-, 4&prime;-octoxy, 3&prime;,5&prime;-di-tert-amyl-, 3&prime;,5&prime;-bis-(&agr;,&agr;-dimethylbenzyl), 3&prime;-tert-butyl-5&prime;-(2-(omega-hydroxy-octa-(ethyleneoxy)carbonyl-ethyl)-, 3&prime;-dodecyl-5&prime;-methyl-, and 3&prime;-tert-butyl-5&prime;-(2-octyloxycarbonyl)ethyl-, and dodecylated-5&prime;-methyl derivatives. </paragraph>
<paragraph id="P-0222" lvl="0"><number>&lsqb;0222&rsqb;</number> 2.2. 2-Hydroxy-benzophenone, for example, the 4-hydroxy-, 4-methoxy-, 4-octoxy, 4-decyloxy-, 4-dodecyloxy-, 4-benzyloxy, 4,2&prime;,4&prime;-trihydroxy- and 2&prime;-hydroxy-4,4&prime;-dimethoxy derivatives. </paragraph>
<paragraph id="P-0223" lvl="0"><number>&lsqb;0223&rsqb;</number> 2.3. Esters of optionally substituted benzoic acids for example, phenyl salicylate, 4-tert-butylphenyl salicylate, octylphenyl salicylate, dibenzoylresorcinol, bis-(4-tert-butylbenzoyl)-resorcinol, benzoylresorcinol, 3,5-di-tert-butyl-4-hydroxybenzoic acid 2,4-di-tert-butylphenyl ester and 3,5-di-tert-butyl-4-hydroxybenzoic acid hexadecyl ester. </paragraph>
<paragraph id="P-0224" lvl="0"><number>&lsqb;0224&rsqb;</number> 2.4. Acrylates, for example, &agr;-cyano-&bgr;,&bgr;-diphenylacrylic acid ethyl ester or isooctyl ester, &agr;-carbomethoxy-cinnamic acid methyl ester, &agr;-cyano-&bgr;-methyl-p-methoxy-cinnamic acid methyl ester or butyl ester, &agr;-carbomethoxy-p-methoxy-cinnamic acid methyl ester, N-(&bgr;-carbomethoxy-&bgr;-cyanovinyl)-2-methyl-indoline. </paragraph>
<paragraph id="P-0225" lvl="0"><number>&lsqb;0225&rsqb;</number> 2.5. Nickel compounds, for example, nickel complexes of 2,2&prime;-thio-bis-&lsqb;4-(1,1,3,3-tetramethylbutyl)-phenol&rsqb;, such as the 1:1 or 1:2 complex, optionally with additional ligands such as n-butylamine, triethanolamine or N-cyclohexyl-diethanolamine, nickel dibutyldithiocarbamate, nickel salts of 4-hydroxy-3,5-di-tert-butylbenzylphosphonic acid monoalkyl esters, such as of the methyl, ethyl or butyl ester, nickel complexes of ketoximes such as of 2-hydroxy-4-methyl-phenyl undecyl ketoxime, nickel complexes of 1-phenyl-4-lauroyl-5-hydroxy-pyrazole, optionally with additional ligands. </paragraph>
<paragraph id="P-0226" lvl="0"><number>&lsqb;0226&rsqb;</number> 2.6. Sterically hindered amines, for example bis-(2,2,6,6-tetramethylpiperidyl) sebacate, bis-(1,2,2,6,6-pentamethylpiperidyl) sebacate, n-butyl-3,5-di-tert.butyl-4-hydroxybenzyl malonic acid bis-(1,2,2,6,6-pentanemethylpiperidyl)ester, condensation product of 1-hydroxyethyl-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, condensation product of N,N&prime;-(2,2,6,6-tetra-methylpiperidyl)-hexamethylenediamine and 4-tert-octylamino-2,6-dichloro-s-triazine, tris-(2,2,6,6-tetramethylpiperidyl)-nitrilotriacetate, tetrakis-(2,2,6,6-tetramethyl-4-piperidyl) 1,2,3,4-butanetetracarboxylate, 1,1&prime;(1,2-ethanediyl)-bis-(3,3,5,5-tetramethylpiperazinone), bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, 1-(2-hydroxy-2-methylpropoxy)-4-octa-decanoyloxy-2,2,6,6-tetramethylpiperidine. </paragraph>
<paragraph id="P-0227" lvl="0"><number>&lsqb;0227&rsqb;</number> 2.7. Oxalic acid diamides, for example, 4,4&prime;-di-octyloxy-oxanilide, 2,2&prime;-di-octyloxy-5,5&prime;-di-tert-butyl-oxanilide, 2,2&prime;-di-dodecyloxy-5,5&prime;-di-tert-butyl-oxanilide, 2-ethoxy-2&prime;-ethyl-oxanilide, N,N&prime;-bis (3-dimethylaminopropyl)-oxalamide, 2-ethoxy-5-tert-butyl-2&prime;-ethyloxanilide and its mixture with 2-ethoxy-2&prime;-ethyl-5,4&prime;-di-tert-butyloxanilide and mixtures of ortho- and para-methoxy- as well as of o- and p-ethoxy-disubstituted oxanilides. </paragraph>
<paragraph id="P-0228" lvl="0"><number>&lsqb;0228&rsqb;</number> 2.8. Hydroxyphenyl-s-triazines, for example 2,6-bis-(2,4-dimethylphenyl)4-(2-hydroxy-4-octyloxyphenyl)-s-triazine; 2,6-bis-(2,4-dimethylphenyl)4-(2,4-dihydroxyphenyl)-s-triazine; 2,4-bis(2,4-dihydroxyphenyl)-6-(4-chlorophenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy4-(2-hydroxy-ethoxy)phenyl&rsqb;-6-(4-chlorophenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy4-(2-hydroxy-4-(2-hydroxy-ethoxy)phenyl&rsqb;-6-(2,4-dimethylphenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy-4-(2-hydroxyethoxy)phenyl&rsqb;-6-(4-bromophenyl)-s-triazine; 2,4-bis&lsqb;2-hydroxy-4-(2-acetoxyethoxy)phenyl&rsqb;-6-(4-chlorophenyl s-triazine, 2,4-bis(2,4-dihydroxyphenyl)-6-(2,4-dimethylphenyl)-s-triazine. </paragraph>
<paragraph id="P-0229" lvl="7"><number>&lsqb;0229&rsqb;</number> 3. Metal deactivators, for example, N,N&prime;-diphenyloxalic acid diamide, N-salicylal-N&prime;-salicyloyl-hydrazine, N,N&prime;-bis-salicyloylhydrazine, N,N&prime;-bis-(3,5-di-tert-butyl-4-hydroxyphenylpropionyl)-hydrazine, 3-salicyloylamino-1,2,4-triazole, bis-benzylidene-oxalic acid dihydrazide. </paragraph>
<paragraph id="P-0230" lvl="7"><number>&lsqb;0230&rsqb;</number> 4. Phosphites and phosphonites, for example, triphenyl phosphite, diphenylalkyl phosphites, phenyldialkyl phosphites, tri-(nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, di-stearyl-pentaerythritol diphosphite, tris-(2,4-di-tert-butylphenyl) phosphite, di-isodecyl-pentaerythritol diphosphite, di-(2,4,6-tri-tert-butylphenyl)-pentaerythritol diphosphite, di-(2,4-di-tert-butyl-6-methylphenyl)-pentaerythritol diphosphite, di-(2,4-di-tert-butylphenyl)pentaerythritol diphosphite, tristearyl-sorbitol triphosphite, tetrakis-(2,4-di-tert-butylphenyl) 4,4&prime;-diphenylylenediphosphonite. </paragraph>
<paragraph id="P-0231" lvl="7"><number>&lsqb;0231&rsqb;</number> 5. Compounds which destroy Peroxide, for example, esters of &bgr;-thiodipropionic acid, for example the lauryl, stearyl, myristyl or tridecyl esters, mercapto-benzimidazole or the zinc salt of 2-mercaptobenzimidazole, zinc dibutyl-dithiocarbamate, dioctadecyl disulfide, pentaerythritol tetrakis-(&bgr;-dodecylmercapto)-propionate. </paragraph>
<paragraph id="P-0232" lvl="7"><number>&lsqb;0232&rsqb;</number> 6. Hydroxylamines, for example, N,N-dibenzylhydroxylamine, N,N-diethylhydroxylamine, N,N-dioctylhydroxylamine, N,N-dilaurylhydroxylamine, N,N-ditetradecylhydroxylamine, N,N-dihexadecylhydroxylamine, N,N-dioctadecylhydroxylamine, N-hexadecyl-N-octadecylhydroxyl-amine, N-heptadecyl-N-octadecylhydroxylamine, N,N-dialkylhydroxylamine derived from hydrogenated tallow amine. </paragraph>
<paragraph id="P-0233" lvl="7"><number>&lsqb;0233&rsqb;</number> 7. Nitrones, for example, N-benzyl-alpha-phenyl nitrone, N-ethyl-alpha-methyl nitrone, N-octyl-alpha-heptyl nitrone, N-lauryl-alpha-undecyl nitrone, N-tetradecyl-alpha-tridecyl nitrone, N-hexadecyl-alpha-pentadecyl nitrone, N-octadecyl-alpha-pentadecyl nitrone, N-hexadecyl-alpha-heptadecyl nitrone, N-octadecyl-alpha-pentadecyl nitrone, N-heptadecyl-alpha-heptadecyl nitrone, N-octadecyl-alpha-hexadecyl nitrone, nitrone derived from N,N-dialkylhydroxylamine derived from hydrogenated tallow amine. </paragraph>
<paragraph id="P-0234" lvl="7"><number>&lsqb;0234&rsqb;</number> 8. Polyamide stabilizers, for example copper salts in combination with iodides and/or phosphorus compounds and salts of divalent manganese. </paragraph>
<paragraph id="P-0235" lvl="7"><number>&lsqb;0235&rsqb;</number> 9 Basic co-stabilizers, for example, melamine, polyvinylpyrrolidone, dicyandiamide, triallyl cyanurate, urea derivatives, hydrazine derivatives, amines, polyamides, polyurethanes, alkali metal salts and alkaline earth metal salts of higher fatty acids for example Ca stearate, Zn stearate, Mg stearate, Na ricinoleate and K palmitate, antimony pyrocatecholate or zinc pyrocatecholate. </paragraph>
<paragraph id="P-0236" lvl="7"><number>&lsqb;0236&rsqb;</number> 10. Nucleating agents, for example, 4-tert-butyl-benzoic acid, adipic acid, diphenylacetic acid. </paragraph>
<paragraph id="P-0237" lvl="7"><number>&lsqb;0237&rsqb;</number> 11. Fillers and reinforcing agents, for example, calcium carbonate, silicates, glass fibers, asbestos, talc, kaolin, mica, barium sulfate, metal oxides and hydroxides, carbon black, graphite. </paragraph>
<paragraph id="P-0238" lvl="7"><number>&lsqb;0238&rsqb;</number> 12. Other additives, for example, plasticizers, lubricants, emulsifiers, pigments, optical brighteners, flameproofing agents, anti-static agents, blowing agents and thiosynergists such as dilauryl thiodipropionate or distearyl thiodipropionate. </paragraph>
<paragraph id="P-0239" lvl="7"><number>&lsqb;0239&rsqb;</number> 13. Benzofuranones and indolinones, for example those disclosed in U.S. Pat. No. 4,325,863, U.S. Pat. No. 4,338,244 or U.S. Pat. No. 5,175,312, or 3-&lsqb;4-(2-acetoxyethoxy)phenyl&rsqb;-5,7-di-tert-butyl-benzofuran-2-one, 5,7-di-tert-butyl-3-&lsqb;4-(2-stearoyloxyethoxy)phenyl&rsqb;benzofuran-2-one, 3,3&prime;-bis&lsqb;5,7-di-tert-butyl-3-(4-&lsqb;2-hydroxyethoxy&rsqb;phenyl)benzofuran-2-one&rsqb;, 5,7-di-tert-butyl-3-(4-ethoxyphenyl)benzofuran-2-one, 3-(4-acetoxy-3,5-dimethylphenyl)-5,7-di-tert-butyl-benzofuran-2-one, 3-(3,5-di-methyl-4-pivaloyloxyphenyl)-5,7-di-tert-butyl-benzofuran-2-one. </paragraph>
<paragraph id="P-0240" lvl="0"><number>&lsqb;0240&rsqb;</number> The co-stabilizers, with the exception of the benzofuranones listed under 13, are added for example in concentrations of 0.01 to 10%, relative to the total weight of the material to be stabilized. </paragraph>
<paragraph id="P-0241" lvl="0"><number>&lsqb;0241&rsqb;</number> Further preferred compositions comprise, in addition to components (a) and (b) further additives, in particular phenolic antioxidants, light stabilizers or processing stabilizers. </paragraph>
<paragraph id="P-0242" lvl="0"><number>&lsqb;0242&rsqb;</number> Particularly preferred additives are phenolic antioxidants (item 1 of the list), sterically hindered amines (item 2.6 of the list), phosphites and phosphonites (item 4 of the list), UV absorbers (item 2 of the list) and peroxide-destroying compounds (item 5 of the list). </paragraph>
<paragraph id="P-0243" lvl="0"><number>&lsqb;0243&rsqb;</number> Additional additives (stabilizers) which are also particularly preferred are benzofuran-2-ones, such as described, for example, in U.S. Pat. No. 4,325,863, U.S. Pat. No. 4,338,244 or U.S. Pat. No. 5,175,312. </paragraph>
<paragraph id="P-0244" lvl="0"><number>&lsqb;0244&rsqb;</number> The phenolic antioxidant of particular interest is selected from the group consisting of n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinammate), di-n-octadecyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, thiodiethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene,3,6-dioxaoctamethylene bis(3-methyl-5-tert-butyl-4-hydroxyhydrocinnamate), 2,6-di-tert-butyl-p-cresol, 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol), 1,3,5-tris(2,6-dimethyl-4-tert-butyl-3-hydroxybenzyl)isocynurate, 1,1,3,-tris(2-methyl-4-hydroxy-5-tert-butylphenyl)butane, 1,3,5-tris-&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)ethyl&rsqb;isocyanur ate, 3,5-di-(3,5-di-tert-butyl-4-hydroxybenzyl)mesitol, hexamethylene bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), 1-(3,5-di-tert-butyl-4-hydroxyanilino)-3,5-di(octylthio)-s-triazine, N,N&prime;-hexamethylene-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamamide), calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzyl-phosphonate), ethylene bis&lsqb;3,3-di(3-tert-butyl-4-hydroxyphenyl)butyrate&rsqb;, octyl 3,5-di-tert-butyl-4-hydroxybenzylmercaptoacetate, bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazide, and N,N&prime;-bis&lsqb;2-(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyloxy)-eth yl&rsqb;-oxamide. </paragraph>
<paragraph id="P-0245" lvl="0"><number>&lsqb;0245&rsqb;</number> A most preferred phenolic antioxidant is neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate), n-octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, 1,3,5-tri-methyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl)isocyanurate, 2,6-di-tert-butyl-p-cresol or 2,2&prime;-ethylidene-bis(4,6-di-tert-butylphenol). </paragraph>
<paragraph id="P-0246" lvl="0"><number>&lsqb;0246&rsqb;</number> The hindered amine compound of particular interest is selected from the group consisting of bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, di(1,2,2,6,6-pentamethylpiperidin-4-yl) (3,5-di-tert-butyl-4-hydroxybenzyl)butylmalonate, 4-benzoyl-2,2,6,6-tetramethylpiperidine, 4-stearyloxy-2,2,6,6-tetramethylpiperidine, 3-n-octyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro&lsqb;4.5&rsqb;decane-2,4-dio ne, tris(2,2,6,6-tetramethylpiperidin-4-yl) nitrilotriacetate, 1,2-bis(2,2,6,6-tetramethyl-3-oxopiperazin-4-yl)ethane, 2,2,4,4-tetramethyl-7-oxa-3,20-diaza-21-oxodispiro&lsqb;5.1.11.2&rsqb; heneicosane, polycondensation product of 2,4-dichloro-6-tert-octylamino-s-triazine and 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, polycondensation product of 4,4&prime;-hexamethylenebis-(amino-2,2,6,6-tetramethylpiperidine) and 1,2-dibromoethane, tetrakis(2,2,6,6-tetramethylpiperidin-4-yl) 1,2,3,4-butanetetracarboxylate, tetrakis(1,2,2,6,6-pentamethylpiperidin-4-yl) 1,2,3,4-butanetetracarboxylate, polycondensation product of 2,4-dichloro-6-morpholino-s-triazine and 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;(4,6-bis(butyl-1,2,2,6,6-pentamethylpiperidin-4-yl)-amino-s-triazin-2-y 1&rsqb;-1,10-diamino-4,7-diazadecane, mixed &lsqb;2,2,6,6-tetramethylpiperidin-4-yl/&bgr;,&bgr;,&bgr;&prime;,&bgr;&prime;-tetramethyl-3,9-(2,4,8,10-tetraoxaspiro&lsqb;5.5&rsqb;-undecane) diethyl&rsqb; 1,2,3,4-butanetetracarboxylate, mixed &lsqb;1,2,2,6,6-pentamethylpiperidin-4-yl/&bgr;,&bgr;,&bgr;&prime;,&bgr;&prime;-tetramethyl-3,9-(2,4,8,10-tetraoxaspiro&lsqb;5.5&rsqb;undecane)diethyl&rsqb; 1,2,3,4-butanetetracarboxylate, octamethylene bis(2,2,6,6-tetramethylpiperidin-4-carboxylate), 4,4&prime;-ethylenebis(2,2,6,6-tetramethylpiperazin-3-one), N-2,2,6,6-tetramethylpiperidin-4-yl-n-dodecylsuccinimide, N-1,2,2,6,6-pentamethylpiperidin-4-yI-n-dodecylsuccinimide, N-1-acetyl-2,2,6,6-tetramethylpiperidin-4-yin-dodecylsuccinimide, 1-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro&lsqb;4.5&rsqb;decane-2,4-dione, di-(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, di-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) succinate, 1-octyloxy-2,2,6,6-tetramethyl-4-hydroxy-piperidine, poly-&lcub;&lsqb;6-tert-octylamino-s-triazin-2,4-diyl&rsqb;&lsqb;2-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino-hexamethylene-&lsqb;4-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino&rsqb;, 2,4,6-tris&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-n-butylamino&rsqb;-s-triazine, bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl)&rsqb; sebacate; a mixture of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate and bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; adipate; 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; adipate; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; succinate; a mixture of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate and bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; succinate; 1-(4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octa-decanoyloxy-2-methylpropane; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;9-(methoxy-carbonyl)-nonanoyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;5-(methoxy-carbonyl)pentanoyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;3-(methoxy-carbonyl)propionyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;4-(methoxy-carbonyl)butyryloxy&rsqb;-2,2,6,6-tetramethylpiperidine; condensation product of 4-hydroxy-1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidine with hexamethylene diisocyanate and terminated with methoxy; condensation product of 4-hydroxy-1-(2-hydroxy-ethoxy)-2,2,6,6-tetramethylpiperidine with hexamethylene diisocyanate and terminated with methoxy; and the condensation product of 4-hydroxy-1-(2-hydroxy-1-phenethoxy)-2,2,6,6-tetra-methylpiperidine with hexamethylene diisocyanate and terminated with methoxy. </paragraph>
<paragraph id="P-0247" lvl="0"><number>&lsqb;0247&rsqb;</number> A most preferred hindered amine compound is bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1,2,2,6,6-pentamethylpiperidin-4-yl) sebacate, di(1,2,2,6,6-pentamethylpiperidin-393 4-yl) (3,5-di-tert-butyl-4-hydroxybenzyl)butylmalonate, the polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, the polycondensation product of 2,4-dichloro-6-tert-octylamino-s-triazine and 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine), N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;(4,6-bis(butyl-(1,2,2,6,6-pentamethylpiperidin-4-yl)amino)-s-triazine-2-yl&rsqb;-1,10-diamino-4,7-diazadecane. di-(1-octyloxy-2,2,6,6-tetramethyl-piperidin-4-yl) sebacate, di-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) succinate, 1-octyloxy-2,2,6,6-tetramethyl-4-hydroxy-piperidine, poly-&lcub;&lsqb;6-tert-octylamino-s-triazin-2,4-diyl&rsqb;&lsqb;2-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino-hexamethylene-&lsqb;4-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)imino&rsqb;, 2,4,6-tris&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethyl-piperidin-4-yl)-n-butylamino&rsqb;-s-triazine, or 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine. </paragraph>
<paragraph id="P-0248" lvl="0"><number>&lsqb;0248&rsqb;</number> The instant composition can additionally contain another UV absorber selected from the group consisting of the benzotriazoles, the s-triazines, the oxanilides, the salicylates, the hydroxybenzophenones, the benzoates and the &agr;-cyanoacrylates. </paragraph>
<paragraph id="P-0249" lvl="0"><number>&lsqb;0249&rsqb;</number> Particularly, the instant composition may additionally contain an effective stabilizing amount of at least one other 2-hydroxyphenyl-2H-benzotriazole; another tris-aryl-s-triazine; or hindered amine or mixtures thereof. </paragraph>
<paragraph id="P-0250" lvl="0"><number>&lsqb;0250&rsqb;</number> Preferably, the 2-hydroxyphenyl-2H-benzotriazole is selected from the group consisting of </paragraph>
<paragraph id="P-0251" lvl="2"><number>&lsqb;0251&rsqb;</number> 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0252" lvl="2"><number>&lsqb;0252&rsqb;</number> 2-&lsqb;2-hydroxy-3,5-di(&agr;,&agr;-dimethylbenzyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0253" lvl="2"><number>&lsqb;0253&rsqb;</number> 2-&lsqb;2-hydroxy-3-(&agr;,&agr;-dimethylbenzyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0254" lvl="2"><number>&lsqb;0254&rsqb;</number> 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(omega-hydroxy-octa(ethyleneoxy)carbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzotriazole; </paragraph>
<paragraph id="P-0255" lvl="2"><number>&lsqb;0255&rsqb;</number> 5-chloro-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0256" lvl="2"><number>&lsqb;0256&rsqb;</number> 5-chloro-2-(2-hydroxy-3-tert-butyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0257" lvl="2"><number>&lsqb;0257&rsqb;</number> 2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0258" lvl="2"><number>&lsqb;0258&rsqb;</number> 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxy)carbonyl)ethyl&rsqb;phenyl&rcub;2H-benzotriazole; </paragraph>
<paragraph id="P-0259" lvl="2"><number>&lsqb;0259&rsqb;</number> (a) 5-trifluoromethyl-2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0260" lvl="2"><number>&lsqb;0260&rsqb;</number> (b) 5-trifluoromethyl-2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0261" lvl="2"><number>&lsqb;0261&rsqb;</number> (c) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-tert-octylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0262" lvl="2"><number>&lsqb;0262&rsqb;</number> (d) 2,2&prime;-methylene-bis&lsqb;6-(5-trifluoromethyl-2H-benzotriazol-2-yl)4-tert-octylphenol&rsqb;; </paragraph>
<paragraph id="P-0263" lvl="2"><number>&lsqb;0263&rsqb;</number> (e) methylene-2-&lsqb;4-tert-octyl-6-(2H-benzotriazol-2-yl)phenol&rsqb;2&prime;-&lsqb;4-tert-octyl-6-(5-trifluoromethyl-2H-benzotriazol-2-yl)phenol&rsqb;; </paragraph>
<paragraph id="P-0264" lvl="2"><number>&lsqb;0264&rsqb;</number> (f) 3-(5-trifluoromethyl-2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamic acid; </paragraph>
<paragraph id="P-0265" lvl="2"><number>&lsqb;0265&rsqb;</number> (g) methyl 3-(5-trifluoromethyl-2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxy-hydrocinnamate; </paragraph>
<paragraph id="P-0266" lvl="2"><number>&lsqb;0266&rsqb;</number> (h) isooctyl 3-(5-trifluoromethyl-2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxy-hydrocinnamate; </paragraph>
<paragraph id="P-0267" lvl="2"><number>&lsqb;0267&rsqb;</number> (i) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-hydroxypropyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0268" lvl="2"><number>&lsqb;0268&rsqb;</number> (j) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-acryloyloxypropyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0269" lvl="2"><number>&lsqb;0269&rsqb;</number> (k) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-methacryloyloxypropyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0270" lvl="2"><number>&lsqb;0270&rsqb;</number> (1) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-acrylylaminopropyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0271" lvl="2"><number>&lsqb;0271&rsqb;</number> (m) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-methacrylylaminopropyl)phenyl&rsqb;-2H-benzo-triazole; </paragraph>
<paragraph id="P-0272" lvl="2"><number>&lsqb;0272&rsqb;</number> (n) 5-trifluoromethyl-2-(2-hydroxy-3-&agr;-cumyl-5-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0273" lvl="2"><number>&lsqb;0273&rsqb;</number> (o) 5-trifluoromethyl-2-(2-hydroxy-3-&agr;-cumyl-5-nonylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0274" lvl="2"><number>&lsqb;0274&rsqb;</number> (p) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-&agr;-cumyl-5-(2-hydroxyethyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0275" lvl="2"><number>&lsqb;0275&rsqb;</number> (q) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-&agr;-cumyl-5-(3-hydroxypropyl)phenyl&rsqb;-2H-benzo-triazole; </paragraph>
<paragraph id="P-0276" lvl="2"><number>&lsqb;0276&rsqb;</number> (r) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0277" lvl="2"><number>&lsqb;0277&rsqb;</number> (s) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0278" lvl="2"><number>&lsqb;0278&rsqb;</number> (t) 5-trifluoromethyl-2-(2-hydroxy-3-dodecyl-5-methylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0279" lvl="2"><number>&lsqb;0279&rsqb;</number> (u) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-tert-butyl-5-(3-hydroxypropyl)phenyl)-2H-benzo-triazole; </paragraph>
<paragraph id="P-0280" lvl="2"><number>&lsqb;0280&rsqb;</number> (v) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-tert-butyl-5-(2-hydroxyethyl)phenyl&rsqb;-2H-benzo-triazole; </paragraph>
<paragraph id="P-0281" lvl="2"><number>&lsqb;0281&rsqb;</number> (w) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(2-hydroxyethyl)phenyl&rsqb;-2H-benzotriazole; </paragraph>
<paragraph id="P-0282" lvl="2"><number>&lsqb;0282&rsqb;</number> (x) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0283" lvl="2"><number>&lsqb;0283&rsqb;</number> (y) 5-fluoro-2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0284" lvl="2"><number>&lsqb;0284&rsqb;</number> (z) 5-butylsulfonyl-2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0285" lvl="2"><number>&lsqb;0285&rsqb;</number> (aa) 5-butylsulfonyl-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </paragraph>
<paragraph id="P-0286" lvl="2"><number>&lsqb;0286&rsqb;</number> (bb) 5-butylsulfonyl-2-(2-hydroxy-3,5-di-tert-octylphenyl)-2H-benzotriazole; and </paragraph>
<paragraph id="P-0287" lvl="2"><number>&lsqb;0287&rsqb;</number> (cc) 5-phenylsulfonyl-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole. </paragraph>
<paragraph id="P-0288" lvl="0"><number>&lsqb;0288&rsqb;</number> Preferably, the other tris-aryl-s-triazine is selected from the group consisting of </paragraph>
<paragraph id="P-0289" lvl="2"><number>&lsqb;0289&rsqb;</number> 2,4-bis(2,4-dimethylphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0290" lvl="2"><number>&lsqb;0290&rsqb;</number> 2,4-diphenyl-6-(2-hydroxy-4-hexyloxyphenyl)-s-triazine; </paragraph>
<paragraph id="P-0291" lvl="2"><number>&lsqb;0291&rsqb;</number> 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-do-/tri-decyloxy-2-hydroxypropoxy)-phenyl&rsqb;-s-triazine; </paragraph>
<paragraph id="P-0292" lvl="2"><number>&lsqb;0292&rsqb;</number> 2,4-bis(2,4-dimethylphenyl)-6-&lsqb;2-hydroxy-4-(3-nonyloxy*-2-hydroxypropyloxy)-5-&agr;-cumyl-phenyl&rsqb;-s-triazine. (* denotes a mixture of octyloxy, nonyloxy and decyloxy groups), and </paragraph>
<paragraph id="P-0293" lvl="2"><number>&lsqb;0293&rsqb;</number> 2,4-bis(biphenylyl)-6-&lsqb;2-hydroxy-4-(3-nonyloxy*-2-hydroxypropyloxy)phenyl&rsqb;-s-triazine (* denotes a mixture of octyloxy, nonyloxy and decyloxy groups). </paragraph>
<paragraph id="P-0294" lvl="0"><number>&lsqb;0294&rsqb;</number> The instant compounds are often used in conjunction with one or more coadditive stabilizers where the coadditive stabilizer is a hindered phenolic antioxidant selected from the group consisting of neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate, octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, 1,3,5-trimethyl-2,4,6-tris(3,5,-di-tert-butyl-4-hydroxybenzyl)benzene, 1,2-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine, calcium &lsqb;bis(monoethyl 3,5-ditert-butyl-4-hydroxybenzyl)phosphonate&rsqb;, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate and 1,3,5-tris(3-hydroxy-4-tert-butyl-2,6-dimethylbenzyl) isocyanurate; or is an organophosphorus stabilizer selected from the group consisting of tris(2,4-di-tert-butylphenyl) phosphite, bis(2,4-di-tert-butyl-6-methylphenyl) ethyl phosphite, 2,2&prime;,2&Prime;-nitrilo&lsqb;triethyl-tris-(3,3&prime;,5,5&prime;-tetra-tert-butyl-1,1&prime;-biphenyl-2,2&prime;-diyl) phosphite&rsqb;, tetrakis(2,4-di-butylphenyl) 4,4&prime;-biphenylenediphosphonite, tris(nonylphenyl) phosphite, bis(2,4-di-tert-butyl-phenyl) pentaerythrityl diphosphite, 2,2&prime;-ethylidenebis(2,4-di-tert-butylphenyl) fluorophosphite and 2-butyl-2-ethylpropan-1,3-diyl 2,4,6-tri-tert-butylphenyl phosphite; or is 5,7-di-tert-butyl-3-(3,4-dimethylphenyl)-2H-benzofuran-2-one; or is N,N-dialkylhydroxylamine made by the direct oxidation of N,N-di(hydrogenated tallow)amine; or is a hindered amine selected from the group consisting of bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate, the polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;4,6-bis(butyl-1,2,2,6,6-pentamethylpiperidin-4-yl)amino-s-triazin-2-yl&rsqb;-1,10-diamino-4,7-diazadecane, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-tert-octylamino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-morpholino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-1,2,2,6,6-pentamethyl-piperidine) and 2,4-dichloro-6-morpholino-s-triazine, 2,2,6,6-tetramethylpiperidin-4-yl octadecanoate, 3-dodecyl-1-(1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl)-pyrrolidin-2,5-dione, 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine, poly&lsqb;methyl 3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl&rsqb;siloxane, the polycondensation product of 2,4-dichloro-6-(2,2,6,6-tetramethylpiperidin-4-yl)butylamino)-s-triazine, 2,2&prime;ethylene-bis&lcub;&lsqb;2,4-(2,2,6,6-tetramethylpiperidin-4-yl)butylamino-s-triazin-6-yl&rsqb;aminotrimethyleneamino&rcub;, oligomer of N-&lcub;&lsqb;2-(N-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutylamino)-s-triazin-6-yl,N,N&prime;,N&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;3,3&prime;-ethylenediiminodipropylamine, N,N&prime;,N&prime;&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butyl-amino&rsqb;-s-triazin-6-yl-3,3&prime;-ethylenediiminodipropylamine and N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediimino-dipropylamine; or is another N-hydrocarbyloxy substituted hindered amines selected from the group consisting of bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) adipate, bis(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) adipate, bis(I-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, 1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl octadecanoate, N,N&prime;,N&Prime;-tris&lcub;2,4-bis&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine, N,N&prime;,N&prime;&Prime;-tris&lcub;2,4-bis&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine and N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lcub;2,4-bis&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine; or a hydroxy substituted N-hydrocarbyloxy substituted hindered amine selected from the group consisting of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl)&rsqb; sebacate; a mixture of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate and bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; adipate; 1-(2-hydroxy-2-methylpropoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; adipate; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; succinate; a mixture of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb;glutarate and bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; succinate; 1-(4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octadecanoyloxy-2-methylpropane; 1(2-hydroxy-2-methylpropoxy)-4-&lsqb;9-(methoxy-carbonyl)nonanoyloxy&rsqb;-2,2,6,6-tetramethyl-piperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;5-(methoxy-carbonyl)pentanoyloxy&rsqb;-2,2,6,6-tetra-methylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;3-(methoxy-carbonyl)propionyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)4-&lsqb;4-(methoxy-carbonyl)butyryloxy&rsqb;-2,2,6,6-tetramethylpiperidine; or is a UV absorber selected from the group consisting of 2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole, 2-(2-hydroxy-5-methylphenyl)-2H-benzotriazole, 5-chloro-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole, 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole, 2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzo-triazole, 2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate, 2-hydroxy-4-n-octyloxy-benzophenone, 2,4-bis(2,4-dimethyphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine, oligomer of N-&lcub;2-&lsqb;(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutyl-amino)-s-triazin-6-yl, the condensation product of 2-morpholino-4,6-dichloro-s-triazine with N,N&prime;-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,6-hexanediamine; or mixtures thereof. </paragraph>
<paragraph id="P-0295" lvl="0"><number>&lsqb;0295&rsqb;</number> Preferably the coadditive stabilizer is neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate, tris(2,4-di-tert-butylphenyl) phosphite, N,N-dialkylhydroxylamine made by the direct oxidation of N,N-di(hydrogenated tallow)amine, N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;4,6-bis(butyl-1,2,2,6,6-pentamethylpiperidin-4-yl)amino-s-triazin-2-yl&rsqb;-1,10-diamino-4,7-diazadecane, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-tert-octylamino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylene-bis(amino-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-morpholino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-1,2,2,6,6-pentamethylpiperidine) and 2,4-dichloro-6-morpholino-s-triazine, oligomer of N-&lcub;&lsqb;2-(N-2,2,6,6-tetramethylpiperidin-4-yl)butyl-amino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutylamino)-s-triazin-6-yl,N,N&prime;,N&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl)-3,3&prime;-ethylenediiminodipropylamine, N,N&prime;,N&prime;&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;3,3&prime;-ethylenediiminodipropylamine and N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butyl-amino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine, oligomer of N-&lcub;2-&lsqb;(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutylamino)-s-triazin-6-yl, or the condensation product of 2-morpholino-4,6-dichloro-s-triazine with N,N&prime;-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,6-hexanediamine. </paragraph>
<paragraph id="P-0296" lvl="0"><number>&lsqb;0296&rsqb;</number> The alkyd resin lacquers which can be stabilized against the action of light and moisture in accordance with the instant invention are the conventional stoving lacquers which are used in particular for coating automobiles (automobile finishing lacquers), for example lacquers based on alkyd/melamine resins and alkyd/acrylic/melamine resins (see H. Wagner and H. F. Sarx, &ldquo;Lackkunstharze&rdquo; (1977), pages 99-123). Other crosslinking agents include glycouril resins, blocked isocyanates or epoxy resins. </paragraph>
<paragraph id="P-0297" lvl="0"><number>&lsqb;0297&rsqb;</number> The lacquers stabilized in accordance with the invention are suitable both for metal finish coatings and solid shade finishes, especially in the case of retouching finishes, as well as various coil coating applications. The lacquers stabilized in accordance with the invention are preferably applied in the conventional manner by two methods, either by the single-coat method or by the two-coat method. In the latter method, the pigment-containing base coat is applied first and then a covering coat of clear lacquer over it. </paragraph>
<paragraph id="P-0298" lvl="0"><number>&lsqb;0298&rsqb;</number> It is also to be noted that the compounds of the present invention are applicable for use in non-acid catalyzed thermoset resins such as epoxy, epoxy-polyester, vinyl, alkyd, acrylic and polyester resins, optionally modified with silicon, isocyanates or isocyanurates. The epoxy and epoxy-polyester resins are crosslinked with conventional crosslinkers such as acids, acid anhydrides, amines and the like. Correspondingly, the epoxide may be utilized as the crosslinking agent for various acrylic or polyester resin systems that have been modified by the presence of reactive groups on the backbone structure. </paragraph>
<paragraph id="P-0299" lvl="0"><number>&lsqb;0299&rsqb;</number> When used in two-coat finishes, the compounds of the instant invention can be incorporated in the clear coat or both in the clear coat and in the pigmented base coat. </paragraph>
<paragraph id="P-0300" lvl="0"><number>&lsqb;0300&rsqb;</number> When water-soluble, water miscible or water dispersible coating are desired ammonium salts of acid groups present in the resin are formed. Powder coating composition can be prepared by reacting glycidyl methacrylate with selected alcohol components. </paragraph>
<paragraph id="P-0301" lvl="0"><number>&lsqb;0301&rsqb;</number> The instant benzotriazoles are made by conventional methods for preparing such compounds. The usual procedure involves the diazotization of a substituted o-nitroaniline followed by coupling the resultant diazonium salt with a substituted phenol and reduction of the azobenzene intermediate to the corresponding desired benzotriazole. The starting materials for these benzotriazoles are largely items of commerce or can be prepared by normal methods of organic synthesis. </paragraph>
<paragraph id="P-0302" lvl="0"><number>&lsqb;0302&rsqb;</number> The instant invention also pertains to the method of making the instant compounds of formula I, II or III  
<chemistry-cwu id="CHEM-US-00010">
<number>10</number>
<image id="EMI-C00010" he="307.22895" wi="198.02475" file="US20030004235A1-20030102-C00010.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00010" file="US20030004235A1-20030102-C00010.CDX"/>
<chemistry-mol-file id="CHEMMOL-00010" file="US20030004235A1-20030102-C00010.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0303" lvl="2"><number>&lsqb;0303&rsqb;</number> where G<highlight><subscript>1</subscript></highlight>, G<highlight><subscript>2</subscript></highlight>, T, E<highlight><subscript>2</subscript></highlight>, E<highlight><subscript>5 </subscript></highlight>and m are as defined above and where E<highlight><subscript>1 </subscript></highlight>is a group of the formula V, </paragraph>
<paragraph id="P-0304" lvl="2"><number>&lsqb;0304&rsqb;</number> by the reaction of an arylboronic acid or ester of formula</paragraph>
<paragraph lvl="0"><in-line-formula>E<highlight><subscript>1</subscript></highlight>&mdash;B(OR<highlight><subscript>1</subscript></highlight>)(OR<highlight><subscript>2</subscript></highlight>)</in-line-formula></paragraph>
<paragraph id="P-0305" lvl="2"><number>&lsqb;0305&rsqb;</number> where E<highlight><subscript>1 </subscript></highlight>is a group of the formula V, R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>are independently hydrogen, alkyl of 1 to 12 carbon atoms, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together are alkylene of 2 to 4 carbon atoms; </paragraph>
<paragraph id="P-0306" lvl="2"><number>&lsqb;0306&rsqb;</number> with a benzotriazole of formula VI  
<chemistry-cwu id="CHEM-US-00011">
<number>11</number>
<image id="EMI-C00011" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00011.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00011" file="US20030004235A1-20030102-C00011.CDX"/>
<chemistry-mol-file id="CHEMMOL-00011" file="US20030004235A1-20030102-C00011.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0307" lvl="2"><number>&lsqb;0307&rsqb;</number> where X is chloro, bromo or iodo, or tosylate, </paragraph>
<paragraph id="P-0308" lvl="2"><number>&lsqb;0308&rsqb;</number> in the presence of an effective amount of a palladium (II) catalyst and optionally in the additional presence of a ligand, such as triphenylphosphine, at a temperature between 10 to 100&deg; C., for example between 50 to 95&deg; C. </paragraph>
<paragraph id="P-0309" lvl="0"><number>&lsqb;0309&rsqb;</number> When a ligand is used, the ligand is for example triphenylphosphine, 2-(di-tert-butyl-phosphino)biphenyl, 1,1&prime;-bis&lsqb;2,4,8,10-tetrakis(tert-butyl)-dibenzo&lsqb;d,f&rsqb;&lsqb;1,3,2&rsqb;dioxaphosphepin-6-yl&rsqb;ferrocene, tris(2,4-di-tert-butylphenyl) phosphite or 2,2&prime;,2&Prime;-nitrilo&lsqb;triethyl-tris(3,3&prime;,5,5&prime;-tetra-tert-butyl-1,1&prime;-biphenyl-2,2&prime;-diyl)phosphite&rsqb;. In another embodiment, the ligand is triphenylphosphine. </paragraph>
<paragraph id="P-0310" lvl="0"><number>&lsqb;0310&rsqb;</number> The amount of palladium (II) catalyst is for example 0.01 to 100 mol percent. </paragraph>
<paragraph id="P-0311" lvl="0"><number>&lsqb;0311&rsqb;</number> In one embodiment of the invention, an anhydrous process is used with dioxane as solvent and potassium fluoride as a base; or the process can be run using n-propanol or isopropanol as solvent with a small amount of water and aqueous sodium carbonate as a base. </paragraph>
<paragraph id="P-0312" lvl="0"><number>&lsqb;0312&rsqb;</number> While the instant benzotriazoles with their enhanced durability are particularly suited for automotive coating applications, it is contemplated that they will also be especially useful in other applications where their enhanced durability is required such as in solar films and the like. </paragraph>
<paragraph id="P-0313" lvl="0"><number>&lsqb;0313&rsqb;</number> The following examples are meant for illustrative purposes only and are not to be construed to limit the instant invention in any manner whatsoever.</paragraph>
</section>
</summary-of-invention>
<detailed-description>
<section>
<heading lvl="1">EXAMPLE 1 </heading>
</section>
<section>
<heading lvl="1"><highlight><bold>4</bold></highlight>-Methoxy-&agr;-methylstyrene </heading>
<paragraph id="P-0314" lvl="0"><number>&lsqb;0314&rsqb;</number> To a 1000 mL three-necked flask equipped with a mechanical stirrer, methyl magnesium bromide/diethyl ether solution (200 mL, 3.0 mol) is added. A solution of 85.3 g of 4&prime;-methoxy-acetophenone dissolved in 80 mL of anhydrous diethyl ether is charged to the Grignard reagent over 90 minutes at ambient temperature. Diethyl ether (200 mL) and 250 mL of 3N hydrochloric acid are added slowly to the reaction mixture. The solution is stirred for another 30 minutes. The aqueous layer is separated and washed twice with 100 mL of diethyl ether. The ethereal layers are combined and vacuum distilled. The desired product is obtained in a yield of 91.7 g as a yellow oil whose structure is verified by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 2 </heading>
</section>
<section>
<heading lvl="1">&agr;-Methylstyrene Derivatives </heading>
<paragraph id="P-0315" lvl="0"><number>&lsqb;0315&rsqb;</number> When following the general procedure of Example 1, the following &agr;-methylstyrene derivatives are made when 4&prime;-methoxyacetophenone is replaced with the corresponding substituted acetophenone intermediate. </paragraph>
<paragraph id="P-0316" lvl="2"><number>&lsqb;0316&rsqb;</number> 2-methoxy-&agr;-methylstyrene </paragraph>
<paragraph id="P-0317" lvl="2"><number>&lsqb;0317&rsqb;</number> 3-methoxy-&agr;-methylstyrene </paragraph>
<paragraph id="P-0318" lvl="2"><number>&lsqb;0318&rsqb;</number> 2-fluoro-&agr;-methylstyrene </paragraph>
<paragraph id="P-0319" lvl="2"><number>&lsqb;0319&rsqb;</number> 3-fluoro-&agr;-methylstyrene </paragraph>
<paragraph id="P-0320" lvl="2"><number>&lsqb;0320&rsqb;</number> 4-fluoro-&agr;-methylstyrene </paragraph>
<paragraph id="P-0321" lvl="2"><number>&lsqb;0321&rsqb;</number> 2-chloro-&agr;-methylstyrene </paragraph>
<paragraph id="P-0322" lvl="2"><number>&lsqb;0322&rsqb;</number> 3-chloro-&agr;-methylstyrene </paragraph>
<paragraph id="P-0323" lvl="2"><number>&lsqb;0323&rsqb;</number> 4-trifluoromethyl-&agr;-methylstyrene </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 3 </heading>
</section>
<section>
<heading lvl="1"><highlight><bold>2</bold></highlight>-(4-Methoxy-&agr;-cumyl)-4-tert-butylphenol </heading>
<paragraph id="P-0324" lvl="0"><number>&lsqb;0324&rsqb;</number> To a three-necked 500 mL flask equipped with a mechanical stirrer, 37 g of 4-tert-butylphenol, 100 mL of toluene and 2.4 g of p-toluenesulfonic acid are charged and heater to 55&deg; C. The 4-methoxy-&agr;-methylstyrene (40 g) prepared in Example 1 is added over 2.5 hours. The reaction mass is stirred for an additional three hours at 65&deg; C. The reaction mass is then washed twice with 200 mL of saturated sodium bicarbonate solution and thrice with 100 mL of water. The solvent is removed by vacuum distillation and unreacted phenol and alkene are moved by Kugelrohr distillation at 100&deg; C./0.16 mm Hg. The title compound is prepared in a yield of 78 g as a light brown oil whose structure is consistent with Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 4 </heading>
</section>
<section>
<heading lvl="1">2-(4-Fluoro-&agr;-cumyl)-4-tert-octylphenol </heading>
<paragraph id="P-0325" lvl="0"><number>&lsqb;0325&rsqb;</number> 4-Fluoro-x-methylstyrene (18 g) as prepared in Example 2 and 20.6 g of 4-tert-octyl-phenol are reacted according to the procedure of Example 3 to yield 26 g of the title compound as a reddish, viscous oil whose structure is consistent with <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 5 </heading>
</section>
<section>
<heading lvl="1">2-(4-Chloro-&agr;-cumyl)-4-tert-butylphenol </heading>
<paragraph id="P-0326" lvl="0"><number>&lsqb;0326&rsqb;</number> 4-Chloro-&agr;-methylstyrene (50 g) and 45 g of 4-tert-butylphenol are reacted according to the procedure of Example 3 to afford the title compound in a yield of 66.6 g as a colorless oil. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 6 </heading>
</section>
<section>
<heading lvl="1">2,4-Di-(4-chloro-&agr;-cumyl)phenol </heading>
<paragraph id="P-0327" lvl="0"><number>&lsqb;0327&rsqb;</number> The title compound is prepared according to the procedure of Example 3 by reacting 19 g of phenol with 80 g of 4-chloro-&agr;-methylstyrene to give 53.4 g of the title compound as a white solid. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 7 </heading>
</section>
<section>
<heading lvl="1">2,4-Di-(4-methoxy-&agr;-cumyl)phenol </heading>
<paragraph id="P-0328" lvl="0"><number>&lsqb;0328&rsqb;</number> The title compound is prepared according to the procedure of Example 3 by reacting 23.5 g of phenol with 96 g of 4-methoxy-&agr;-methylstyrene to give 53 g of the title compound as a white solid. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 8 </heading>
</section>
<section>
<heading lvl="1">4-Trifluoromethyl-2-nitrobenzenediazonium Bisulfate </heading>
<paragraph id="P-0329" lvl="0"><number>&lsqb;0329&rsqb;</number> To a 500 mL three-necked flask fitted with a mechanical stirrer are added 40 g of 40% nitrosylsulfuric acid and 120 g of concentrated sulfuric acid. 4-Trifluoro-2-nitroaniline (&equals;4-amino-3-nitrobenzotrifluoride) (25 g) is charged portionwise so as to maintain a temperature of less than 30&deg; C. The resulting solution is then stored at 0&deg; C. until use. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 9 </heading>
</section>
<section>
<heading lvl="1">4-Trifluoromethyl-2-nitrobenzenediazonium Bisulfate </heading>
<paragraph id="P-0330" lvl="0"><number>&lsqb;0330&rsqb;</number> To a 500 mL three-necked flask fitted with a mechanical stirrer are added 99.5 g of concentrated sulfuric acid and 62.5 g of 4-trifluoro-2-nitroaniline (&equals;4-amino-3-nitrobenzo-trifluoride). After heating to 75&deg; C., 200 g of water is added at which time the temperature is reduced to 0&deg; C. Sodium nitrite (52.9 g, 40 wt %) is added over two hours while maintaining the solution at 0-5&deg; C. The diazonium salt solution (351 g) is then filtered and stored at &minus;15&deg; C. until use. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 10 </heading>
</section>
<section>
<heading lvl="1">2-Nitrobenzenediazonium Bisulfate </heading>
<paragraph id="P-0331" lvl="0"><number>&lsqb;0331&rsqb;</number> To a 500 mL three-necked flask fitted with a mechanical stirrer are added 65 g of concentrated sulfuric acid and 41.4 g of 2-nitroaniline. After heating to 75&deg; C., 164 g of water is added at which time the temperature is reduced to 0&deg; C. Sodium nitrite (54 g, 40 wt %) is added over two hours while maintaining the solution at 0-5&deg; C. The diazonium salt solution (292 g) is then filtered and stored at &minus;15&deg; C. until use. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 11 </heading>
</section>
<section>
<heading lvl="1">4-Chloro-2-nitrobenzenediazonium Chloride </heading>
<paragraph id="P-0332" lvl="0"><number>&lsqb;0332&rsqb;</number> To a 500 mL three-necked flask fitted with a mechanical stirrer are added 134.2 g of concentrated hydrochloric acid and 60 g of 4-chloro-2-nitroaniline. After heating to 65&deg; C., 106.6 g of water is added at which time the temperature is reduced to 0&deg; C. Sodium nitrite (63.4 g, 40 wt %) is slowly added to the slurry while maintaining the solution at 0&deg; C. The diazonium salt solution (281 g) is then filtered and stored at &minus;15&deg; C. until later use. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 12 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-nitro-2&prime;-hydroxy-3&prime;-(4-methoxy-&agr;-cumyl)-5&prime;-tert-butylazobenzene </heading>
<paragraph id="P-0333" lvl="0"><number>&lsqb;0333&rsqb;</number> To a 1 L three-necked flask equipped with a mechanical stirrer, 33 g of 2-(4-methoxy-&agr;-cumyl)4-tert-butylphenol prepared in Example 3, 2 g of PETROSUL&reg; M-60 and 85 mL of xylenes are added. After dissolution of the phenol, the solution is cooled to 10-15&deg; C. at which time the diazonium salt prepared in Example 8 is charged over a three hour period. The reaction mass is agitated an additional three hours at 25-30&deg; C. The aqueous layer is separated and the organic layer is vacuum distilled. The desired product is obtained in a 50 g yield as a dark red solid whose structure is consistent by <highlight><superscript>1</superscript></highlight>Hnmr. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 13 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0334" lvl="0"><number>&lsqb;0334&rsqb;</number> To a 2 L, five-necked flask equipped with a mechanical stirrer, 500 mL of 2-butanol and 8 g of sodium hydroxide pellets are charged and heated to 90&deg; C. A solution of 50 g of the monoazo compound prepared in Example 12, 2.3 g of 2,3-dichloro-1,4-naphthoquinone and 300 mL of heptane is charged to the hot butanol solution over a three hour period. After the addition is complete, the reaction mass is stirred for an additional hour at reflux. To the reaction mass is then added, 100 mL of water and the pH is adjusted to 2 with 30% aqueous sulfuric acid. The aqueous layer is removed and the organic layer is washed once with 100 mL of saturated sodium chloride solution and twice with water. The desired product is crystallized from the solution yielding the title compound as a light yellow solid melting at 140&deg; C. The structure is verified by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 14 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-nitro-2&prime;-hydroxy-3&prime;-(4-fluoro-&agr;-cumyl)-5&prime;-tert-octylazobenzene </heading>
<paragraph id="P-0335" lvl="0"><number>&lsqb;0335&rsqb;</number> The title compound is prepared according to the procedure of Example 12 from 24 g of 2-(4-fluoro-&agr;-cumyl)-4-tert-octylphenol prepared in Example 4 and 126 g (ca. 21.5%) of the aqueous diazonium salt solution of Example 9. The title compound is obtained as a crimson red oil (51.4 g) which still contains some traces of solvent. The structure is consistent by <highlight><superscript>1</superscript></highlight>Hnmr. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 15 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-fluoro-&agr;-cumyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole-N-oxide </heading>
<paragraph id="P-0336" lvl="0"><number>&lsqb;0336&rsqb;</number> To a 500 mL three-necked flask fitted with a mechanical stirrer are charged 51.4 g of the crude monoazo compound prepared in Example 14, 50 g of xylenes, 0.5 g of 5% palladium on carbon catalyst and 85 g of n-butylamine. This solution is cooled to 10&deg; C. and 3.8 g of hydrazine is added slowly over two hours while not allowing the temperature to rise above 20&deg; C. The catalyst is removed by filtration and the solvent is vacuum distilled. The title compound is then crystallized from methanol. After vacuum drying, 20.6 g of the desired product is obtained as an orange solid melting at 146-149&deg; C. The structure is verified by <highlight><superscript>1</superscript></highlight>Hnmr, <highlight><superscript>19</superscript></highlight>Fnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 16 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-fluoro-&agr;-cumyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0337" lvl="0"><number>&lsqb;0337&rsqb;</number> To a 500 mL three-necked flask equipped with a mechanical stirrer, 3.7 g of sodium hydroxide pellets and 50 mL of 2-butanol are charged and heated to 83&deg; C. To this solution is added over a 90-minute period a solution of 230 mL of methyl ethyl ketone, 20 g of the benzo-triazole-N-oxide prepared in Example 15 and 0.85 g of 2,3-dichloro-1,4-naphthoquinone. The mixture is refluxed at 88&deg; C. for one hour while distilling off methyl ethyl ketone. After cooling down to ambient temperature, 25 g of water and 30 mL of ethyl acetate are added at which time the pH is reduced to 3 with 30% aqueous sulfuric acid. After splitting off the aqueous layer, the solvent is removed by distillation. The crude solid is purified by silica gel chromatography using heptane/ethyl acetate (49/1) as eluent. After collecting the desired fractions and crystallizing from methanol/toluene, the title compound is obtained in a yield of 14 g as a light yellow solid melting at 120-122&deg; C. The structure is consistent with analyses by <highlight><superscript>1</superscript></highlight>Hnmr, <highlight><superscript>19</superscript></highlight>Fnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 17 </heading>
</section>
<section>
<heading lvl="1">2-Nitro-2&prime;-hydroxy-3&prime;-(4-methoxy-&agr;-cumyl)-5&prime;-tert-butylazobenzene </heading>
<paragraph id="P-0338" lvl="0"><number>&lsqb;0338&rsqb;</number> The title compound is prepared according to the procedure of Example 12 using 36 g of 2-(4-methoxy-&agr;-cumyl)-4-tert-butylphenol prepared in Example 3 and 130 g of the diazonium salt solutions (ca. 23% solution) prepared in Example 10. The title compound is obtained in a yield of 60 g as a crimson red oil whose structure is consistent with <highlight><superscript>1</superscript></highlight>Hnmr analysis. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 18 </heading>
</section>
<section>
<heading lvl="1">2-&lsqb;2-Hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole-N-oxide </heading>
<paragraph id="P-0339" lvl="0"><number>&lsqb;0339&rsqb;</number> The title compound is prepared in a yield of 56.8 g according to the procedure of Example 15 using 60 g of the monoazo derivative prepared in Example 17. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 19 </heading>
</section>
<section>
<heading lvl="1">2-&lsqb;2-Hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0340" lvl="0"><number>&lsqb;0340&rsqb;</number> The title compound is prepared according to the procedure given in Example 16 using 56 g of the N-oxide compound of Example 18. The desired product is obtained in a yield of 13.2 g as a white solid melting at 139-140&deg; C. The structure is verified by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 20 </heading>
</section>
<section>
<heading lvl="1">2-Nitro-2&prime;-hydroxy-3&prime;-(4-chloro-&agr;-cumyl)-5&prime;-tert-butylazobenzene </heading>
<paragraph id="P-0341" lvl="0"><number>&lsqb;0341&rsqb;</number> The title compound is prepared according to the method given in Example 12 using 45 g of 2-(4-chloro-&agr;-cumyl)-4-tert-butylphenol prepared in Example 5 and 161 g of the diazonium salt solution (ca. 23%) prepared in Example 10. The desired compound is prepared in a yield of 70 g as a crimson viscous oil. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 21 </heading>
</section>
<section>
<heading lvl="1">2-&lsqb;2-Hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole-N-oxide </heading>
<paragraph id="P-0342" lvl="0"><number>&lsqb;0342&rsqb;</number> The title compound is prepared according to the method of Example 15 using 70 g of the monoazo compound of Example 20. The title compound is obtained in a yield of 12.8 g as a solid melting at 136-141&deg; C. The structure is consistent by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 22 </heading>
</section>
<section>
<heading lvl="1">2-&lsqb;2-Hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0343" lvl="0"><number>&lsqb;0343&rsqb;</number> The title compound is prepared according to the procedure of Example 16 using 10 g of the N-oxide prepared in Example 21. The product is obtained in a yield of 7.7 g as a solid melting at 153-155&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 23 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-nitro-2&prime;-hydroxy-3&prime;-(4-chloro-&agr;-cumyl)-5&prime;-tert-butylazobenzene </heading>
<paragraph id="P-0344" lvl="0"><number>&lsqb;0344&rsqb;</number> To a 500 mL three-necked flask equipped with a mechanical stirrer are added 43.6 g of 2-(4-chloro-&agr;-cumyl)-4-tert-butylphenol prepared in Example 5,167 g of methanol, 27.8 g of sodium hydroxide pellets and 11 g of water. The solution is cooled to &minus;15&deg; C. and 168 g of the diazonium salt solution prepared in Example 11 is slowly added over three hours. The crimson slurry is acidified to pH 2-3 with dilute hydrochloric acid. The monoazo title compound is filtered and washed with water. The crude cake is oven dried to yield 77.5 g of crimson red solid which still contains some residual sodium chloride. This product has a melting point of 195-197&deg; C. The structure is verified by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 24 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole-N-oxide </heading>
<paragraph id="P-0345" lvl="0"><number>&lsqb;0345&rsqb;</number> The title compound is prepared according to the method given in Example 15 using 31 g of the monoazo compound prepared in Example 23. The title compound is obtained in a yield of 15.5 g as an orange solid melting at 207-209&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 25 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0346" lvl="0"><number>&lsqb;0346&rsqb;</number> The title compound is prepared according to the procedure of Example 16 using 14 g of the N-oxide prepared in Example 24 to give 10.5 g of the desired product as a light yellow solid melting at 130-131&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 26 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-nitro-2&prime;-hydroxy-3&prime;,5&prime;-di-(4-chloro-&agr;-cumyl)azobenzene </heading>
<paragraph id="P-0347" lvl="0"><number>&lsqb;0347&rsqb;</number> The title compound is prepared according to the procedure of Example 23 using 45 g of 2,4-di-(4-chloro-&agr;-cumyl)phenol prepared in Example 6 and 138 g of the diazonium salt solution prepared in Example 11 in a yield of 66.3 g. The desired product is a crimson red solid containing some residual salt and melts at 163-165&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 27 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3,5-di-(4-chloro-&agr;-cumyl)phenyl&rsqb;-2H-benzotriazole-N-oxide </heading>
<paragraph id="P-0348" lvl="0"><number>&lsqb;0348&rsqb;</number> The title compound is prepared according to the procedure of Example 15 using 35 g of the monoazo compound prepared in Example 26. The title compound is obtained in a yield of 18.6 g as an orange solid melting at 189-190&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 28 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3,5-di-(4-chloro-&agr;-cumyl)phenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0349" lvl="0"><number>&lsqb;0349&rsqb;</number> The title compound is prepared by the method given in Example 16 using 15 g of the N-oxide compound prepared in Example 27. The desired product is obtained in a yield of 14.3 g as a light yellow solid melting at 155-157&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 29 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-nitro-2&prime;-hydroxy-3&prime;,5&prime;-di-(4-methoxy-&agr;-cumyl)azobenzene </heading>
<paragraph id="P-0350" lvl="0"><number>&lsqb;0350&rsqb;</number> The title compound is prepared according to the procedure of Example 23 using 45 g of 2,4-di-(4-methoxy-&agr;-cumyl)phenol prepared in Example 7 and 131 g of the diazonium salt solution of Example 11. The desired product is obtained in a yield of 49.1 g as a crimson red solid melting at 150-152&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 30 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3,5-di-(4-methoxy-&agr;-cumyl)phenyl&rsqb;-2H-benzotriazole-N-oxide </heading>
<paragraph id="P-0351" lvl="0"><number>&lsqb;0351&rsqb;</number> The title compound is prepared according to Example 15 using 25 g of the monoazo compound of Example 29. The desired product is obtained in a yield of 19.9 g as an orange solid melting at 155-162&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 31 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3,5-di-(4-methoxy-&agr;-cumyl)phenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0352" lvl="0"><number>&lsqb;0352&rsqb;</number> The title compound is prepared according to the method of Example 16 using 11.5 g of the N-oxide compound made in Example 30. The desired product is obtained in a yield of 10 g as a light yellow solid melting at 58-68&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 32 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lsqb;2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0353" lvl="0"><number>&lsqb;0353&rsqb;</number> Following the general procedure of Example 13, starting with the substituted phenol prepared in Example 5 and the diazonium salt prepared in Example 8, the title compound is prepared as a light yellow solid melting at 129-132&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr, <highlight><superscript>19</superscript></highlight>Fnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 33 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3-(4-methoxy-&agr;-cumyl)-5-tert-butylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0354" lvl="0"><number>&lsqb;0354&rsqb;</number> Following the general procedure of Example 13, starting with the substituted phenol prepared in Example 3 and the diazonium salt prepared in Example 11, the title compound is prepared as a light yellow solid melting at 121-122&deg; C. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 34a </heading>
</section>
<section>
<heading lvl="1">2-&lsqb;2-Hydroxy-3-(4-chlorosulfonyl-&agr;-cumyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0355" lvl="0"><number>&lsqb;0355&rsqb;</number> 2-(2-Hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzotriazole (60.5 g) is dissolved in 200 mL of 1,2-dichloroethane and dried by distilling off 25 mL of solvent using a Dean-Stark trap under nitrogen. The trap is replaced with a condenser and the solution is heated to reflux. While at reflux, the nitrogen feed is replaced by a drying tube and a solution of 200 g of chlorosulfonic acid in 100 mL of 1,2-dichloroethane is added dropwise from an addition funnel over a 45-minute period. The reaction mixture is stirred at reflux for an additional 30 minutes, then cooled to room temperature and pured over 1400 mL of ice and water to form a thick white emulsion. Salt and 1000 mL of ethyl acetate are added and the mixture is separated with the organic layer being dried over anhydrous sodium sulfate. The organic solution is concentrated to yield 67.8 g of a thick brown oil. Separation by chromatography on silica gel with heptane/ethyl acetate 6/1 as eluent, followed by recrystallization from heptane/ethyl acetate affords 18.0 g of the title compound as light yellow crystals melting at 166-168&deg; C. The structure of the compound is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopic analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 34b </heading>
</section>
<section>
<heading lvl="1">2-&lcub;2-Hydroxy-3-&lsqb;4-(2-dimethylaminoethyl)aminosulfonyl-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;2H-benzotriazole </heading>
<paragraph id="P-0356" lvl="0"><number>&lsqb;0356&rsqb;</number> The title compound is prepared according to the procedure given in instant Example 35 using 8.0 g of the intermediate compound prepared in Example 34a and 1.4 g of 2-dimethylaminoethylamine. After several recrystallizations from ethyl acetate and ethyl acetate/heptane mixtures, 5.6 g of the title compound is prepared as a near white solid melting at 118-120&deg; C. The structure of the compound is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopy analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 35 </heading>
</section>
<section>
<heading lvl="1">2-&lcub;2-hydroxy-3-&lsqb;4-(3-dimethylaminopropyl)aminosulfonyl-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;2H-benzotriazole </heading>
<paragraph id="P-0357" lvl="0"><number>&lsqb;0357&rsqb;</number> A solution of 8.0 g of the intermediate prepared in instant Example 34a in 50 mL of methylene chloride is added dropwise to a stirred solution of 1.5 g of 3-dimethylaminopropyl-amine, 5 g of triethylamine and 5 mL of methylene chloride at 0&deg; C. to 5&deg; C. over a 30 minute period. The reaction mixture turns yellow and some white precipitate forms. The mixture is allowed to warm to room temperature and is then washed three times with brine. An additional 5 mL of triethylamine is added between the brine washings. The organic layer is dried over anhydrous sodium sulfate and is then concentrated to give 9.2 g of a yellow oil which solidifies on standing. Heptane is added and the mixture is reconcentrated to drive off any residual triethylamine. The product is recrystallized from heptane/toluene to afford 8.4 g of the title compound as a near white solid melting at 96-101&deg; C. The structure of the compound is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopic analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 36 </heading>
</section>
<section>
<heading lvl="1">Polycarbonate </heading>
<paragraph id="P-0358" lvl="0"><number>&lsqb;0358&rsqb;</number> The durability of representative instant benzotriazoles in thermoplastic substrates is determined by incorporating various test compounds into solvent cast films of polycarbonate resins. The free standing films are mounted into cardboard holders, secured in metal frames and exposed in an Atlas C165 Xenon-arc Weather-Ometer under dry conditions according to ASTM G26. Loss of UV absorber is determined by monitoring the loss of diagnostic UV absorption. </paragraph>
<paragraph id="P-0359" lvl="0"><number>&lsqb;0359&rsqb;</number> Polycarbonate flake (LEXAN&reg; 145, General Electric) is dissolved in methylene chloride at room temperature along with between 1 and 3% by weight of test benzotriazole, based on the polycarbonate. Films are cast using a calibrated drawdown bar to prepare 1 mil thick film after drying.  
<table-cwu id="TABLE-US-00003">
<number>3</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="98PT" align="center"/>
<colspec colname="2" colwidth="105PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Compound of</entry>
<entry>Change in Initial</entry>
</row>
<row>
<entry></entry>
<entry>Example* (% by weight)</entry>
<entry>Absorbance after 750 hours</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="center"/>
<colspec colname="3" colwidth="105PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 234*</entry>
<entry>(2.50%)</entry>
<entry>0.18</entry>
</row>
<row>
<entry></entry>
<entry>Example 13</entry>
<entry>(2.70%)</entry>
<entry>0.03</entry>
</row>
<row>
<entry></entry>
<entry>Example 32</entry>
<entry>(2.72%)</entry>
<entry>0.08</entry>
</row>
<row>
<entry></entry>
<entry>Example 22</entry>
<entry>(2.34%)</entry>
<entry>0.06</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00001">*TINUVIN&thinsp;&reg; 234 is 2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0360" lvl="0"><number>&lsqb;0360&rsqb;</number> These data show that the instant compounds are particularly efficacious when used in thermoplastic compositions, such as polycarbonate, even surpassing a commercial UV absorber in effectiveness. This is shown by the reduction in absorbance loss after exposure to actinic radiation. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 37 </heading>
</section>
<section>
<heading lvl="1">Polycarbonate </heading>
<paragraph id="P-0361" lvl="0"><number>&lsqb;0361&rsqb;</number> Polycarbonate films of about 1 mil thickness and containing a UV absorber are prepared by dissolving polycarbonate granules (LEXAN&reg; 145, General Electric) and UV absorbers in methylene chloride and casting the films on a glass plate using a drawdown bar. The films are exposed for 750 hours in a Xenon Arc Weather-Ometer according to ASTM G26 test method and the color change (&Dgr;YI) versus that for unexposed films are recorded below. The color measurements (yellowness index-YI) are carried out on an ACS spectrophotometer, small area view, spectral component included d/8, D65, 10&deg; observer, YI 1925 for unexposed and exposed samples after 750 hours.  
<table-cwu id="TABLE-US-00004">
<number>4</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="119PT" align="center"/>
<colspec colname="2" colwidth="77PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Compound of</entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry>Example* (% by weight)</entry>
<entry>&Dgr;YI</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="91PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="77PT" align="char" char="."/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Blank (no stabilizer)</entry>
<entry></entry>
<entry>12.30</entry>
</row>
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 234</entry>
<entry>(2.50%)</entry>
<entry>2.28</entry>
</row>
<row>
<entry></entry>
<entry>Example 22</entry>
<entry>(2.34%)</entry>
<entry>1.93</entry>
</row>
<row>
<entry></entry>
<entry>Example 19</entry>
<entry>(2.32%)</entry>
<entry>1.80</entry>
</row>
<row>
<entry></entry>
<entry>Example 32</entry>
<entry>(2.72%)</entry>
<entry>1.52</entry>
</row>
<row>
<entry></entry>
<entry>Example 13</entry>
<entry>(2.70%)</entry>
<entry>1.38</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00002">*TINUVIN&thinsp;&reg; 234 is 2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0362" lvl="0"><number>&lsqb;0362&rsqb;</number> These data show that the instant compounds are particularly efficacious when used in thermoplastic compositions, such as polycarbonate, even surpassing a commerical UV absorber in effectiveness. This is shown by the reduction of yellowing (&Dgr;YI) after exposure to actinic radiation. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 38 </heading>
</section>
<section>
<heading lvl="1">Poly(methyl methacrylate) </heading>
<paragraph id="P-0363" lvl="0"><number>&lsqb;0363&rsqb;</number> The durability of representative instant benzotriazoles in thermoplastic substrates is determined by incorporating various test compounds into solvent cast films of a poly(methyl methacrylate) (PMMA) resin. The free standing films are mounted into cardboard holders, secured in metal frames and exposed in an Atlas C165 Xenon-arc Weather-Ometer under dry conditions according to ASTM G26. Loss of UV absorber is determined by monitoring the loss of diagnostic UV absorption as described earlier. Performance is measured by a change in color or the physical integrity of the film, or in loss of absorbance of the UV absorber at &lgr;max. </paragraph>
<paragraph id="P-0364" lvl="0"><number>&lsqb;0364&rsqb;</number> Poly(methyl methacrylate), medium molecular weight, Aldrich, is dissolved in methylene chloride at room temperature along with between 1 and 3% by weight of test benzotriazole, based on the PMMA resin. Films are cast using a calibrated drawdown bar to prepare 1 mil thick film after drying.  
<table-cwu id="TABLE-US-00005">
<number>5</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="98PT" align="center"/>
<colspec colname="2" colwidth="105PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Compound of</entry>
<entry>Change in Initial</entry>
</row>
<row>
<entry></entry>
<entry>Example* (% by weight)</entry>
<entry>Absorbance after 750 hours</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="center"/>
<colspec colname="3" colwidth="105PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 234*</entry>
<entry>(2.50%)</entry>
<entry>0.18</entry>
</row>
<row>
<entry></entry>
<entry>Example 25</entry>
<entry>(2.54%)</entry>
<entry>0.15</entry>
</row>
<row>
<entry></entry>
<entry>Example 28</entry>
<entry>(3.07%)</entry>
<entry>0.07</entry>
</row>
<row>
<entry></entry>
<entry>Example 31</entry>
<entry>(3.03%)</entry>
<entry>0.10</entry>
</row>
<row>
<entry></entry>
<entry>Example 32</entry>
<entry>(2.72%)</entry>
<entry>0.02</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00003">*TINUVIN&thinsp;&reg; 234 is 2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0365" lvl="0"><number>&lsqb;0365&rsqb;</number> These data show that the instant compounds are particularly efficacious when used in thermoplastic compositions, such as poly(methyl methacrylate), even surpassing a commercial UV absorber in effectiveness. This is shown by the reduction in absorbance loss after exposure to actinic radiation. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 39 </heading>
</section>
<section>
<heading lvl="1">Incorporation into Photographic Layers </heading>
<paragraph id="P-0366" lvl="0"><number>&lsqb;0366&rsqb;</number> A gelatin coat of the following composition (per m<highlight><superscript>2</superscript></highlight>) is applied in the customary manner to a polyester base.  
<table-cwu id="TABLE-US-00006">
<number>6</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="119PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Components</entry>
<entry>Amount</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="35PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="63PT" align="right"/>
<colspec colname="3" colwidth="56PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Gelatin</entry>
<entry>1200</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Tricresyl Phosphate</entry>
<entry>510</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Hardener*</entry>
<entry>40</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Wetting Agent**</entry>
<entry>100</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Test UV Absorber</entry>
<entry>400</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00004">*potassium salt of 2-hydroxy-4,6-dichloro-s-triazine </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00005">**sodium 4,8-diisobutylnaphthalene-2-sulfonate </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0367" lvl="0"><number>&lsqb;0367&rsqb;</number> The gelatin coats are dried at 20&deg; C. for seven days. </paragraph>
<paragraph id="P-0368" lvl="0"><number>&lsqb;0368&rsqb;</number> When the instant UV absorbers are used, clear transparent coats are obtained which are suitable for photographic recording material for example as a UV filter coat.  
<table-cwu id="TABLE-US-00007">
<number>7</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="77PT" align="left"/>
<colspec colname="1" colwidth="126PT" align="center"/>
<colspec colname="2" colwidth="14PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>% Change in Initial Optical</entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry>Density (2.0) after</entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="center"/>
<colspec colname="3" colwidth="84PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Test Compound</entry>
<entry>60 KJ Exposure</entry>
<entry>120 KJ Exposure</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 328</entry>
<entry>19&ensp;</entry>
<entry>66&ensp;</entry>
</row>
<row>
<entry></entry>
<entry>Example 25</entry>
<entry>2</entry>
<entry>6</entry>
</row>
<row>
<entry></entry>
<entry>Example 33</entry>
<entry>1</entry>
<entry>5</entry>
</row>
<row>
<entry></entry>
<entry>Example 32</entry>
<entry>1</entry>
<entry>4</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00006">TINUVIN&thinsp;&reg; 328 is 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0369" lvl="0"><number>&lsqb;0369&rsqb;</number> These data show that the instant compounds when used in a photographic layer are extremely photostable. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 40 </heading>
</section>
<section>
<heading lvl="1">Photographic Compositions </heading>
<paragraph id="P-0370" lvl="0"><number>&lsqb;0370&rsqb;</number> A polyethylene-coated base material is coated with a gelatin coat comprising silver bromide and a magenta coupler (M-9). The gelatin coat includes the following component (per m<highlight><superscript>2 </superscript></highlight>of base material):  
<table-cwu id="TABLE-US-00008">
<number>8</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="105PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Component</entry>
<entry>AgBr coat</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="42PT" align="left"/>
<colspec colname="1" colwidth="70PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="right"/>
<colspec colname="3" colwidth="49PT" align="left"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>Gelatin</entry>
<entry>5.15</entry>
<entry>g</entry>
</row>
<row>
<entry></entry>
<entry>Hardener*</entry>
<entry>300</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Wetting Agent**</entry>
<entry>85</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Silver Bromide</entry>
<entry>260</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Magenta Coupler(M-9)</entry>
<entry>325</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry>Tricresyl Phosphate</entry>
<entry>162</entry>
<entry>mg</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00007">*potassium salt of 2-hydroxy-4,6-dichloro-s-triazine </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00008">**sodium 4,8-diisobutylnaphthalene-2-sulfonate </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00009">M-9 is 3-tridecyl-6-tert-butyl-7-chloro-1H-pyrazolo&lsqb;4,2-d&rsqb;pyrazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0371" lvl="0"><number>&lsqb;0371&rsqb;</number> A step wedge having a density difference of 0.3 log E per step is exposed onto each of the resulting samples which are then processed in accordance with the manufacturer&apos;s instructions in the P94 process of Agfa Gevaert for negative color papers. </paragraph>
<paragraph id="P-0372" lvl="0"><number>&lsqb;0372&rsqb;</number> After exposure and processing, the density of reflectance in the green region for the magenta stage is measured at a density of between 0.9 and 1.1 of the wedge. </paragraph>
<paragraph id="P-0373" lvl="0"><number>&lsqb;0373&rsqb;</number> A UV absorber filter comprising an instant test benzotriazole is prepared on transparent base material as described in Example 39. </paragraph>
<paragraph id="P-0374" lvl="0"><number>&lsqb;0374&rsqb;</number> The wedge is subsequently exposed behind the UV absorber filter in an Atlas exposure instrument at 15 kJ/cm<highlight><superscript>2 </superscript></highlight>and the reflectance density is measured again. The magenta dye density loss (&minus;&Dgr;D) is greatly reduced by the instant test compound as stabilizer in comparison with the sample containing no stabilizer. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 41 </heading>
</section>
<section>
<heading lvl="1">Photographic Compositions </heading>
<paragraph id="P-0375" lvl="0"><number>&lsqb;0375&rsqb;</number> The procedure described in Example 39 is repeated using a mixture of 2 parts by weight of an instant test compound and 1 part by weight of an s-triazine UV absorber. Clear transparent coats are obtained which are suitable for a photographic recording material. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 42 </heading>
</section>
<section>
<heading lvl="1">Photographic Compositions </heading>
<paragraph id="P-0376" lvl="0"><number>&lsqb;0376&rsqb;</number> A photographic material having the following layer structure is prepared: </paragraph>
<paragraph id="P-0377" lvl="2"><number>&lsqb;0377&rsqb;</number> top layer </paragraph>
<paragraph id="P-0378" lvl="2"><number>&lsqb;0378&rsqb;</number> red-sensitive layer </paragraph>
<paragraph id="P-0379" lvl="2"><number>&lsqb;0379&rsqb;</number> second gelatin layer </paragraph>
<paragraph id="P-0380" lvl="2"><number>&lsqb;0380&rsqb;</number> green-sensitive layer </paragraph>
<paragraph id="P-0381" lvl="2"><number>&lsqb;0381&rsqb;</number> first gelatin layer </paragraph>
<paragraph id="P-0382" lvl="2"><number>&lsqb;0382&rsqb;</number> blue-sensitive layer </paragraph>
<paragraph id="P-0383" lvl="2"><number>&lsqb;0383&rsqb;</number> polyethylene base </paragraph>
<paragraph id="P-0384" lvl="0"><number>&lsqb;0384&rsqb;</number> The gelatin layers consist of the following components (per m<highlight><superscript>2 </superscript></highlight>of base material): </paragraph>
<paragraph id="P-0385" lvl="7"><number>&lsqb;0385&rsqb;</number> Blue-sensitive Layer </paragraph>
<paragraph id="P-0386" lvl="2"><number>&lsqb;0386&rsqb;</number> &agr;-(3-benzyl-4-ethoxyhydantoin-1-yl)-&agr;-pivaloyl-2-chloro-5-&lsqb;&agr;-(2,4-di-tert-amylphenoxy)acetanilide (400 mg) </paragraph>
<paragraph id="P-0387" lvl="2"><number>&lsqb;0387&rsqb;</number> &agr;-(1-butylphenylurazol-4-yl)-&agr;-pivaloyl-5-(3-dodecanesulfonyl-2-methylpropanamido)-2-methoxyacetamide (400 mg) </paragraph>
<paragraph id="P-0388" lvl="2"><number>&lsqb;0388&rsqb;</number> dibutyl phthalate (130 mg) </paragraph>
<paragraph id="P-0389" lvl="2"><number>&lsqb;0389&rsqb;</number> dinonyl phthalate (130 mg) </paragraph>
<paragraph id="P-0390" lvl="2"><number>&lsqb;0390&rsqb;</number> gelatin (1200 mg) </paragraph>
<paragraph id="P-0391" lvl="2"><number>&lsqb;0391&rsqb;</number> 1,5-dioxa-3-ethyl-3-&lsqb;&bgr;-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxymethyl&rsqb;-8,10-diphenyl-9-thia&lsqb;5.5&rsqb;spiroundecane (150 mg) </paragraph>
<paragraph id="P-0392" lvl="2"><number>&lsqb;0392&rsqb;</number> bis(1-acryloyl-2,2,6,6-tetramethyl-4-piperidyl) 2,2-bis(3,5-di-tert-butyl-4-hydroxybenzyl)malonate (150 mg) </paragraph>
<paragraph id="P-0393" lvl="2"><number>&lsqb;0393&rsqb;</number> 3,5-di-tert-butyl-4-hydroxy(2,4-di-tert-amylphenyl)benzoate (150 mg) </paragraph>
<paragraph id="P-0394" lvl="2"><number>&lsqb;0394&rsqb;</number> poly(N-tert-butylacrylamide) (50 mg) </paragraph>
<paragraph id="P-0395" lvl="2"><number>&lsqb;0395&rsqb;</number> blue-sensitive silver chlorobromide emulsion (240 mg) </paragraph>
<paragraph id="P-0396" lvl="7"><number>&lsqb;0396&rsqb;</number> First Gelatin Interlayer </paragraph>
<paragraph id="P-0397" lvl="2"><number>&lsqb;0397&rsqb;</number> gelatin (1000 mg) </paragraph>
<paragraph id="P-0398" lvl="2"><number>&lsqb;0398&rsqb;</number> 2,5-di-tert-octylhydroquinone (100 mg) </paragraph>
<paragraph id="P-0399" lvl="2"><number>&lsqb;0399&rsqb;</number> hexyl 5-&lsqb;2,5-dihydroxy4-(4-hexyloxycarbonyl-1,1-dimethylbutyl)phenyl&rsqb;-5-methylhexanoate (100 mg) </paragraph>
<paragraph id="P-0400" lvl="2"><number>&lsqb;0400&rsqb;</number> dibutyl phthalate (200 mg) </paragraph>
<paragraph id="P-0401" lvl="2"><number>&lsqb;0401&rsqb;</number> diisobutyl phthalate (200 mg) </paragraph>
<paragraph id="P-0402" lvl="7"><number>&lsqb;0402&rsqb;</number> Green-sensitive Layer </paragraph>
<paragraph id="P-0403" lvl="2"><number>&lsqb;0403&rsqb;</number> 7-chloro-2-&lcub;2-&lsqb;2-(2,4-di-tert-amylphenoxy)octanamido&rsqb;-1-methylethyl&rcub;-6-methyl-1H-pyrazolo&lsqb;1,5b&rsqb;&lsqb;1,2,4&rsqb;triazole (100 mg) </paragraph>
<paragraph id="P-0404" lvl="2"><number>&lsqb;0404&rsqb;</number> 6-tert-butyl-7-chloro-3-(3-dodecanesulfonylpropyl)-1H-pyrazolo)-1H-pyrazolo&lsqb;5,1-o&rsqb;&lsqb;1,2,4&rsqb;-triazole (100 mg) </paragraph>
<paragraph id="P-0405" lvl="2"><number>&lsqb;0405&rsqb;</number> dibutyl phthalate (100 mg) </paragraph>
<paragraph id="P-0406" lvl="2"><number>&lsqb;0406&rsqb;</number> dicresyl phosphate (100 mg) </paragraph>
<paragraph id="P-0407" lvl="2"><number>&lsqb;0407&rsqb;</number> trioctyl phosphate (100 mg) </paragraph>
<paragraph id="P-0408" lvl="2"><number>&lsqb;0408&rsqb;</number> gelatin (1400 mg) </paragraph>
<paragraph id="P-0409" lvl="2"><number>&lsqb;0409&rsqb;</number> 3,3,3&prime;,3&prime;-tetramethyl-5,5&prime;,6,6&prime;-tetrapropoxy-1,1&prime;-spirobiindane (100 mg) </paragraph>
<paragraph id="P-0410" lvl="2"><number>&lsqb;0410&rsqb;</number> 4-(isotridecyloxyphenyl)thiomorpholine-1,1-dioxide (100 mg) </paragraph>
<paragraph id="P-0411" lvl="2"><number>&lsqb;0411&rsqb;</number> 4,4&prime;-butylidenebis(3-methyl-6-tert-butylphenol) (50 mg) </paragraph>
<paragraph id="P-0412" lvl="2"><number>&lsqb;0412&rsqb;</number> 2,2&prime;-isobutylidenebis(4,6-dimethylphenol) (10 mg) </paragraph>
<paragraph id="P-0413" lvl="2"><number>&lsqb;0413&rsqb;</number> 3,5-dichloro-4-(hexadecyloxycarbpnyloxy)ethylbenzoate (20 mg) </paragraph>
<paragraph id="P-0414" lvl="2"><number>&lsqb;0414&rsqb;</number> 3,5-bis&lsqb;3-(2,4-di-tert-amylphenoxy)propylcarbamoyl&rsqb; sodium benzenesulfinate (20 mg) </paragraph>
<paragraph id="P-0415" lvl="2"><number>&lsqb;0415&rsqb;</number> green-sensitive silver chlorobromide emulsion (150 mg) </paragraph>
<paragraph id="P-0416" lvl="7"><number>&lsqb;0416&rsqb;</number> Second Gelatin Interlayer </paragraph>
<paragraph id="P-0417" lvl="2"><number>&lsqb;0417&rsqb;</number> gelatin (1000 mg) </paragraph>
<paragraph id="P-0418" lvl="2"><number>&lsqb;0418&rsqb;</number> 5-chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)benzo-1,2,3-triazole (200 mg) </paragraph>
<paragraph id="P-0419" lvl="2"><number>&lsqb;0419&rsqb;</number> 2-(3-dodecyl-2-hydroxy-5-methylphenyl)benzo-1,2,3-triazole (200 mg) </paragraph>
<paragraph id="P-0420" lvl="2"><number>&lsqb;0420&rsqb;</number> trinonyl phosphate (300 mg) </paragraph>
<paragraph id="P-0421" lvl="2"><number>&lsqb;0421&rsqb;</number> 2,5-di-tert-octylhydroquinone (50 mg) </paragraph>
<paragraph id="P-0422" lvl="2"><number>&lsqb;0422&rsqb;</number> hexyl 5-&lsqb;2,5-dihydroxy-4-(4-hexyloxycarbonyl-1,1-dimethylbutyl)phenyl&rsqb;-5-methylhexanoate (50 mg) </paragraph>
<paragraph id="P-0423" lvl="7"><number>&lsqb;0423&rsqb;</number> Red-sensitive Layer </paragraph>
<paragraph id="P-0424" lvl="2"><number>&lsqb;0424&rsqb;</number> 2-&lsqb;&agr;-(2,4-di-tert-amylphenoxy)butanamido&rsqb;4,6-dichloro-5-ethylphenol (150 mg) </paragraph>
<paragraph id="P-0425" lvl="2"><number>&lsqb;0425&rsqb;</number> 2,4-dichloro-3-ethyl-6-hexadecanamidophenol (150 mg) </paragraph>
<paragraph id="P-0426" lvl="2"><number>&lsqb;0426&rsqb;</number> 4-chloro-2-(1,2,3,4,5-pentafluorobenzamido)-5-&lsqb;2-(2,4-di-tert-amylphenoxy)-3-methylbutanamido&rsqb;phenol (100 mg) </paragraph>
<paragraph id="P-0427" lvl="2"><number>&lsqb;0427&rsqb;</number> dioctyl phthalate (100 mg) </paragraph>
<paragraph id="P-0428" lvl="2"><number>&lsqb;0428&rsqb;</number> dicyclohexyl phthalate (100 mg) </paragraph>
<paragraph id="P-0429" lvl="2"><number>&lsqb;0429&rsqb;</number> gelatin (1200 mg) </paragraph>
<paragraph id="P-0430" lvl="2"><number>&lsqb;0430&rsqb;</number> 5-chloro-2-(3,5-di-tert-butyl-2-hydroxyphenyl)benzo-1,2,3-triazole (100 mg) </paragraph>
<paragraph id="P-0431" lvl="2"><number>&lsqb;0431&rsqb;</number> 2-(3-dodecyl-2-hydroxy-5-methylphenyl)benzo-1,2,3-triazole (100 mg) </paragraph>
<paragraph id="P-0432" lvl="2"><number>&lsqb;0432&rsqb;</number> 3,5-di-tert-butyl-4-hydroxy(2,4-di-tert-amylphenyl)benzoate (50 mg) </paragraph>
<paragraph id="P-0433" lvl="2"><number>&lsqb;0433&rsqb;</number> poly(N-tert-butylacrylamide) (300 mg) </paragraph>
<paragraph id="P-0434" lvl="2"><number>&lsqb;0434&rsqb;</number> N,N-diethyl-2,4-di-tert-amylphenoxyacetamide (100 mg) </paragraph>
<paragraph id="P-0435" lvl="2"><number>&lsqb;0435&rsqb;</number> 2,5-di-tert-octylhydroquinone (50 mg) </paragraph>
<paragraph id="P-0436" lvl="2"><number>&lsqb;0436&rsqb;</number> red-sensitive silver chlorobromide emulsion (200 mg) </paragraph>
<paragraph id="P-0437" lvl="0"><number>&lsqb;0437&rsqb;</number> The top-most layer is prepared with and without a UV absorber: </paragraph>
<paragraph id="P-0438" lvl="7"><number>&lsqb;0438&rsqb;</number> with a UV Absorber </paragraph>
<paragraph id="P-0439" lvl="2"><number>&lsqb;0439&rsqb;</number> 2,5-di-tert-octylhydroquinone (20 mg) </paragraph>
<paragraph id="P-0440" lvl="2"><number>&lsqb;0440&rsqb;</number> hexyl 5-&lsqb;2,5-dihydroxy-4-(4-hexyloxycarbpnyl-1,1-dimethylbutyl)phenyl&rsqb;-5-methylhexanoate (20 mg) </paragraph>
<paragraph id="P-0441" lvl="2"><number>&lsqb;0441&rsqb;</number> gelatin (400 mg) </paragraph>
<paragraph id="P-0442" lvl="2"><number>&lsqb;0442&rsqb;</number> trinonyl phosphate (120 mg) </paragraph>
<paragraph id="P-0443" lvl="2"><number>&lsqb;0443&rsqb;</number> UV absorber test compound (385 mg) </paragraph>
<paragraph id="P-0444" lvl="7"><number>&lsqb;0444&rsqb;</number> without a UV Absorber </paragraph>
<paragraph id="P-0445" lvl="2"><number>&lsqb;0445&rsqb;</number> gelatin (800 mg) </paragraph>
<paragraph id="P-0446" lvl="0"><number>&lsqb;0446&rsqb;</number> The hardener used is 2,4-dichloro-6-hydroxy-s-triazine potassium salt. The wetting agemt is the sodium salt of diisobutylhaphthalenesulfonic acid. </paragraph>
<paragraph id="P-0447" lvl="0"><number>&lsqb;0447&rsqb;</number> Three step wedges with a density difference of 0.3 log E per step are exposed onto each of the samples (with blue, green and red light, respectively). The processing process RA-4 (Kodak) for color papers is then carried out. </paragraph>
<paragraph id="P-0448" lvl="0"><number>&lsqb;0448&rsqb;</number> After exposure and processing, the reflectance densities in the red for the cyan step, in the green for the magenta step and in the blue for the yellow step are measured at a density of between 0.9 and 1.1 of the wedges. The wedges are then exposed in an Atlas exposure instrument at a total of 15 KJ/cm<highlight><superscript>2</superscript></highlight>, and the reflectance densities are measured again. </paragraph>
<paragraph id="P-0449" lvl="0"><number>&lsqb;0449&rsqb;</number> In the case of the magenta wedge as well, the reflectance density before and after exposure is measured in the blue for yellowing. </paragraph>
<paragraph id="P-0450" lvl="0"><number>&lsqb;0450&rsqb;</number> The presence of the instant UV absorbers reduces the dye density loss of the cyan, magenta and yellow image dyes. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 43 </heading>
</section>
<section>
<heading lvl="1">Photographic Compositions </heading>
<paragraph id="P-0451" lvl="0"><number>&lsqb;0451&rsqb;</number> The procedure described in Example 39 is repeated using a mixture of 1 part by weight of an instant UV absorber and 1 part by weight of a second instant UV absorber. Clear transparent coats are obtained which are suitable for a photographic recording material. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 44 </heading>
</section>
<section>
<heading lvl="1">Photographic Compositions </heading>
<paragraph id="P-0452" lvl="0"><number>&lsqb;0452&rsqb;</number> The procedure described in Example 39 is repeated using a mixture of 1 part by weight of an instant UV absorber and 1 part by weight of a second benzotriazole UV absorber. Clear transparent coats are obtained which are suitable for a photographic recording material. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 45 </heading>
</section>
<section>
<heading lvl="1">Automotive Coating Compositions </heading>
<paragraph id="P-0453" lvl="0"><number>&lsqb;0453&rsqb;</number> To ascertain the effect on thermal durability and loss rate from a high solids thermoset acrylic coating containing an instant benzotriazole UV absorber, the following tests are carried out. </paragraph>
<paragraph id="P-0454" lvl="0"><number>&lsqb;0454&rsqb;</number> A high solids thermoset acrylic clear coat is prepared by mixing an experimental acrylic polyol resin and hexamethoxymethylmelamine (Resimene&reg; 747, Monsanto) at a solids ratio of 60/40. The dodecylbenzene sulfonic acid catalyst (Nacure&reg; 5225; King Industries) is added at 0.70% by weight. A flow aid Modaflow&reg; (Monsanto) is added at 0.25% by weight to form a model acrylic melamine resin system. </paragraph>
<paragraph id="P-0455" lvl="0"><number>&lsqb;0455&rsqb;</number> The model clear coat is reduced with xylene to a viscosity of 26-27 second using a Zahn &num;2 cup and applied via a conventional air spray at 50 psi (3.5 Kg/cm<highlight><superscript>2</superscript></highlight>) over a 1&Prime;&times;3&Prime; (2.54 cm&times;7.62 cm) quartz slide. Cure is achieved by baking the slide for 30 minutes at 260&deg; F. (127&deg; C.). The clear coat is stabilized with 1% by weight of a hindered amine light stabilizer, bis-(1-octyl-oxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, (TINUVIN&reg; 123, Ciba). The various test benzotriazole UV absorbers are incorporated at the 5 mmol % by weight in the clear coat. The film thickness on the quartz slides range from 1.15 to 1.41 mils (0.029 to 0.036 mm). </paragraph>
<paragraph id="P-0456" lvl="0"><number>&lsqb;0456&rsqb;</number> The films on the quartz slides are weathered according to the following conditions in Xenon Arc Weather-Ometer with a controlled irradiance at 6500 W , using inner quartz and outer borosilicate S-type filter. The irradiation cycle is as follows: 40 minutes of straight irradiation with no water spray, followed by 20 minutes of light plus front spray, followed by 60 minutes of light irradiation and finally by 60 minutes dart plus rear spray (condensation). The setting is at 0.55 W/M<highlight><superscript>2 </superscript></highlight>at 340 nm, 1.98 kJ/hour. In the light cycle the black panel temperature is controlled at 70&plusmn;2&deg; C. The relative humidity in the light cycle is in the range of 50-55% and in the dark cycle 100%. The absorbance of the long wavelength UV band as a function of Xenon arc weathering hours are recorded. </paragraph>
<paragraph id="P-0457" lvl="0"><number>&lsqb;0457&rsqb;</number> To follow the loss of UV absorbers from the clear coats, UV spectra are measured initially and after weathering at regular time intervals. The UV spectrophotometer measures absorbance linearly up to 5.5 absorbance units using a reference beam attenuation technique. </paragraph>
<paragraph id="P-0458" lvl="0"><number>&lsqb;0458&rsqb;</number> It is assumed that the degradation products from the UV absorber do not contribute to the UV spectrum. This is tested by following the ratio of absorbance of the band at about 300 nm and the band at about 340 nm. The ratio does not change upon weathering the sample. This suggests that the UV spectrum of the weathered films correspond to the amount of UV absorber remaining in the film with very little if any contribution to the spectrum by photo degradants. </paragraph>
<paragraph id="P-0459" lvl="0"><number>&lsqb;0459&rsqb;</number> Representative benzotriazole test compounds are incorporated into a high solid thermoset acrylic melamine resin at a concentration of 3% by weight to give equal molar concentrations of the test benzotriazole in equal film thickness and sufficient to give a starting absorbance of approximately 2.0 absorbance units. The test samples are exposed for 1026, 2025 and 3335 hours respectively.  
<table-cwu id="TABLE-US-00009">
<number>9</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="2">
<colspec colname="OFFSET" colwidth="28PT" align="left"/>
<colspec colname="1" colwidth="189PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Compound of</entry>
</row>
<row>
<entry></entry>
<entry>Example*</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="1" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="28PT" align="left"/>
<colspec colname="1" colwidth="63PT" align="left"/>
<colspec colname="2" colwidth="126PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry></entry>
<entry>Units of Absorbance</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Loss after 1026 hours</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 384*</entry>
<entry>0.42</entry>
</row>
<row>
<entry></entry>
<entry>Example 22</entry>
<entry>0.41</entry>
</row>
<row>
<entry></entry>
<entry>Example 25</entry>
<entry>0.18</entry>
</row>
<row>
<entry></entry>
<entry>Example 19</entry>
<entry>0.16</entry>
</row>
<row>
<entry></entry>
<entry>Example 16</entry>
<entry>0.13</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Units of Absorbance</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Loss after 2025 hours</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 928*</entry>
<entry>0.43</entry>
</row>
<row>
<entry></entry>
<entry>Example 25</entry>
<entry>0.34</entry>
</row>
<row>
<entry></entry>
<entry>Example 16</entry>
<entry>0.20</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Units of Absorbance</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Loss after 3336 hours</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 928*</entry>
<entry>0.69</entry>
</row>
<row>
<entry></entry>
<entry>Example 25</entry>
<entry>0.60</entry>
</row>
<row>
<entry></entry>
<entry>Example 16</entry>
<entry>0.30</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00010">*TINUVIN&thinsp;&reg; 384 is 2-&lcub;2-hydroxy-3-tert-butyl-5-&lsqb;2-(octyloxycarbonyl)ethyl&rsqb;phenyl&rcub;-2H-benzotriazole. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="left"><footnote id="FOO-00011">*TINUVIN&thinsp;&reg; 928 is 2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzotriazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0460" lvl="0"><number>&lsqb;0460&rsqb;</number> The test shows that the instant benzotriazoles are especially durable in automotive coatings as judged by low loss rates. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 46 </heading>
</section>
<section>
<heading lvl="1">Methyl 3-(Benzotriazole-2-yl)-4-hydroxy-5-(4-methoxy-&agr;-cumyl)hydrocinnamate </heading>
<paragraph id="P-0461" lvl="0"><number>&lsqb;0461&rsqb;</number> Following the general procedure of Example 16, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 47 </heading>
</section>
<section>
<heading lvl="1">Methyl 3-(5-Chloro-benzotriazol-2-yI)-4-hydroxy-5-(4-chloro-&agr;-cumyl)hydrocinnamate </heading>
<paragraph id="P-0462" lvl="0"><number>&lsqb;0462&rsqb;</number> Following the general procedure of Example 16, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 48 </heading>
</section>
<section>
<heading lvl="1">Octyl 3-(5-Chloro-benzotriazol-2-yl)-4-hydroxy-5-(4-chloro-&agr;-cumyl)hydrocinnamate </heading>
<paragraph id="P-0463" lvl="0"><number>&lsqb;0463&rsqb;</number> The compound prepared in Example 47 is refluxed in toluene in the presence of lithium amide and EXXAL&reg; 8 (mixture of octanols, Exxon-Mobil) for four hours. The title compound is obtained. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 49 </heading>
</section>
<section>
<heading lvl="1">&ohgr;-Hydroxy-hepta-(ethyleneoxy)ethyl 3-(Benzotriazol-2-yl)-4-hydroxy-5-(4-methoxy-&agr;-cumyl)hydrocinnamate and 3,6,9,12,15,18,21-Heptaoxatricosanylene Bis(3-(benzotriazol-2-yl)-4-hydroxy-5-(4-methoxy-&agr;-cumyl)hydrocinnamate) </heading>
<paragraph id="P-0464" lvl="0"><number>&lsqb;0464&rsqb;</number> The methyl ester compound prepared in Example 46 is heated to 170&deg; C. in the presence of poly(ethylene glycol) (molecular weight&equals;300, available from DOW) and dibutyltin oxide, under a full vacuum, for four hours. The desired product which is a mixture of monomeric and dimeric esters depending on the stoichiometry is obtained. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 50 </heading>
</section>
<section>
<heading lvl="1">Methyl 3-(5-Trifluoromethyl-benzotriazol-2-yl)-4-hydroxy-5-(2-fluoro-&agr;-cumyl)hydrocinnamate </heading>
<paragraph id="P-0465" lvl="0"><number>&lsqb;0465&rsqb;</number> Following the general procedure of Example 16, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 51 </heading>
</section>
<section>
<heading lvl="1"><highlight><bold>3</bold></highlight>-(5-Trifluoromethyl-benzotriazol-2-yl)-4-hydroxy-5-(2-fluoro-&agr;-cumyl)hydrocinnamic Acid </heading>
<paragraph id="P-0466" lvl="0"><number>&lsqb;0466&rsqb;</number> The title compound is prepared by refluxing the compound prepared in Example 50 in aqueous sodium hydroxide solution followed by neutralization with aqueous hydrochloric acid. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 52 </heading>
</section>
<section>
<heading lvl="1">3-Methacryloyloxy-2-hydroxypropyl 3-(5-Trifluoromethyl-benzotriazol-2-yl)-4-hydroxy-5-(2-fluoro-&agr;-cumyl)hydrocinnamate and 3-Methacryloyloxy-1-hydroxyprop-2-yl 3-(5-Trifluoromethyl-benzotriazol-2-yl)-4-hydroxy-5-(2-fluoro-&agr;-cumyl)hydrocinnamate </heading>
<paragraph id="P-0467" lvl="0"><number>&lsqb;0467&rsqb;</number> The desired mixture of the title compounds is obtained when the instant compound of Example 51, toluene, tetrabutylammonium bromide and glycidyl methacrylate are heated to 105&deg; C. and held there for four hours. After cooling the reaction mixture to 80&deg; C., washing thrice with water, the toluene is removed by vacuum distillation to give the desired mixture of title compounds. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES 53-71</heading>
<paragraph id="P-0468" lvl="0"><number>&lsqb;0468&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00012">
<number>12</number>
<image id="EMI-C00012" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00012.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00012" file="US20030004235A1-20030102-C00012.CDX"/>
<chemistry-mol-file id="CHEMMOL-00012" file="US20030004235A1-20030102-C00012.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0469" lvl="0"><number>&lsqb;0469&rsqb;</number> Following the general procedure of Example 16, the title compounds are prepared as represented by formula I (above) where G<highlight><subscript>1 </subscript></highlight>and G<highlight><subscript>2 </subscript></highlight>are hydrogen, E<highlight><subscript>2 </subscript></highlight>is tert-butyl and E<highlight><subscript>1 </subscript></highlight>is of formula IV  
<chemistry-cwu id="CHEM-US-00013">
<number>13</number>
<image id="EMI-C00013" he="69.37245" wi="198.02475" file="US20030004235A1-20030102-C00013.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00013" file="US20030004235A1-20030102-C00013.CDX"/>
<chemistry-mol-file id="CHEMMOL-00013" file="US20030004235A1-20030102-C00013.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0470" lvl="7"><number>&lsqb;0470&rsqb;</number> E<highlight><subscript>25 </subscript></highlight>is hydrogen in all examples.  
<table-cwu id="TABLE-US-00010">
<number>10</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="35PT" align="center"/>
<colspec colname="2" colwidth="21PT" align="left"/>
<colspec colname="3" colwidth="21PT" align="left"/>
<colspec colname="4" colwidth="21PT" align="left"/>
<colspec colname="5" colwidth="21PT" align="left"/>
<colspec colname="6" colwidth="28PT" align="left"/>
<colspec colname="7" colwidth="28PT" align="left"/>
<colspec colname="8" colwidth="42PT" align="left"/>
<thead>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Example</entry>
<entry>E<highlight><subscript>27</subscript></highlight></entry>
<entry>E<highlight><subscript>28</subscript></highlight></entry>
<entry>E<highlight><subscript>22</subscript></highlight></entry>
<entry>E<highlight><subscript>23</subscript></highlight></entry>
<entry>E<highlight><subscript>24</subscript></highlight></entry>
<entry>E<highlight><subscript>26</subscript></highlight></entry>
<entry>E<highlight><subscript>3 </subscript></highlight>or G<highlight><subscript>3</subscript></highlight></entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="8">
<colspec colname="1" colwidth="35PT" align="char" char="."/>
<colspec colname="2" colwidth="21PT" align="left"/>
<colspec colname="3" colwidth="21PT" align="left"/>
<colspec colname="4" colwidth="21PT" align="left"/>
<colspec colname="5" colwidth="21PT" align="left"/>
<colspec colname="6" colwidth="28PT" align="left"/>
<colspec colname="7" colwidth="28PT" align="left"/>
<colspec colname="8" colwidth="42PT" align="left"/>
<tbody valign="top">
<row>
<entry>53</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>Cl</entry>
<entry>H</entry>
<entry>Cl</entry>
<entry>Cl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>54</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>F</entry>
<entry>Me</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>55</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>IP</entry>
<entry>H</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>56</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>OAl</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>57</entry>
<entry>Oc</entry>
<entry>Oc</entry>
<entry>H</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>58</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>CN</entry>
<entry>H</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>59</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>OH</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>60</entry>
<entry>Do</entry>
<entry>H</entry>
<entry>OMe</entry>
<entry>H</entry>
<entry>OMe</entry>
<entry>OMe</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>61</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>*</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>62</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>**</entry>
<entry>H</entry>
<entry>methyl</entry>
</row>
<row>
<entry>63</entry>
<entry>Et</entry>
<entry>Et</entry>
<entry>H</entry>
<entry>H</entry>
<entry>**</entry>
<entry>H</entry>
<entry>allyl</entry>
</row>
<row>
<entry>64</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>**</entry>
<entry>H</entry>
<entry>H</entry>
<entry>octadecyl</entry>
</row>
<row>
<entry>65</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>F</entry>
<entry>H</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>66</entry>
<entry>Me</entry>
<entry>Cy</entry>
<entry>H</entry>
<entry>H</entry>
<entry>***</entry>
<entry>H</entry>
<entry>E<highlight><subscript>29 </subscript></highlight>&equals; Octa</entry>
</row>
<row>
<entry>67</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>****</entry>
<entry>H</entry>
<entry>phenyl</entry>
</row>
<row>
<entry>68</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>****</entry>
<entry>H</entry>
<entry>butyl</entry>
</row>
<row>
<entry>69</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>****</entry>
<entry>H</entry>
<entry>dodecyl</entry>
</row>
<row>
<entry>70</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>71</entry>
<entry>Me</entry>
<entry>Me</entry>
<entry>H</entry>
<entry>H</entry>
<entry>NHE<highlight><subscript>4</subscript></highlight></entry>
<entry>H</entry>
<entry>E<highlight><subscript>4 </subscript></highlight>&equals; Do</entry>
</row>
<row><entry namest="1" nameend="8" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><footnote id="FOO-00012">In Examle 61, </footnote></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><footnote id="FOO-00013">* is &mdash;OCOE<highlight><subscript>11 </subscript></highlight>where E<highlight><subscript>11 </subscript></highlight>is butyl. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><footnote id="FOO-00014">** is &mdash;COOG<highlight><subscript>3</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><footnote id="FOO-00015">*** is &mdash;SO<highlight><subscript>2</subscript></highlight>NHE<highlight><subscript>29</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><footnote id="FOO-00016">**** is &mdash;SO<highlight><subscript>2</subscript></highlight>E<highlight><subscript>3</subscript></highlight>. </footnote></entry>
</row>
<row>
<entry namest="1" nameend="8" align="left"><footnote id="FOO-00017">Do is dodecyl; Et is ethyl; IP is isopropenyl; Me is methyl; OAl is allyloxy; Oc is octyl; Octa is octadecyl; and OMe is methoxy. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLES 72-90 </heading>
<paragraph id="P-0471" lvl="0"><number>&lsqb;0471&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00014">
<number>14</number>
<image id="EMI-C00014" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00014.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00014" file="US20030004235A1-20030102-C00014.CDX"/>
<chemistry-mol-file id="CHEMMOL-00014" file="US20030004235A1-20030102-C00014.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0472" lvl="0"><number>&lsqb;0472&rsqb;</number> Following the general procedure of Example 16, the title compounds are prepared as represented by formula I (above) where E<highlight><subscript>1 </subscript></highlight>is 4-chloro-&agr;-cumyl in all examples.  
<table-cwu id="TABLE-US-00011">
<number>11</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="35PT" align="center"/>
<colspec colname="2" colwidth="21PT" align="left"/>
<colspec colname="3" colwidth="35PT" align="left"/>
<colspec colname="4" colwidth="42PT" align="left"/>
<colspec colname="5" colwidth="42PT" align="left"/>
<colspec colname="6" colwidth="42PT" align="left"/>
<thead>
<row>
<entry></entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry>Example</entry>
<entry>G<highlight><subscript>1</subscript></highlight></entry>
<entry>G<highlight><subscript>2</subscript></highlight></entry>
<entry>E<highlight><subscript>2</subscript></highlight></entry>
<entry>G<highlight><subscript>3 </subscript></highlight>or E<highlight><subscript>3</subscript></highlight></entry>
<entry>E<highlight><subscript>6 </subscript></highlight>or E<highlight><subscript>8</subscript></highlight></entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="1" colwidth="35PT" align="char" char="."/>
<colspec colname="2" colwidth="21PT" align="left"/>
<colspec colname="3" colwidth="35PT" align="left"/>
<colspec colname="4" colwidth="42PT" align="left"/>
<colspec colname="5" colwidth="42PT" align="left"/>
<colspec colname="6" colwidth="42PT" align="left"/>
<tbody valign="top">
<row>
<entry>72</entry>
<entry>Cl</entry>
<entry>Cl</entry>
<entry>t-butyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>73</entry>
<entry>F</entry>
<entry>F</entry>
<entry>octyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>74</entry>
<entry>H</entry>
<entry>F</entry>
<entry>t-butyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>75</entry>
<entry>H</entry>
<entry>F</entry>
<entry>EtCOOE<highlight><subscript>6</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>methyl</entry>
</row>
<row>
<entry>76</entry>
<entry>H</entry>
<entry>F</entry>
<entry>EtCONHE<highlight><subscript>8</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>octadecyl</entry>
</row>
<row>
<entry>77</entry>
<entry>H</entry>
<entry>*</entry>
<entry>dodecyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>78</entry>
<entry>H</entry>
<entry>**</entry>
<entry>octadecyl</entry>
<entry>ethyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>79</entry>
<entry>H</entry>
<entry>***</entry>
<entry>t-butyl</entry>
<entry>methyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>80</entry>
<entry>H</entry>
<entry>***</entry>
<entry>t-butyl</entry>
<entry>octyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>81</entry>
<entry>H</entry>
<entry>****</entry>
<entry>octyl</entry>
<entry>octadecyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>82</entry>
<entry>H</entry>
<entry>E<highlight><subscript>3</subscript></highlight>SO</entry>
<entry>t-butyl</entry>
<entry>phenyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>83</entry>
<entry>H</entry>
<entry>E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight></entry>
<entry>methyl</entry>
<entry>butyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>84</entry>
<entry>H</entry>
<entry>E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight></entry>
<entry>methyl</entry>
<entry>octadecyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>85</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>t-octyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>86</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtOH</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>87</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtOAl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry>88</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtCOOE<highlight><subscript>6</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>octyl</entry>
</row>
<row>
<entry>89</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtCOOE<highlight><subscript>6</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>methyl</entry>
</row>
<row>
<entry>90</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtCONHE<highlight><subscript>8</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>octadecyl</entry>
</row>
<row><entry namest="1" nameend="6" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00018">EtCOOE<highlight><subscript>6 </subscript></highlight>is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>COOE<highlight><subscript>6</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00019">EtCONHE<highlight><subscript>8 </subscript></highlight>is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CONHE<highlight><subscript>8</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00020">* is P(O)(C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>5</subscript></highlight>)<highlight><subscript>2</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00021">** is P(O)(OG<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00022">*** is COOG<highlight><subscript>3</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00023">**** is CONHG<highlight><subscript>3</subscript></highlight>; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00024">EtOH is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>OH; </footnote></entry>
</row>
<row>
<entry namest="1" nameend="6" align="left"><footnote id="FOO-00025">EtOAl is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>OCH<highlight><subscript>2</subscript></highlight>CH&boxH;CH<highlight><subscript>2</subscript></highlight>. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 91 </heading>
</section>
<section>
<heading lvl="1">5-Carboxy-2-(2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl)-2H-benzotriazole </heading>
<paragraph id="P-0473" lvl="0"><number>&lsqb;0473&rsqb;</number> Following the general procedure of Example 16, the title compound is prepared. The structure is confirmed by <highlight><superscript>1</superscript></highlight>Hnmr and mass spectroscopic analyses. The title compound has a melting point of 287-288&deg; C. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 92 </heading>
</section>
<section>
<heading lvl="1">5-Methoxycarbonyl-2-(2-hydroxy-3-(4-chloro-&agr;-cumyl)-5-tert-butylphenyl)-2H-benzotriazole </heading>
<paragraph id="P-0474" lvl="0"><number>&lsqb;0474&rsqb;</number> The compound prepared in Example 91 (6.0 g, 0.012 mol), toluene (15 g, 0.16 mol), methanol (100 g, 3.1 mol) and concentrated sulfuric acid (0.4 g, 0.004 mol) are added to a reaction flask and heated to reflux. After eight hours at reflux, the solvents are removed by distillation and the residue is dissolved in 200 g of toluene. The solution is then passed through an absorbent (silica gel) to remove residual acid. The toluene is distilled off and the residue is twice recrystallized from methanol. The title compound is obtained in a yield of 4.9 g as a light yellow powder melting at 93-104&deg; C. whose structure is consistent with <highlight><superscript>1</superscript></highlight>Hnmr and mass spectrometric analyses. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 93 </heading>
</section>
<section>
<heading lvl="1">Poly(Methyl Methacrylate) </heading>
<paragraph id="P-0475" lvl="0"><number>&lsqb;0475&rsqb;</number> Poly(methyl methacrylate), medium molecular weight, Aldrich, is dissolved in methylene chloride at room temperature along with between 1 and 3% by weight of test benzotriazole, based on the PMMA resin. Films are cast using a calibrated drawdown bar to prepare 1 mil thick film after drying. The free standing films are mounted into cardboard holders, secured in metal frames and exposed in an Atlas C165 Xenon-arc Weather-Ometer under dry conditions according to ASTM G26. Performance is measured by a change in color or the physical integrity of the film, or in loss of absorbance of the UV absorber at &lgr;max. Color measurements are carried out in an ACS spectrophotometer, small area view, spectral component included d/8, D65, 10&deg; observer, YI 1925 for unexposed and exposed samples after 750 hours exposure.  
<table-cwu id="TABLE-US-00012">
<number>12</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="119PT" align="center"/>
<colspec colname="2" colwidth="77PT" align="center"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>Compound of</entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry>Example* (% by weight)</entry>
<entry>&Dgr;YI</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="21PT" align="left"/>
<colspec colname="1" colwidth="91PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="77PT" align="center"/>
<tbody valign="top">
<row>
<entry></entry>
<entry>TINUVIN&thinsp;&reg; 234</entry>
<entry>(2.50%)</entry>
<entry>1.34</entry>
</row>
<row>
<entry></entry>
<entry>Example 25</entry>
<entry>(2.54%)</entry>
<entry>0.75</entry>
</row>
<row>
<entry></entry>
<entry>Example 28</entry>
<entry>(3.07%)</entry>
<entry>0.93</entry>
</row>
<row>
<entry></entry>
<entry>Example 31</entry>
<entry>(3.03%)</entry>
<entry>0.81</entry>
</row>
<row>
<entry></entry>
<entry>Example 32</entry>
<entry>(2.72%)</entry>
<entry>0.46</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="left"><footnote id="FOO-00026">*TINUVIN&thinsp;&reg; 234 is 2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
<paragraph id="P-0476" lvl="0"><number>&lsqb;0476&rsqb;</number> These data show that the instant compounds are particularly efficacious when used in thermoplastic compositions, such as poly(methyl methacrylate), even surpassing a commerical UV absorber in effectiveness. This is shown by the reduction of yellowing (&Dgr;YI) after exposure to actinic radiation. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 94 </heading>
</section>
<section>
<heading lvl="1">2-&lcub;2-Hydroxy-3-&lsqb;4-(2-hydroxyethoxy)-&agr;-cumyl&rsqb;-5-tert-butylphenyl&rcub;-2H-benzotriazole </heading>
<paragraph id="P-0477" lvl="0"><number>&lsqb;0477&rsqb;</number> When the compound of instant Example 59 is reacted with ethylene carbonate, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 95 </heading>
</section>
<section>
<heading lvl="1">2-&lcub;2-Hydroxy-3-&lsqb;4-(2-bromoethoxy)-&agr;-cumyl&rsqb;-5-tert-butylphenyl&rcub;-2H-benzotriazole </heading>
<paragraph id="P-0478" lvl="0"><number>&lsqb;0478&rsqb;</number> When the compound of instant Example 94 is reacted with hydrobromic acid according to the procedure given in Brown &amp; Patai, &ldquo;The Chemistry of the Hydroxyl Group&rdquo;, Part 1, pages 595-622, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 96 </heading>
</section>
<section>
<heading lvl="1">2-&lcub;2-Hydroxy-3-&lsqb;4-(2-phthalimidoethoxy)-&agr;-cumyl&rsqb;-5-tert-butylphenyl&rcub;-2H-benzotriazole </heading>
<paragraph id="P-0479" lvl="0"><number>&lsqb;0479&rsqb;</number> When the compound of instant Example 95 is treated with potassium phthalimide according to Gibson &amp; Bradshaw, Ange. Chem. Int. Ed. Engl., 7, 919-930 (1968), the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 97 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lsqb;2-hydroxy-3-(3-isopropenyl-&agr;-cumyl)-5-tert-octylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0480" lvl="0"><number>&lsqb;0480&rsqb;</number> The title compound is prepared following the general procedure given in instant Example 16. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 98 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lcub;2-hydroxy-3-&lsqb;3-(2-hydroxy-1-methylethyl)-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;2H-benzotriazole; </heading>
<paragraph id="P-0481" lvl="0"><number>&lsqb;0481&rsqb;</number> When the compound of instant Example 97 is subjected to hydroboration conditions followed by alkaline hydrogen peroxide according to the procedure of J. March, &ldquo;Advanced Organic Chemistry&rdquo;, 2nd Ed., McGraw-Hill, p. 720, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 99 </heading>
</section>
<section>
<heading lvl="1">5-Trifluoromethyl-2-&lcub;2-hydroxy-3-&lsqb;3-(2-methacryloyl-oxy-1-methylethyl)-&agr;-cumyl&rsqb;-5-tert-octylphenyl&rcub;-2H-benzotriazole </heading>
<paragraph id="P-0482" lvl="0"><number>&lsqb;0482&rsqb;</number> When the compound of instant Example 98 is refluxed in toluene with a molar equivalent of methacrylic acid and a catalytic amount of p-toluenesulfonic acid, the title compound is obtained. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 100 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3-(4-carboxy-&agr;-cumyl)-5-methylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0483" lvl="0"><number>&lsqb;0483&rsqb;</number> Following the general procedure of instant Example 16, the title compound is prepared. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 101 </heading>
</section>
<section>
<heading lvl="1">5-Chloro-2-&lsqb;2-hydroxy-3-(4-octadecyloxycarbonyl-&agr;-cumyl)-5-methylphenyl&rsqb;-2H-benzotriazole </heading>
<paragraph id="P-0484" lvl="0"><number>&lsqb;0484&rsqb;</number> When the compound of instant Example 100 is refluxed in toluene with a molar equivalent of octadecyl alcohol and a catalytic amount of p-toluenesulfonic acid, the title compound is obtained. </paragraph>
<paragraph id="P-0485" lvl="0"><number>&lsqb;0485&rsqb;</number> Examples 103-106 are prepared for example by the procedures disclosed in S. L. Buchwald, et al. <highlight><italic>J. Am. Chem. Soc. </italic></highlight>1999, 121, 9550, a general reference for the Suzuki reaction. </paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 102 </heading>
</section>
<section>
<heading lvl="1">2-Chloro -4-(1,1,3,3-tetramethyl-butyl)-6-(5-trifluromethyl-benzotriazol-2-yl)phenol </heading>
<paragraph id="P-0486" lvl="0"><number>&lsqb;0486&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00015">
<number>15</number>
<image id="EMI-C00015" he="86.4108" wi="146.42775" file="US20030004235A1-20030102-C00015.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00015" file="US20030004235A1-20030102-C00015.CDX"/>
<chemistry-mol-file id="CHEMMOL-00015" file="US20030004235A1-20030102-C00015.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0487" lvl="0"><number>&lsqb;0487&rsqb;</number> A flask containing 2-chloro-4-(1,1,3,3tetramethyl-butyl)-6-(5-trifluromethyl-benzotriazol-2-yl)phenol (7.5 g, 0.014 mol), 7% aqueous sodium hypochlorite (125 g, 0.12 mol), ethanol (85 g, 1.83 mol), and heptane (85 g, 0.84 mol) is heated to 45&deg; C. with agitation. After a one hour hold, water (150 g, 8.33 mol) and heptane (150 g, 1.49 mol) are added to the reaction mass to dissolve all solids. The aqueous layer is removed and heptane is distilled off yielding a white residue. The white residue is crystallized from methanol yielding the title compound as a white solid (5.4 g, 91%) melting at 72-81&deg; C. </paragraph>
<paragraph id="P-0488" lvl="0"><number>&lsqb;0488&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>; 499.8494 MHz): &dgr; 11.50 (s, 1H), 8.37 (d, 1H), 8.34 (d, 1H), 8.11 (d, 1H), 7.71 (dd, 1H), 7.53 (d, 1H), 1.81 (s, 2H), 1.45 (s, 6H), 0.80 (s, 9H). </paragraph>
<paragraph id="P-0489" lvl="0"><number>&lsqb;0489&rsqb;</number> <highlight><superscript>19</superscript></highlight>FNMR (CDCl<highlight><subscript>3</subscript></highlight>; 282.3300 MHz): &dgr; &minus;69.04 </paragraph>
<paragraph id="P-0490" lvl="0"><number>&lsqb;0490&rsqb;</number> MS (m/z): 425  
<table-cwu id="TABLE-US-00013">
<number>13</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="42PT" align="left"/>
<colspec colname="2" colwidth="70PT" align="left"/>
<colspec colname="3" colwidth="91PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Analysis:</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>C<highlight><subscript>21</subscript></highlight>H<highlight><subscript>23</subscript></highlight>CIF<highlight><subscript>3</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O:</entry>
<entry>C, 59.23; H, 5.44; N, 9.87</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Found:</entry>
<entry>C, 59.86; H, 5.46; N, 9.71</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 103 </heading>
</section>
<section>
<heading lvl="1">4&prime;-Methoxy-5-(1,1,3,3-Tetramethyl-butyl)-3-(5trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol </heading>
<paragraph id="P-0491" lvl="0"><number>&lsqb;0491&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00016">
<number>16</number>
<image id="EMI-C00016" he="127.94355" wi="170.41185" file="US20030004235A1-20030102-C00016.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00016" file="US20030004235A1-20030102-C00016.CDX"/>
<chemistry-mol-file id="CHEMMOL-00016" file="US20030004235A1-20030102-C00016.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0492" lvl="0"><number>&lsqb;0492&rsqb;</number> A flask, equipped with a mechanical stirrer and reflux condenser, containing a mixture of 2-chloro4-(1,1,3,3-tetramethyl-butyl)-6-(5-trifluromethyl-benzotriazol-2-yl)phenol (1.18 g, 2.75 mmol), 4-methoxyphenylboronic acid (3.8 g, 0.024 mol), palladium (II) diacetate (0.44 g, 1.94 mmol), potassium fluoride (1.16 g, 0.02 mol), and 2-(dicyclohexylphosphino)biphenyl (1.40 g, 3.92 mmol) is evacuated and filled three times with nitrogen. To this mixture is then added 175 ml of 1,4-dioxane that had been previously degassed with nitrogen. The flask is then evacuated and filled with nitrogen three times. The reaction mixture is stirred for ten minutes at room temperature. The reaction mixture is then heated to 90&deg; C. and kept at this temperature for 8 hours. After cooling to ambient temperature, the solvent is removed under vacuum. The resulting residue is dissolved in toluene and chromatographed on silica gel. After chromatography, the residue is crystallized from methanol yielding the title compound (0.82 g, 60%) as a light yellow solid that melts at 99-102&deg; C. </paragraph>
<paragraph id="P-0493" lvl="0"><number>&lsqb;0493&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>; 499.8494 MHz): &dgr; 11.35 (s, 1H), 8.42 (d, 1H), 8.33 (d, 1H), 8.09 (d, 1H), 7.69 (dd, 1H), 7.60 (d, 2H), 7.47 (d, 1H), 7.04 (d, 2H), 3.90 (s, 3H), 1.84 (s, 2H), 1.49 (s, 6H), 0.82 (s , 9H). </paragraph>
<paragraph id="P-0494" lvl="0"><number>&lsqb;0494&rsqb;</number> <highlight><superscript>19</superscript></highlight>FNMR (CDCl<highlight><subscript>3</subscript></highlight>; 282.3300 MHz): &dgr; &minus;64.9 </paragraph>
<paragraph id="P-0495" lvl="0"><number>&lsqb;0495&rsqb;</number> MS: 496 (M&minus;H)  
<table-cwu id="TABLE-US-00014">
<number>14</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="49PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="left"/>
<colspec colname="3" colwidth="98PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Analysis:</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>C<highlight><subscript>28</subscript></highlight>H<highlight><subscript>30</subscript></highlight>F<highlight><subscript>3</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O<highlight><subscript>2</subscript></highlight>:</entry>
<entry>C, 67.59; H, 6.08; N, 8.45</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Found:</entry>
<entry>C, 67.95; H, 6.11; N, 8.35</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 104 </heading>
</section>
<section>
<heading lvl="1">3&prime;-Methoxy-5-(1,1,3,3-Tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol </heading>
<paragraph id="P-0496" lvl="0"><number>&lsqb;0496&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00017">
<number>17</number>
<image id="EMI-C00017" he="112.3227" wi="178.8318" file="US20030004235A1-20030102-C00017.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00017" file="US20030004235A1-20030102-C00017.CDX"/>
<chemistry-mol-file id="CHEMMOL-00017" file="US20030004235A1-20030102-C00017.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0497" lvl="0"><number>&lsqb;0497&rsqb;</number> Following the synthetic procedure of Example 103, the title compound is obtained (0.9 g, 68%) as a light yellow solid melting at 110-111.5&deg; C. </paragraph>
<paragraph id="P-0498" lvl="0"><number>&lsqb;0498&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr(CDCl<highlight><subscript>3</subscript></highlight>; 499.8494 MHz): &dgr; 11.35 (s, 1H), 8.45 (d, 1H), 8.33 (d, 1H), 8.09 (d, 1H), 7.70 (dd, 1H), 7.49 (d, 1H), 7.42 (t, 1H), 7.23 (d,1H), 7.22 (d, 1H), 6.96 (d, 1H), 3.90 (s, 3H), 1.84 (s, 2H), 1.49 (s, 6H), 0.82 (s, 9H). </paragraph>
<paragraph id="P-0499" lvl="0"><number>&lsqb;0499&rsqb;</number> <highlight><superscript>19</superscript></highlight>FNMR (CDCl<highlight><subscript>3</subscript></highlight>; 282.3300 MHz): &dgr; &minus;63.0 </paragraph>
<paragraph id="P-0500" lvl="0"><number>&lsqb;0500&rsqb;</number> MS: 498 (M&plus;H)  
<table-cwu id="TABLE-US-00015">
<number>15</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="49PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="left"/>
<colspec colname="3" colwidth="98PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Analysis:</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>C<highlight><subscript>28</subscript></highlight>H<highlight><subscript>30</subscript></highlight>F<highlight><subscript>3</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O<highlight><subscript>2</subscript></highlight>:</entry>
<entry>C, 67.59; H, 6.08; N, 8.45</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Found:</entry>
<entry>C, 67.74; H, 6.14; N, 8.47</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 105 </heading>
</section>
<section>
<heading lvl="1">2&prime;-Methoxy-5-(1,1,3,3-Tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol </heading>
<paragraph id="P-0501" lvl="0"><number>&lsqb;0501&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00018">
<number>18</number>
<image id="EMI-C00018" he="112.3227" wi="156.492" file="US20030004235A1-20030102-C00018.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00018" file="US20030004235A1-20030102-C00018.CDX"/>
<chemistry-mol-file id="CHEMMOL-00018" file="US20030004235A1-20030102-C00018.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0502" lvl="0"><number>&lsqb;0502&rsqb;</number> Following the synthetic procedure of Example 103, the title compound is obtained (1.1 g, 84%) as a light yellow solid melting at 124-125&deg; C. </paragraph>
<paragraph id="P-0503" lvl="0"><number>&lsqb;0503&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>; 499.8494 MHz): &dgr; 11.14 (s,1H), 8.43 (d, 1H), 8.31 (d, 1H), 8.07 (d, 1H), 7.68 (dd, 1H), 7.44 (d, 1H), 7.42 (t, 1H), 7.38 (d, 1H), 7.10 (t, 1H), 7.06 (d, 1H), 3.82 (s, 3H), 1.82 (s, 2H), 1.48 (s, 6H), 0.83 (s, 9H). </paragraph>
<paragraph id="P-0504" lvl="0"><number>&lsqb;0504&rsqb;</number> <highlight><superscript>19</superscript></highlight>FNMR (CDCl<highlight><subscript>3</subscript></highlight>; 282.3300 MHz): &dgr; &minus;63.0 </paragraph>
<paragraph id="P-0505" lvl="0"><number>&lsqb;0505&rsqb;</number> MS: 498 (M&plus;H)  
<table-cwu id="TABLE-US-00016">
<number>16</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="49PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="left"/>
<colspec colname="3" colwidth="98PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Analysis:</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>C<highlight><subscript>28</subscript></highlight>H<highlight><subscript>30</subscript></highlight>F<highlight><subscript>3</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O<highlight><subscript>2</subscript></highlight>:</entry>
<entry>C, 67.59; H, 6.08; N, 8.45</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Found:</entry>
<entry>C, 67.61; H, 6.08; N, 8.34</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 106 </heading>
</section>
<section>
<heading lvl="1">5-(1,1,3,3-Tetramethyl-butyl)-3&prime;-trifluromethyl-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol </heading>
<paragraph id="P-0506" lvl="0"><number>&lsqb;0506&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00019">
<number>19</number>
<image id="EMI-C00019" he="114.0237" wi="180.0225" file="US20030004235A1-20030102-C00019.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00019" file="US20030004235A1-20030102-C00019.CDX"/>
<chemistry-mol-file id="CHEMMOL-00019" file="US20030004235A1-20030102-C00019.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0507" lvl="0"><number>&lsqb;0507&rsqb;</number> Following the synthetic procedure of Example 103, the title compound is obtained (0.95 g, 51%) as a light yellow solid melting at 103-104.5&deg; C. </paragraph>
<paragraph id="P-0508" lvl="0"><number>&lsqb;0508&rsqb;</number> <highlight><superscript>1</superscript></highlight>Hnmr (CDCl<highlight><subscript>3</subscript></highlight>; 499.8494 MHz): &dgr; 11.43 (s, 1H), 8.50 (d, 1H), 8.34 (d, 1H), 8.10 (d, 1H), 7.94 (d, 1H), 7.83 (d, 1H), 7.71 (dd, 1H), 7.67 (d, 1H), 7.61 (t, 1 H), 7.47 (d, 1H), 1.86 (s, 2H), 1.51 (s, 6H), 0.83 (s, 9H). </paragraph>
<paragraph id="P-0509" lvl="0"><number>&lsqb;0509&rsqb;</number> <highlight><superscript>19</superscript></highlight>FNMR (CDCl<highlight><subscript>3</subscript></highlight>; 282.3300 MHz): &dgr; &minus;63.1 &amp; &minus;63.0 </paragraph>
<paragraph id="P-0510" lvl="0"><number>&lsqb;0510&rsqb;</number> MS: 534 (M&minus;H)  
<table-cwu id="TABLE-US-00017">
<number>17</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="4">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="49PT" align="left"/>
<colspec colname="2" colwidth="56PT" align="left"/>
<colspec colname="3" colwidth="98PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Analysis:</entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>C<highlight><subscript>28</subscript></highlight>H<highlight><subscript>27</subscript></highlight>F<highlight><subscript>6</subscript></highlight>N<highlight><subscript>3</subscript></highlight>O:</entry>
<entry>C, 62.80; H, 5.08; N, 7.85</entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry>Found:</entry>
<entry>C, 62.63; H, 5.05; N, 7.87</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 107 </heading>
<paragraph id="P-0511" lvl="0"><number>&lsqb;0511&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00020">
<number>20</number>
<image id="EMI-C00020" he="86.184" wi="181.69515" file="US20030004235A1-20030102-C00020.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00020" file="US20030004235A1-20030102-C00020.CDX"/>
<chemistry-mol-file id="CHEMMOL-00020" file="US20030004235A1-20030102-C00020.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0512" lvl="0"><number>&lsqb;0512&rsqb;</number> Following the general procedure of Example 103, the title compounds are prepared as represented by the above formula where G<highlight><subscript>1 </subscript></highlight>and G<highlight><subscript>2 </subscript></highlight>are hydrogen and E<highlight><subscript>2 </subscript></highlight>is tert-butyl. E<highlight><subscript>25 </subscript></highlight>is hydrogen in all examples.  
<table-cwu id="TABLE-US-00018">
<number>18</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="42PT" align="left"/>
<colspec colname="2" colwidth="28PT" align="left"/>
<colspec colname="3" colwidth="49PT" align="left"/>
<colspec colname="4" colwidth="35PT" align="left"/>
<colspec colname="5" colwidth="49PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>E<highlight><subscript>22</subscript></highlight></entry>
<entry>E<highlight><subscript>23</subscript></highlight></entry>
<entry>E<highlight><subscript>24</subscript></highlight></entry>
<entry>E<highlight><subscript>26</subscript></highlight></entry>
<entry>E<highlight><subscript>3 </subscript></highlight>or G<highlight><subscript>3</subscript></highlight></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Cl</entry>
<entry>H</entry>
<entry>Cl</entry>
<entry>Cl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>Me</entry>
<entry>H</entry>
<entry>F</entry>
<entry>Me</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>IP</entry>
<entry>H</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>OAl</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CN</entry>
<entry>H</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>OH</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>OMe</entry>
<entry>H</entry>
<entry>OMe</entry>
<entry>OMe</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>*</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>**</entry>
<entry>H</entry>
<entry>methyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>**</entry>
<entry>H</entry>
<entry>allyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>**</entry>
<entry>H</entry>
<entry>H</entry>
<entry>octadecyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>F</entry>
<entry>H</entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>***</entry>
<entry>H</entry>
<entry>E<highlight><subscript>29 </subscript></highlight>&equals; Octa</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>****</entry>
<entry>H</entry>
<entry>phenyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>****</entry>
<entry>H</entry>
<entry>butyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>****</entry>
<entry>H</entry>
<entry>dodecyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>H</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>H</entry>
<entry>NHE<highlight><subscript>4</subscript></highlight></entry>
<entry>H</entry>
<entry>E<highlight><subscript>4 </subscript></highlight>&equals; Do</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="left"><footnote id="FOO-00027">*is &mdash;OCOE<highlight><subscript>11 </subscript></highlight>where E<highlight><subscript>11 </subscript></highlight>is butyl. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="left"><footnote id="FOO-00028">**is &mdash;COOG<highlight><subscript>3</subscript></highlight>; ***is &mdash;SO<highlight><subscript>2</subscript></highlight>NHE<highlight><subscript>29</subscript></highlight>; ****is &mdash;SO<highlight><subscript>2</subscript></highlight>E<highlight><subscript>3</subscript></highlight>. </footnote></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="left"><footnote id="FOO-00029">Do is dodecyl; Et is ethyl; IP is isopropenyl; Me is methyl; OAl is allyloxy; Oc is octyl; Octa is octadecyl; and OMe is methoxy. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 108 </heading>
<paragraph id="P-0513" lvl="0"><number>&lsqb;0513&rsqb;</number>  
<chemistry-cwu id="CHEM-US-00021">
<number>21</number>
<image id="EMI-C00021" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00021.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00021" file="US20030004235A1-20030102-C00021.CDX"/>
<chemistry-mol-file id="CHEMMOL-00021" file="US20030004235A1-20030102-C00021.MOL"/>
</chemistry-cwu>
</paragraph>
<paragraph id="P-0514" lvl="0"><number>&lsqb;0514&rsqb;</number> Following the general procedure of Example 103, the title compounds are prepared as represented by formula I (above) where E<highlight><subscript>1 </subscript></highlight>is ortho, meta or para methoxyphenyl, or E<highlight><subscript>1 </subscript></highlight>is ortho, meta or para substituted trifluoromethylphenyl  
<table-cwu id="TABLE-US-00019">
<number>19</number>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="6">
<colspec colname="OFFSET" colwidth="14PT" align="left"/>
<colspec colname="1" colwidth="21PT" align="left"/>
<colspec colname="2" colwidth="42PT" align="left"/>
<colspec colname="3" colwidth="49PT" align="left"/>
<colspec colname="4" colwidth="49PT" align="left"/>
<colspec colname="5" colwidth="42PT" align="left"/>
<thead>
<row>
<entry></entry>
<entry></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry>G<highlight><subscript>1</subscript></highlight></entry>
<entry>G<highlight><subscript>2</subscript></highlight></entry>
<entry>E<highlight><subscript>2</subscript></highlight></entry>
<entry>G<highlight><subscript>3 </subscript></highlight>or E<highlight><subscript>3</subscript></highlight></entry>
<entry>E<highlight><subscript>6 </subscript></highlight>or E<highlight><subscript>8</subscript></highlight></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry>Cl</entry>
<entry>Cl</entry>
<entry>t-butyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>F</entry>
<entry>F</entry>
<entry>octyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>F</entry>
<entry>t-butyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>F</entry>
<entry>EtCOOE<highlight><subscript>6</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>methyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>F</entry>
<entry>EtCONHE<highlight><subscript>8</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>octadecyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>*</entry>
<entry>dodecyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>**</entry>
<entry>octadecyl</entry>
<entry>ethyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>***</entry>
<entry>t-butyl</entry>
<entry>methyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>***</entry>
<entry>t-butyl</entry>
<entry>octyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>****</entry>
<entry>octyl</entry>
<entry>octadecyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>E<highlight><subscript>3</subscript></highlight>SO</entry>
<entry>t-butyl</entry>
<entry>phenyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight></entry>
<entry>methyl</entry>
<entry>butyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight></entry>
<entry>methyl</entry>
<entry>octadecyl</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>t-octyl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtOH</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtOAl</entry>
<entry>&mdash;</entry>
<entry>&mdash;</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtCOOE<highlight><subscript>6</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>octyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtCOOE<highlight><subscript>6</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>methyl</entry>
</row>
<row>
<entry></entry>
<entry>H</entry>
<entry>CF<highlight><subscript>3</subscript></highlight></entry>
<entry>EtCONHE<highlight><subscript>8</subscript></highlight></entry>
<entry>&mdash;</entry>
<entry>octadecyl</entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="center" rowsep="1"></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="5" align="left"><footnote id="FOO-00030">EtCOOE<highlight><subscript>6 </subscript></highlight>is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>COOE<highlight><subscript>6</subscript></highlight>; EtCONHE<highlight><subscript>8 </subscript></highlight>is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>CONHE<highlight><subscript>8</subscript></highlight>; *is P(O)(C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>5</subscript></highlight>)<highlight><subscript>2</subscript></highlight>; **is P(O)(OG<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>; ***is COOG<highlight><subscript>3</subscript></highlight>; ****is CONHG<highlight><subscript>3</subscript></highlight>; EtOH is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>OH; EtOAl is CH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>OCH<highlight><subscript>2</subscript></highlight>CH&boxH;CH<highlight><subscript>2</subscript></highlight>. </footnote></entry>
</row>
</tbody>
</tgroup>
</table>
</table-cwu>
</paragraph>
</section>
<section>
<heading lvl="1">EXAMPLE 109 </heading>
<paragraph id="P-0515" lvl="0"><number>&lsqb;0515&rsqb;</number> Examples 36-45 and 93 are repeated with the inclusion of test additives selected from those of present Examples 103-108. Excellent results are achieved. </paragraph>
</section>
</detailed-description>
</subdoc-description>
<subdoc-claims>
<heading lvl="1">What is claimed is: </heading>
<claim id="CLM-00001">
<claim-text><highlight><bold>1</bold></highlight>. A compound of formula I,II or III </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00022">
<number>22</number>
<image id="EMI-C00022" he="301.2471" wi="198.02475" file="US20030004235A1-20030102-C00022.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00022" file="US20030004235A1-20030102-C00022.CDX"/>
<chemistry-mol-file id="CHEMMOL-00022" file="US20030004235A1-20030102-C00022.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein 
<claim-text>G<highlight><subscript>1 </subscript></highlight>is hydrogen or halogen, </claim-text>
<claim-text>G<highlight><subscript>2 </subscript></highlight>is hydrogen, cyano, perfluoroalkyl of 1 to 12 carbon atoms, halogen, &mdash;CO&mdash;G<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, &mdash;CONHG<highlight><subscript>3</subscript></highlight>, &mdash;CON(G<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>SO&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash;, nitro, &mdash;P(O)(C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>5</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;P(O)(OG<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00023">
<number>23</number>
<image id="EMI-C00023" he="33.1128" wi="144.72675" file="US20030004235A1-20030102-C00023.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00023" file="US20030004235A1-20030102-C00023.CDX"/>
<chemistry-mol-file id="CHEMMOL-00023" file="US20030004235A1-20030102-C00023.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>G<highlight><subscript>3 </subscript></highlight>is hydrogen, straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 4 alkyl of 1 to 4 carbon atoms, </claim-text>
<claim-text>E<highlight><subscript>1 </subscript></highlight>is hydrogen, straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 24 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 4 alkyl of 1 to 4 carbon atoms; or E<highlight><subscript>1 </subscript></highlight>is alkyl of 1 to 24 carbon atoms substituted by one or two hydroxy groups; </claim-text>
<claim-text>or E<highlight><subscript>1 </subscript></highlight>is alkyl of 1 to 24 carbon atoms, alkenyl of 2 to 18 carbon atoms, said alkyl or said alkenyl substituted by one or more &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11</subscript></highlight>, or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or straight or branched chain alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2</subscript></highlight>, or mixtures thereof; </claim-text>
<claim-text>or E<highlight><subscript>1 </subscript></highlight>is a group of formula IV or V </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00024">
<number>24</number>
<image id="EMI-C00024" he="166.32945" wi="198.02475" file="US20030004235A1-20030102-C00024.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00024" file="US20030004235A1-20030102-C00024.CDX"/>
<chemistry-mol-file id="CHEMMOL-00024" file="US20030004235A1-20030102-C00024.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;where </claim-text>
<claim-text>E<highlight><subscript>27 </subscript></highlight>and E<highlight><subscript>28 </subscript></highlight>are independently alkyl of 1 to 18 carbon atoms, or cycloalkyl of 5 to 12 carbon atoms; </claim-text>
<claim-text>E<highlight><subscript>22</subscript></highlight>, E<highlight><subscript>23</subscript></highlight>, E<highlight><subscript>24</subscript></highlight>, E<highlight><subscript>25 </subscript></highlight>and E<highlight><subscript>26 </subscript></highlight>are independently hydrogen, halogen, straight or branched alkyl of 1 to 18 carbon atoms, alkenyl of 2 to 18 carbon atoms, said alkyl or said alkenyl substituted by one or more halogen, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or straight or branched chain alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2</subscript></highlight>, or mixtures thereof; or </claim-text>
<claim-text>E<highlight><subscript>22</subscript></highlight>, E<highlight><subscript>23</subscript></highlight>, E<highlight><subscript>24</subscript></highlight>, E<highlight><subscript>25 </subscript></highlight>and E<highlight><subscript>26 </subscript></highlight>are independently phenyl, &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>29</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, cyano, nitro, perfluoroalkyl of 1 to 12 carbon atoms, &mdash;COG<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, &mdash;CON(G<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;CONHG<highlight><subscript>3</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>S&mdash;, E<highlight><subscript>3</subscript></highlight>SO&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;P(O)(C<highlight><subscript>6</subscript></highlight>H<highlight><subscript>5</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;P(O))OG<highlight><subscript>3</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;X<highlight><subscript>1</subscript></highlight>&mdash;E<highlight><subscript>29</subscript></highlight>; </claim-text>
<claim-text>X<highlight><subscript>1 </subscript></highlight>is &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash;; </claim-text>
<claim-text>E<highlight><subscript>29 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, said alkyl or said alkenyl substituted by one or more &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11</subscript></highlight>, &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, phthalimido, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00025">
<number>25</number>
<image id="EMI-C00025" he="33.1128" wi="141.8634" file="US20030004235A1-20030102-C00025.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00025" file="US20030004235A1-20030102-C00025.CDX"/>
<chemistry-mol-file id="CHEMMOL-00025" file="US20030004235A1-20030102-C00025.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2</subscript></highlight>, or mixtures thereof; or E<highlight><subscript>29 </subscript></highlight>is phenyl or phenylalkyl of 7 to 15 carbon atoms, or said phenyl or said phenylalkyl substituted by one to three alkyl groups of 1 to 4 carbon atoms; </claim-text>
<claim-text>E<highlight><subscript>2 </subscript></highlight>is straight or branched alkyl chain of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by one to three alkyl of 1 to 4 carbon atoms; or E<highlight><subscript>2 </subscript></highlight>is alkyl of 1 to 24 carbon atoms or said alkenyl of 2 to 18 carbon atoms substituted by one or more &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2 </subscript></highlight>groups or mixtures thereof, or E<highlight><subscript>2 </subscript></highlight>is a group of formula IV or formula V as described above; </claim-text>
<claim-text>n is 1 or 2, </claim-text>
<claim-text>when n is 1, E<highlight><subscript>5 </subscript></highlight>is OE<highlight><subscript>6 </subscript></highlight>or NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or </claim-text>
<claim-text>E<highlight><subscript>5 </subscript></highlight>is &mdash;PO(OE<highlight><subscript>12</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, &mdash;OSi(E<highlight><subscript>11</subscript></highlight>)<highlight><subscript>3 </subscript></highlight>or &mdash;OCO&mdash;E<highlight><subscript>11</subscript></highlight>, or straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl which is interrupted by &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NE<highlight><subscript>11 </subscript></highlight>and which can be unsubstituted or substituted by &mdash;OH or &mdash;OCO&mdash;E<highlight><subscript>11</subscript></highlight>, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>12 </subscript></highlight>cycloalkyl which is unsubstituted or substituted by &mdash;OH, straight chain or branched C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkenyl which is unsubstituted or substituted by &mdash;OH, C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CHOH&mdash;E<highlight><subscript>13 </subscript></highlight>or glycidyl, </claim-text>
<claim-text>E<highlight><subscript>6 </subscript></highlight>is hydrogen, straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>24</subscript></highlight>alkyl which is unsubstituted or substituted by one or more OH, OE<highlight><subscript>4 </subscript></highlight>or NH<highlight><subscript>2 </subscript></highlight>grlups, or &mdash;OE<highlight><subscript>6 </subscript></highlight>is &mdash;(OCH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>w</subscript></highlight>OH or &mdash;(OCH<highlight><subscript>2</subscript></highlight>CH<highlight><subscript>2</subscript></highlight>)<highlight><subscript>w</subscript></highlight>OE<highlight><subscript>21 </subscript></highlight>where w is 1 to 12 and E<highlight><subscript>21 </subscript></highlight>is alkyl of 1 to 12 carbon atoms, </claim-text>
<claim-text>E<highlight><subscript>7 </subscript></highlight>and E<highlight><subscript>8 </subscript></highlight>are independently hydrogen, alkyl of 1 to 18 carbon atoms, straight or branched chain C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl which is interrupted by &mdash;O&mdash;, &mdash;S&mdash; or &mdash;NE<highlight><subscript>11</subscript></highlight>&mdash;, straight or branched chain alkenyl of 2 to 18 carbon atoms, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>cycloalkyl, C<highlight><subscript>6</subscript></highlight>-C<highlight><subscript>14</subscript></highlight>aryl or C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>3</subscript></highlight>hydroxylalkyl, or E<highlight><subscript>7 </subscript></highlight>and E<highlight><subscript>8 </subscript></highlight>together with the N atom are a pyrrolidine, piperidine, piperazine or morpholine ring, or </claim-text>
<claim-text>E<highlight><subscript>5 </subscript></highlight>is &mdash;X&mdash;(Z)<highlight><subscript>p</subscript></highlight>&mdash;Y&mdash;E<highlight><subscript>15 </subscript></highlight></claim-text>
<claim-text>wherein 
<claim-text>X is &mdash;O&mdash; or &mdash;N(E<highlight><subscript>16</subscript></highlight>)&mdash;, </claim-text>
<claim-text>Y is &mdash;O&mdash; or &mdash;N(E<highlight><subscript>17</subscript></highlight>)&mdash;, </claim-text>
<claim-text>Z is C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkylene, C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkylene interrupted by one to three nitrogen atoms, oxygen atoms or a mixture thereof, or is C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkylene, butenylene, butynylene, cyclohexylene or phenylene, each substituted by a hydroxyl group, </claim-text>
<claim-text>m is zero, 1 or 2, </claim-text>
<claim-text>p is 1, or p is also zero when X and Y are &mdash;N(E<highlight><subscript>16</subscript></highlight>)&mdash; and &mdash;N(E<highlight><subscript>17</subscript></highlight>)&mdash;, respectively, </claim-text>
<claim-text>E<highlight><subscript>15 </subscript></highlight>is a group &mdash;CO&mdash;C(E<highlight><subscript>18</subscript></highlight>)&boxH;C(H)E<highlight><subscript>19 </subscript></highlight>or, when Y is &mdash;N(E<highlight><subscript>17</subscript></highlight>)&mdash;, forms together with E<highlight><subscript>17 </subscript></highlight>a group &mdash;CO&mdash;CH&boxH;CH&mdash;CO&mdash;, wherein E<highlight><subscript>18 </subscript></highlight>is hydrogen or methyl, and E<highlight><subscript>19 </subscript></highlight>is hydrogen, methyl or &mdash;CO&mdash;X&mdash;E<highlight><subscript>20</subscript></highlight>, wherein E<highlight><subscript>20 </subscript></highlight>is hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkyl or a group of the formula </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00026">
<number>26</number>
<image id="EMI-C00026" he="72.009" wi="186.0327" file="US20030004235A1-20030102-C00026.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00026" file="US20030004235A1-20030102-C00026.CDX"/>
<chemistry-mol-file id="CHEMMOL-00026" file="US20030004235A1-20030102-C00026.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;wherein the symbols E<highlight><subscript>1</subscript></highlight>, G<highlight><subscript>2</subscript></highlight>, X, Z, m and p have the meanings defined above, and E<highlight><subscript>16 </subscript></highlight>and E<highlight><subscript>17 </subscript></highlight>independently of one another are hydrogen, C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkyl, C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>-alkyl interrupted by 1 to 3 oxygen atoms, or is cyclohexyl or C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, and E<highlight><subscript>16 </subscript></highlight>together with E<highlight><subscript>17 </subscript></highlight>in the case where Z is ethylene, also forms ethylene, </claim-text>
<claim-text>when n is 2, E<highlight><subscript>5 </subscript></highlight>is one of divalent radicals &mdash;O&mdash;E<highlight><subscript>9</subscript></highlight>&mdash;O&mdash; or &mdash;N(E<highlight><subscript>11</subscript></highlight>)&mdash;E<highlight><subscript>10</subscript></highlight>&mdash;N(E<highlight><subscript>11</subscript></highlight>)&mdash;, </claim-text>
<claim-text>E<highlight><subscript>9 </subscript></highlight>is C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>8</subscript></highlight>alkylene, C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>8</subscript></highlight>alkenylene, C<highlight><subscript>4</subscript></highlight>alkynylene, cyclohexylene, straight or branched chain C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>10</subscript></highlight>alkylene which is interrupted by &mdash;O&mdash; or by &mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CHOH&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;O&mdash;E<highlight><subscript>14</subscript></highlight>&mdash;O&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CHOH&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;, </claim-text>
<claim-text>E<highlight><subscript>10 </subscript></highlight>being straight or branched chain C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>alkylene which may be interrupted by &mdash;O&mdash;, cyclohexylene, or </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00027">
<number>27</number>
<image id="EMI-C00027" he="80.88255" wi="146.65455" file="US20030004235A1-20030102-C00027.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00027" file="US20030004235A1-20030102-C00027.CDX"/>
<chemistry-mol-file id="CHEMMOL-00027" file="US20030004235A1-20030102-C00027.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>&emsp;or E<highlight><subscript>10 </subscript></highlight>and E<highlight><subscript>11 </subscript></highlight>with the two nitrogen atoms form a piperazine ring, </claim-text>
<claim-text>E<highlight><subscript>14 </subscript></highlight>is straight or branched chain C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>8</subscript></highlight>alkylene, straight or branched chain C<highlight><subscript>4</subscript></highlight>-C<highlight><subscript>10</subscript></highlight>alkylene which is interrupted by &mdash;O&mdash;, cycloalkylene, arylene or </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00028">
<number>28</number>
<image id="EMI-C00028" he="111.84075" wi="141.8634" file="US20030004235A1-20030102-C00028.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00028" file="US20030004235A1-20030102-C00028.CDX"/>
<chemistry-mol-file id="CHEMMOL-00028" file="US20030004235A1-20030102-C00028.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>E<highlight><subscript>11 </subscript></highlight>is hydrogen, straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>12</subscript></highlight>cycloalkyl, straight or branched chain C<highlight><subscript>2</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkenyl, C<highlight><subscript>6</subscript></highlight>-C<highlight><subscript>14</subscript></highlight>aryl or C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, </claim-text>
<claim-text>E<highlight><subscript>12 </subscript></highlight>is straight or branched chain C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl, straight or branched chain C<highlight><subscript>3</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkenyl, C<highlight><subscript>5</subscript></highlight>-C<highlight><subscript>10</subscript></highlight>cycloalkyl, C<highlight><subscript>6</subscript></highlight>-C<highlight><subscript>16</subscript></highlight>aryl or C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl, </claim-text>
<claim-text>E<highlight><subscript>13 </subscript></highlight>is hydrogen, straight chain or branched C<highlight><subscript>1</subscript></highlight>-C<highlight><subscript>18</subscript></highlight>alkyl which is substituted by &mdash;PO(OE<highlight><subscript>12</subscript></highlight>)<highlight><subscript>2</subscript></highlight>, phenyl which is unsubstituted or substituted by OH, C<highlight><subscript>7</subscript></highlight>-C<highlight><subscript>15</subscript></highlight>aralkyl or &mdash;CH<highlight><subscript>2</subscript></highlight>OE<highlight><subscript>12</subscript></highlight>, </claim-text>
<claim-text>E<highlight><subscript>3 </subscript></highlight>is alkyl of 1 to 20 carbon atoms, hydroxyalkyl of 2 to 20 carbon atoms, alkenyl of 3 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms or said aryl substituted by one or two alkyl of 1 to 4 carbon atoms or 1,1,2,2-tetrahydroperfluoroalkyl where the perfluoroalkyl moiety is of 6 to 16 carbon atoms, </claim-text>
</claim-text>
<claim-text>T is &mdash;SO&mdash;, &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;SO&mdash;E&mdash;SO&mdash;, &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;E&mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;, &mdash;CO&mdash;, &mdash;CO&mdash;CO&mdash;, &mdash;CO&mdash;CH<highlight><subscript>2</subscript></highlight>&mdash;CO&mdash;, &mdash;CO&mdash;E&mdash;CO&mdash;, &mdash;COO&mdash;E&mdash;OCO&mdash; or &mdash;CO&mdash;NG<highlight><subscript>5</subscript></highlight>&mdash;E&mdash;NG<highlight><subscript>5</subscript></highlight>&mdash;CO&mdash;, </claim-text>
<claim-text>where E is alkylene of 2 to 12 carbon atoms, cycloalkylene of 5 to 12 carbon atoms, or alkylene interrupted or terminated by cyclohexylene of 8 to 12 carbon atoms; </claim-text>
<claim-text>G<highlight><subscript>5 </subscript></highlight>is G<highlight><subscript>3 </subscript></highlight>or hydrogen, and </claim-text>
<claim-text>with the proviso that at least one of E<highlight><subscript>1 </subscript></highlight>and E<highlight><subscript>2 </subscript></highlight>is a group of formula V where E<highlight><subscript>22</subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>are not each hydrogen; where if 1 to 4 of E<highlight><subscript>22 </subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>are each hydrogen, the remaining E<highlight><subscript>22 </subscript></highlight>to E<highlight><subscript>26 </subscript></highlight>groups are not each alkyl. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00002">
<claim-text><highlight><bold>2</bold></highlight>. A compound of formula I according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00029">
<number>29</number>
<image id="EMI-C00029" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00029.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00029" file="US20030004235A1-20030102-C00029.CDX"/>
<chemistry-mol-file id="CHEMMOL-00029" file="US20030004235A1-20030102-C00029.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>wherein 
<claim-text>G<highlight><subscript>1 </subscript></highlight>is hydrogen, </claim-text>
<claim-text>G<highlight><subscript>2 </subscript></highlight>is hydrogen, cyano, &mdash;CF<highlight><subscript>3</subscript></highlight>, fluoro, chloro, &mdash;CO&mdash;G<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3 </subscript></highlight>or E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash;, </claim-text>
<claim-text>G<highlight><subscript>3 </subscript></highlight>is hydrogen, straight or branched chain alkyl of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 4 alkyl of 1 to 4 carbon atoms, </claim-text>
<claim-text>E<highlight><subscript>1 </subscript></highlight>is a group of formula IV or formula V wherein E<highlight><subscript>22</subscript></highlight>-E<highlight><subscript>26 </subscript></highlight>are independently hydrogen, alkyl of 1 to 12 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, OH, cyano, &mdash;OE<highlight><subscript>29</subscript></highlight>, chloro, fluoro, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;CF<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>S&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash; or &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;NH&mdash;E<highlight><subscript>29</subscript></highlight>; </claim-text>
<claim-text>E<highlight><subscript>27 </subscript></highlight>and E<highlight><subscript>28 </subscript></highlight>are methyl; </claim-text>
<claim-text>E<highlight><subscript>2 </subscript></highlight>is straight or branched alkyl chain of 1 to 24 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, phenyl, or said phenyl or said phenylalkyl substituted on the phenyl ring by 1 to 3 alkyl of 1 to 4 carbon atoms; or E<highlight><subscript>2 </subscript></highlight>is said alkyl of 1 to 24 carbon atoms or straight or branched alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl substituted by one or more &mdash;OH, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;OE<highlight><subscript>4</subscript></highlight>, &mdash;NCO, &mdash;NHCOE<highlight><subscript>11 </subscript></highlight>or &mdash;NE<highlight><subscript>7</subscript></highlight>E<highlight><subscript>8</subscript></highlight>, or mixtures thereof, where E<highlight><subscript>4 </subscript></highlight>is straight or branched chain alkyl of 1 to 24 carbon atoms or straight or branched chain alkenyl of 2 to 18 carbon atoms; or said alkyl or said alkenyl interrupted by one or more &mdash;O&mdash;, &mdash;NH&mdash; or &mdash;NE<highlight><subscript>4</subscript></highlight>&mdash; groups or mixtures thereof and which can be unsubstituted or substituted by one or more &mdash;OH, &mdash;OE<highlight><subscript>4 </subscript></highlight>or &mdash;NH<highlight><subscript>2 </subscript></highlight>groups or mixtures thereof; or E<highlight><subscript>2 </subscript></highlight>is a group of formula IV or formula V wherein E<highlight><subscript>22</subscript></highlight>-E<highlight><subscript>26 </subscript></highlight>are independently hydrogen, alkyl of 1 to 12 carbon atoms, straight or branched chain alkenyl of 2 to 18 carbon atoms, OH, cyano, &mdash;OE<highlight><subscript>29</subscript></highlight>, chloro, fluoro, &mdash;OCOE<highlight><subscript>11</subscript></highlight>, &mdash;CF<highlight><subscript>3</subscript></highlight>, &mdash;COOG<highlight><subscript>3</subscript></highlight>, E<highlight><subscript>3</subscript></highlight>S&mdash;, E<highlight><subscript>3</subscript></highlight>SO<highlight><subscript>2</subscript></highlight>&mdash; or &mdash;SO<highlight><subscript>2</subscript></highlight>&mdash;NH&mdash;E<highlight><subscript>29</subscript></highlight>; </claim-text>
<claim-text>E<highlight><subscript>3 </subscript></highlight>is alkyl of 1 to 20 carbon atoms, hydroxyalkyl of 2 to 20 carbon atoms, alkenyl of 3 to 18 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, phenylalkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms or said aryl substituted by one or two alkyl of 1 to 4 carbon atoms or 1,1,2,2-tetrahydroperfluoroalkyl where the perfluoroalkyl moiety is of 6 to 16 carbon atoms; and where E<highlight><subscript>11 </subscript></highlight>and E<highlight><subscript>29 </subscript></highlight>are as defined above. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00003">
<claim-text><highlight><bold>3</bold></highlight>. A compound of formula I according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> which is 
<claim-text>4&prime;-methoxy-5-(1,1,3,3-tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, </claim-text>
<claim-text>3&prime;-methoxy-5-(1,1,3,3-tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, </claim-text>
<claim-text>2&prime;-methoxy-5-(1,1,3,3-tetramethyl-butyl)-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, </claim-text>
<claim-text>5-(1,1,3,3-tetramethyl-butyl)-3&prime;-trifluromethyl-3-(5-trifluromethyl-benzotriazol-2-yl)-biphenyl-2-ol, </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00030">
<number>30</number>
<image id="EMI-C00030" he="581.3451" wi="173.53035" file="US20030004235A1-20030102-C00030.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00030" file="US20030004235A1-20030102-C00030.CDX"/>
<chemistry-mol-file id="CHEMMOL-00030" file="US20030004235A1-20030102-C00030.MOL"/>
</chemistry-cwu>
</claim-text>
</claim-text>
</claim>
<claim id="CLM-00004">
<claim-text><highlight><bold>4</bold></highlight>. A stabilized composition which comprises 
<claim-text>(a) an organic material subject to degradation by heat, light or oxygen, and </claim-text>
<claim-text>(b) an effective stabilizing amount of a compound of formula I, II or III according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference>. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00005">
<claim-text><highlight><bold>5</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> wherein component (a) is a thermoplastic polyolefin, polyester, polyester urethane, polyether urethane or a water-borne coating. </claim-text>
</claim>
<claim id="CLM-00006">
<claim-text><highlight><bold>6</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein component (a) is selected from the group consisting of polypropylene, thermoplastic polyolefin, low density polyethylene, medium density polyethylene, high density polyethylene, linear low density polyethylene, poly(butene-1), ethylene/vinyl acetate copolymer, ethylene/propylene copolymer, copolymers of ethylene or propylene with other alpha-olefins, copolymers of acrylonitrile-butadiene-styrene (ABS), copolymers of acrylonitrile and styrene that are impact modified with ethylene-propylene rubber or ethylene/propylene/alpha-olefin rubber or butyl acrylate rubber, blends of ABS and polycarbonate, blends of ABS and poly(vinyl chloride) (PVC), poly(vinyl chloride), copolymers of styrene and butadiene (HIPS), copolymers of styrene and butadiene that also contain ethylene-propylene rubber or ethylene/propylene/alpha-olefin rubber or butyl acrylate rubber, thermoplastic elastomers and thermoplastic vulcanizates. </claim-text>
</claim>
<claim id="CLM-00007">
<claim-text><highlight><bold>7</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00005">claim 5</dependent-claim-reference> wherein component (a) is a polyester or polyether urethane or water-borne coating. </claim-text>
</claim>
<claim id="CLM-00008">
<claim-text><highlight><bold>8</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> which additionally contains an effective stabilizing amount of at least one coadditive stabilizer selected from the group consisting of the phenolic antioxidants, metal stearates, metal oxides, organophosphorus compounds, furanone antioxidants, hydroxylamines, UV absorbers, non-NOR hindered amines, NOR hindered amines and mixtures thereof. </claim-text>
</claim>
<claim id="CLM-00009">
<claim-text><highlight><bold>9</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> which additionally contains a filler. </claim-text>
</claim>
<claim id="CLM-00010">
<claim-text><highlight><bold>10</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00009">claim 9</dependent-claim-reference> wherein the filler is calcium carbonate, clay, talc, mica or glass. </claim-text>
</claim>
<claim id="CLM-00011">
<claim-text><highlight><bold>11</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein component (a) is a polyolefin film, fiber or thick section, ABS, high impact polystyrene (HIPS), thermoplastic polyolefin, thermoplastic elastomer or thermoplastic vulcanizate which additionally contains a halogenated flame retardant. </claim-text>
</claim>
<claim id="CLM-00012">
<claim-text><highlight><bold>12</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 11</dependent-claim-reference> wherein the flame retardant is tris&lsqb;3-bromo-2,2-bis(bromomethyl)propyl&rsqb; phosphate, decabromodiphenyl oxide, ethylene bis(tetrabromophthalimide) or ethylene bis(dibromonorbornanedicarboximide). </claim-text>
</claim>
<claim id="CLM-00013">
<claim-text><highlight><bold>13</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein component (a) is polypropylene fiber. </claim-text>
</claim>
<claim id="CLM-00014">
<claim-text><highlight><bold>14</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00006">claim 6</dependent-claim-reference> wherein component (a) is polypropylene, polyethylene or thermoplastic polyolefin (TPO). </claim-text>
</claim>
<claim id="CLM-00015">
<claim-text><highlight><bold>15</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 14</dependent-claim-reference> wherein component (a) is a paintable thermoplastic olefin (TPO). </claim-text>
</claim>
<claim id="CLM-00016">
<claim-text><highlight><bold>16</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> which additionally comprises a coadditive stabilizer which is a hindered phenolic antioxidant selected from the group consisting of neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate, octadecyl 3,5-di-tert-butyl-4-hydroxyhydrocinnamate, 1,3,5-trimethyl-2,4,6-tris(3,5,-di-tert-butyl-4-hydroxybenzyl)-benzene, 1,2-bis(3,5-di-tert-butyl-4-hydroxyhydrocinnamoyl)hydrazine, calcium &lsqb;bis(monoethyl 3,5-ditert-butyl-4-hydroxybenzyl)phosphonate&rsqb;, 1,3,5-tris(3,5-di-tert-butyl-4-hydroxybenzyl) isocyanurate and 1,3,5-tris(3-hydroxy4-tert-butyl-2,6-dimethylbenzyl) isocyanurate; or is an organophosphorus stabilizer selected from the group consisting of tris(2,4-di-tert-butylphenyl) phosphite, bis(2,4-di-tert-butyl-6-methylphenyl) ethyl phosphite, 2,2&prime;,2&Prime;-nitrilo&lsqb;triethyl-tris-(3,3&prime;,5,5&prime;-tetra-tert-butyl-1,1&prime;-biphenyl-2,2&prime;-diyl) phosphite&rsqb;, tetrakis(2,4-di-butylphenyl) 4,4&prime;-biphenylenediphosphonite, tris(nonylphenyl) phosphite, bis(2,4-di-tert-butylphenyl) pentaerythrityl diphosphite, 2,2&prime;-ethylidenebis(2,4-di-tert-butylphenyl) fluorophosphite and 2-butyl-2-ethylpropan-1,3-diyl 2,4,6-tri-tert-butylphenyl phosphite; or is 5,7-di-tert-butyl-3-(3,4-dimethylphenyl)-2H-benzofuran-2-one; or is N,N-dialkylhydroxylamine made by the direct oxidation of N,N-di(hydrogenated tallow)amine; or is a hindered amine selected from the group consisting of bis(2,2,6,6-tetramethylpiperidin-4-yl) sebacate, the polycondensation product of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;4,6-bis(butyl-1,2,2,6,6-pentamethylpiperidin-4-yl)amino-s-triazin-2-yl&rsqb;-1,10-diamino-4,7-diazadecane, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetra-methylpiperidine) and 2,4-dichloro-6-tert-octylamino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-morpholino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-1,2,2,6,6-pentamethyl-piperidine) and 2,4-dichloro-6-morpholino-s-triazine, 2,2,6,6-tetramethylpiperidin-4-yl octadecanoate, 3-dodecyl-1-(1-acetyl-2,2,6,6-tetramethylpiperidin-4-yl)-pyrrolidin-2,5-dione, 1,3,5-tris&lcub;N-cyclohexyl-N-&lsqb;2-(2,2,6,6-tetramethylpiperazin-3-on-4-yl)ethyl&rsqb;amino&rcub;-s-triazine, poly&lsqb;methyl 3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl&rsqb;siloxane, the polycondensation product of 2,4-dichloro-6-(2,2,6,6-tetramethylpiperidin-4-yl)butylamino)-s-triazine, 2,2&prime;ethylene-bis &lcub;&lsqb;2,4-(2,2,6,6-tetramethylpiperidin-4-yl)butylamino-s-triazin-6-yl&rsqb;aminotrimethyleneamino&rcub;, oligomer of N-&lcub;&lsqb;2-(N-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutylamino)-s-triazin-6-yl,N,N&prime;,N&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine, N,N&prime;,N&prime;&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butyl-amino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine and N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;3,3&prime;-ethylenediimino-dipropylamine; or is another N-hydrocarbyloxy substituted hindered amines selected from the group consisting of bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, bis(1-octyloxy-2,2,6,6-tetramethylpiperidin-4-yl) adipate, bis(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) adipate, bis(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl) sebacate, 1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl octadecanoate, N,N&prime;,N&Prime;-tris&lcub;2,4-bis&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine, N,N&prime;,N&prime;&Prime;-tris&lcub;2,4-bis&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;3,3&prime;-ethylenediiminodipropylamine and N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lcub;2,4-bis&lsqb;N-(1-cyclohexyloxy-2,2,6,6-tetra-methylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine; or a hydroxy substituted N-hydrocarbyloxy substituted hindered amine selected from the group consisting of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl)&rsqb; sebacate; a mixture of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate and bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; adipate; 1-(2-hydroxy-2-methyl-propoxy)-4-octadecanoyloxy-2,2,6,6-tetramethylpiperidine; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; adipate; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate; bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; succinate; a mixture of bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; glutarate and bis&lsqb;1-(2-hydroxy-2-methylpropoxy)-2,2,6,6-tetramethylpiperidin-4-yl&rsqb; succinate; 1-(4-octadecanoyloxy-2,2,6,6-tetramethylpiperidin-1-yloxy)-2-octadecanoyloxy-2-methylpropane; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;9-(methoxy-carbonyl)nonanoyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;5-(methoxy-carbonyl)pentanoyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;3-(methoxy-carbonyl)propionyloxy&rsqb;-2,2,6,6-tetramethylpiperidine; 1-(2-hydroxy-2-methylpropoxy)-4-&lsqb;4-(methoxy-carbonyl)butyryloxy&rsqb;-2,2,6,6-tetramethylpiperidine; or is a UV absorber selected from the group consisting of 2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole, 2-(2-hydroxy-5-methylphenyl)-2H-benzo-triazole, 5-chloro-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole, 2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole, 2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzo-triazole, 2,4-di-tert-butylphenyl 3,5-di-tert-butyl-4-hydroxybenzoate, 2-hydroxy4-n-octyloxy-benzophenone, 2,4-bis(2,4-dimethyphenyl)-6-(2-hydroxy-4-octyloxyphenyl)-s-triazine, oligomer of N-&lcub;2-&lsqb;(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutyl-amino)-s-triazin-6-yl, the condensation product of 2-morpholino-4,6-dichloro-s-triazine with N,N&prime;-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,6-hexanediamine; or mixtures thereof. </claim-text>
</claim>
<claim id="CLM-00017">
<claim-text><highlight><bold>17</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00011">claim 16</dependent-claim-reference> wherein the coadditive stabilizer is neopentanetetrayl tetrakis(3,5-di-tert-butyl-4-hydroxyhydrocinnamate, tris(2,4-di-tert-butyl-phenyl) phosphite, N,N-dialkylhydroxylamine made by the direct oxidation of N,N-di(hydrogenated tallow)amine, N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lsqb;4,6-bis(butyl-1,2,2,6,6-pentamethylpiperidin-4-yl)amino-s-triazin-2-yl&rsqb;-1,10-diamino-4,7-diazadecane, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethylpiperidine) and 2,4-dichloro-6-tert-octylamino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-2,2,6,6-tetramethyl-piperidine) and 2,4-dichloro-6-morpholino-s-triazine, the polycondensation product of 4,4&prime;-hexamethylenebis(amino-1,2,2,6,6-pentamethylpiperidine) and 2,4-dichloro-6-morpholino-s-triazine, oligomer of N-&lcub;&lsqb;2-(N-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutylamino)-s-triazin-6-yl, N,N&prime;,N&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;3,3&prime;-ethylenediiminodipropylamine, N,N&prime;,N&prime;&Prime;-tris&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butyl-amino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediiminodipropylamine and N,N&prime;,N&Prime;,N&prime;&Prime;-tetrakis&lcub;2,4-bis&lsqb;N-(1,2,2,6,6-pentamethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-6-yl&rcub;-3,3&prime;-ethylenediimino-dipropylamine, oligomer of N-&lcub;2-&lsqb;(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)butylamino&rsqb;-s-triazin-4-yl&rcub;-N,N&prime;-bis(1-propoxy-2,2,6,6-tetramethylpiperidin-4-yl)-1,6-hexanediamine terminated with 2,4-bis(dibutylamino)-s-triazin-6-yl, or the condensation product of 2-morpholino-4,6-dichloro-s-triazine with N,N&prime;-bis(1,2,2,6,6-pentamethylpiperidin-4-yl)-1,6-hexanediamine. </claim-text>
</claim>
<claim id="CLM-00018">
<claim-text><highlight><bold>18</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> which additionally contains another UV absorber selected from the group consisting of the benzotriazoles, the s-triazines, the oxanilides, the salicylates, the hydroxybenzophenones, the benzoates and the &agr;-cyanoacrylates. </claim-text>
</claim>
<claim id="CLM-00019">
<claim-text><highlight><bold>19</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> which additionally contains a UV absorber selected from the group consisting of 
<claim-text>(a) 5-trifluoromethyl-2-(2-hydroxy-3-&agr;-cumyl-5-tert-octylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(b) 5-trifluoromethyl-2-(2-hydroxy-5-tert-octylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(c) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-tert-octylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(d) 2,2&prime;-methylene-bis&lsqb;6-(5-trifluoromethyl-2H-benzotriazol-2-yl)-4-tert-octylphenol&rsqb;; </claim-text>
<claim-text>(e) methylene-2-&lsqb;4-tert-octyl-6-(2H-benzotriazol-2-yl)phenol&rsqb;2&prime;-&lsqb;4-tert-octyl-6-(5-trifluoromethyl-2H-benzotriazol-2-yl)phenol&rsqb;; </claim-text>
<claim-text>(f) 3-(5-trifluoromethyl-2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyhydrocinnamic acid; </claim-text>
<claim-text>(g) methyl 3-(5-trifluoromethyl-2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxy-hydrocinnamate; </claim-text>
<claim-text>(h) isooctyl 3-(5-trifluoromethyl-2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxy-hydrocinnamate; </claim-text>
<claim-text>(i) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-hydroxypropyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(j) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-acryloyloxypropyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(k) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-methacryloyloxypropyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(l) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-acrylylaminopropyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(m) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(3-methacrylylaminopropyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(n) 5-trifluoromethyl-2-(2-hydroxy-3-&agr;-cumyl-5-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(o) 5-trifluoromethyl-2-(2-hydroxy-3-&agr;-cumyl-5-nonylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(p) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-&agr;-cumyl-5-(2-hydroxyethyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(q) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-&agr;-cumyl-5-(3-hydroxypropyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(r) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-tert-amylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(s) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(t) 5-trifluoromethyl-2-(2-hydroxy-3-dodecyl-5-methylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(u) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-tert-butyl-5-(3-hydroxypropyl)phenyl)-2H-benzotriazole; </claim-text>
<claim-text>(v) 5-trifluoromethyl-2-&lsqb;2-hydroxy-3-tert-butyl-5-(2-hydroxyethyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(w) 5-trifluoromethyl-2-&lsqb;2-hydroxy-5-(2-hydroxyethyl)phenyl&rsqb;-2H-benzotriazole; </claim-text>
<claim-text>(x) 5-trifluoromethyl-2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(y) 5-fluoro-2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(z) 5-butylsulfonyl-2-(2-hydroxy-3,5-di-&agr;-cumylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(aa) 5-butylsulfonyl-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole; </claim-text>
<claim-text>(bb) 5-butylsulfonyl-2-(2-hydroxy-3,5-di-tert-octylphenyl)-2H-benzotriazole; and </claim-text>
<claim-text>(cc) 5-phenylsulfonyl-2-(2-hydroxy-3,5-di-tert-butylphenyl)-2H-benzotriazole. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00020">
<claim-text><highlight><bold>20</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> which is a stabilized stoving lacquer wherein component (a) is an acid catalyzed resin based on hot crosslinkable, acrylic, acrylic melamine, polyester, polyurethane, polyamide or alkyd resin. </claim-text>
</claim>
<claim id="CLM-00021">
<claim-text><highlight><bold>21</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference> which additionally contains a UV absorber. </claim-text>
</claim>
<claim id="CLM-00022">
<claim-text><highlight><bold>22</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 20</dependent-claim-reference> which is an enamel of high solids content for industrial finishes. </claim-text>
</claim>
<claim id="CLM-00023">
<claim-text><highlight><bold>23</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 22</dependent-claim-reference> which is a finishing enamel for automobiles. </claim-text>
</claim>
<claim id="CLM-00024">
<claim-text><highlight><bold>24</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> which is a stabilized ambient curable composition wherein component (a) is a resin selected from the group consisting of unmodified or modified alkyd resin, acrylic resin, acrylic alkyd resin, polyester resin or crosslinkable epoxide resin. </claim-text>
</claim>
<claim id="CLM-00025">
<claim-text><highlight><bold>25</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 24</dependent-claim-reference> wherein the resin is selected from the group consisting of unmodified alkyl, acrylic, acrylic alkyd or polyester resins; said resins modified with silicon, isocyanates, isocyanurates, ketimines or oxazolidines; crosslinked epoxy resins; and epoxy-crosslinked acrylic and polyester resins. </claim-text>
</claim>
<claim id="CLM-00026">
<claim-text><highlight><bold>26</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 25</dependent-claim-reference> which is an enamel of high solids content for industrial finishes. </claim-text>
</claim>
<claim id="CLM-00027">
<claim-text><highlight><bold>27</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 26</dependent-claim-reference> which is a finishing enamel for automobiles. </claim-text>
</claim>
<claim id="CLM-00028">
<claim-text><highlight><bold>28</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 27</dependent-claim-reference> which is a curable electrocoat composition wherein component (a) is an amino-group containing resin having functional groups that are reactive with an isocyanate and an aromatic polyisocyanate crosslinking agent. </claim-text>
</claim>
<claim id="CLM-00029">
<claim-text><highlight><bold>29</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> which is a non-gelling liquid coating composition wherein component (a) comprises (A) at least one acrylic monomer, (B) silica and (C) at least one initiator for ultraviolet radication-induced curing of said composition. </claim-text>
</claim>
<claim id="CLM-00030">
<claim-text><highlight><bold>30</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00022">claim 29</dependent-claim-reference> which contains a silyl acrylate, a polyfunctional acrylate, silica and a photoinitiator. </claim-text>
</claim>
<claim id="CLM-00031">
<claim-text><highlight><bold>31</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> wherein component (a) is a polyolefin, polycarbonate, a styrenic, ABS, a nylon (polyamide), a polyester, a polyurethane, a polyacrylate, a rubber modified styrenic, poly(vinyl chloride), poly(vinyl butyral), polyacetal (polyoxymethylene), or other blends or copolymers such as poly(ethylene/1,4-cyclohexylenedimethylene terephthalate) PETG or an ethylene/acrylic acid copolymer or salts thereof (an ionomer). </claim-text>
</claim>
<claim id="CLM-00032">
<claim-text><highlight><bold>32</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 31</dependent-claim-reference> wherein the polymer is a polyester or a polyacrylate. </claim-text>
</claim>
<claim id="CLM-00033">
<claim-text><highlight><bold>33</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference> wherein the polyester is poly(ethylene terephthalate), poly(butylene terephthalate) or poly(ethylene naphthalenedicarboxylate), or copolymer poly(ethylene/1,4-cyclohexylenedimethylene terephthalate) PETG. </claim-text>
</claim>
<claim id="CLM-00034">
<claim-text><highlight><bold>34</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> wherein component (a) is a thermoplastic polymer. </claim-text>
</claim>
<claim id="CLM-00035">
<claim-text><highlight><bold>35</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 34</dependent-claim-reference> wherein the polymer is a polyolefin or polycarbonate. </claim-text>
</claim>
<claim id="CLM-00036">
<claim-text><highlight><bold>36</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference> wherein the polymer is polyethylene or polypropylene. </claim-text>
</claim>
<claim id="CLM-00037">
<claim-text><highlight><bold>37</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00004">claim 4</dependent-claim-reference> wherein component (a) is a photographic composition. </claim-text>
</claim>
<claim id="CLM-00038">
<claim-text><highlight><bold>38</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 35</dependent-claim-reference> wherein the polymer is polycarbonate. </claim-text>
</claim>
<claim id="CLM-00039">
<claim-text><highlight><bold>39</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 32</dependent-claim-reference> wherein the polymer is a polyacrylate. </claim-text>
</claim>
<claim id="CLM-00040">
<claim-text><highlight><bold>40</bold></highlight>. A composition according to <dependent-claim-reference depends_on="CLM-00033">claim 39</dependent-claim-reference> wherein the polyacrylate is poly(methyl methacrylate). </claim-text>
</claim>
<claim id="CLM-00041">
<claim-text><highlight><bold>41</bold></highlight>. A process for the preparation of a compound of formula I, II or III according to <dependent-claim-reference depends_on="CLM-00001">claim 1</dependent-claim-reference> </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00031">
<number>31</number>
<image id="EMI-C00031" he="294.52815" wi="198.02475" file="US20030004235A1-20030102-C00031.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00031" file="US20030004235A1-20030102-C00031.CDX"/>
<chemistry-mol-file id="CHEMMOL-00031" file="US20030004235A1-20030102-C00031.MOL"/>
</chemistry-cwu>
<claim-text>where E<highlight><subscript>1 </subscript></highlight>is a group of the formula V, </claim-text>
<claim-text>which process comprises reacting an arylboronic acid or ester of formula</claim-text>
<claim-text><in-line-formula>E<highlight><subscript>1</subscript></highlight>&mdash;B(OR<highlight><subscript>1</subscript></highlight>)(OR<highlight><subscript>2</subscript></highlight>)</in-line-formula></claim-text>
<claim-text>where E<highlight><subscript>1 </subscript></highlight>is a group of the formula V, R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>are independently hydrogen, alkyl of 1 to 12 carbon atoms, or R<highlight><subscript>1 </subscript></highlight>and R<highlight><subscript>2 </subscript></highlight>together are alkylene of 2 to 4 carbon atoms; </claim-text>
<claim-text>with a benzotriazole of formula VI </claim-text>
<claim-text> 
<chemistry-cwu id="CHEM-US-00032">
<number>32</number>
<image id="EMI-C00032" he="78.0192" wi="198.02475" file="US20030004235A1-20030102-C00032.TIF"/>
<chemistry-chemdraw-file id="CHEMCDX-00032" file="US20030004235A1-20030102-C00032.CDX"/>
<chemistry-mol-file id="CHEMMOL-00032" file="US20030004235A1-20030102-C00032.MOL"/>
</chemistry-cwu>
</claim-text>
<claim-text>where X is chloro, bromo or iodo, or tosylate, </claim-text>
<claim-text>in the presence of an effective amount of a palladium (II) catalyst at a temperature between 10 to 100&deg; C. </claim-text>
</claim-text>
</claim>
<claim id="CLM-00042">
<claim-text><highlight><bold>42</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> wherein X is bromo. </claim-text>
</claim>
<claim id="CLM-00043">
<claim-text><highlight><bold>43</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> wherein the reaction is carried out at a temperature between 50 to 95&deg; C. </claim-text>
</claim>
<claim id="CLM-00044">
<claim-text><highlight><bold>44</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> wherein the amount of palladium (II) catalyst is 0.01 to 100 mol percent. </claim-text>
</claim>
<claim id="CLM-00045">
<claim-text><highlight><bold>45</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> wherein additionally a ligand is present. </claim-text>
</claim>
<claim id="CLM-00046">
<claim-text><highlight><bold>46</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 45</dependent-claim-reference> wherein the ligand is triphenylphosphine, 2-(di-tert-butylphosphino)biphenyl, 1,1&prime;-bis&lsqb;2,4,8,10-tetrakis(tert-butyl)-dibenzo&lsqb;d,f&rsqb;&lsqb;1,3,2&rsqb;dioxaphosphepin-6-yl&rsqb;ferrocene, tris(2,4-di-tert-butylphenyl) phosphite or 2,2&prime;,2&Prime;-nitrilo&lsqb;triethyl-tris(3,3&prime;,5,5&prime;-tetra-tert-butyl-1,1&prime;biphenyl-2,2&prime;-diyl)phosphite&rsqb;. </claim-text>
</claim>
<claim id="CLM-00047">
<claim-text><highlight><bold>47</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 46</dependent-claim-reference> wherein the ligand is triphenylphosphine. </claim-text>
</claim>
<claim id="CLM-00048">
<claim-text><highlight><bold>48</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> wherein the process is an anhydrous process with dioxane as solvent and potassium fluoride as a base. </claim-text>
</claim>
<claim id="CLM-00049">
<claim-text><highlight><bold>49</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> wherein the process is carried out using n-propanol or isopropanol as solvent with a small amount of water present and aqueous sodium carbonate as base. </claim-text>
</claim>
<claim id="CLM-00050">
<claim-text><highlight><bold>50</bold></highlight>. A process according to <dependent-claim-reference depends_on="CLM-00044">claim 41</dependent-claim-reference> in which the benzotriazole of formula VI is 2-chloro-4-(1,1,3,3-tetramethyl-butyl)-6-(5-trifluromethyl-benzotriazol-2-yl)phenol.</claim-text>
</claim>
</subdoc-claims>
</patent-application-publication>
